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Summary 
Background and aim: Ischaemic heart disease (IHD) is the leading cause of morbidity and 
mortality worldwide with an estimated 7.4 million deaths due to IHD in 2015. Addressing 
modifiable risk-factors such as diet can help prevent IHD.  
The overall aim of this thesis was to study the effects of targeted substitution dietary guidelines on 
dietary intake and IHD risk factors in an adult Danish population. The specific research objectives 
were: i) to investigate the associations between adherence to the current Danish official dietary 
guidelines assessed by a diet quality index (DQI) and selected cardio-metabolic risk factors (paper 
I); and ii) to examine the short- and long term effects of applying targeted substitution dietary 
guidelines on dietary intake (paper II) and IHD risk factors (Paper III). 
Methods: A 6-month single-blinded parallel randomised controlled trial (RCT) with a 6-month 
follow-up was conducted in a real-life setting including an adult Danish population with a minimum 
of one self-reported risk factor of IHD. At baseline participants were assigned to either a control 
group advised to follow their habitual diet or one of two intervention groups receiving either 
targeted substitution dietary guidelines or the Danish official dietary guidelines. 
At baseline and after 6 and 12 months, information on dietary intake of the participants was 
obtained by a 7-day web-based dietary record, and a DQI score was calculated as a marker for 
adherence to the two sets of dietary guidelines. Fasting blood samples were analysed for lipid- and 
glyceamic biomarkers and alkylresorcinols, and blood pressure, heart rate, anthropometric 
measurements, and background questionnaires were collected. Linear regression analyses were 
applied.  
Results: A total of 222 participants were enrolled with a median age of 51 years, 59% were women, 
and 73 % were overweight or obese. 
In the cross-sectional study (paper I) based on the baseline data of the RCT, the DQI score was 
significantly inversely associated with low-density lipoprotein cholesterol/high-density lipoprotein 
cholestreol (HDL-c) -ratio and triglycerides and positively associated with HDL-c. For men, DQI 
was inversely associated with body mass index, trunk fat, high-sensitivity C-reactive protein, 
haemoglobin A1c, insulin, and insulin resistance. In women, DQI was positively associated with 
systolic blood pressure. 
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The overall results of the RCT (paper II and paper III) showed that compared with the habitual diet 
group, the group following the targeted substitution dietary guidelines statistically significantly 
increased their intake of whole grains, dietary fibre, and fine vegetables, and statistically 
significantly decreased their percentage of energy (E%) intake from saturated fat (SFA) from 
baseline to 6 months. In the same period the group following the Danish official dietary guidelines 
statistically significantly decreased their E% intake from SFA compared with the habitual diet 
group. From baseline to 12 months, both intervention groups statistically significantly increased 
their intake of whole grains and fish, and the group receiving the Danish official dietary guidelines 
still showed a statistically significantly decrease in E% intake from SFA compared with the habitual 
diet group. Additional analysis showed that from baseline to 6 and 12 months the DQI score 
statistically significantly increased in both intervention groups compared to the habitual diet group. 
No overall statistically significantly differences in change in cardio-metabolic risk factors were 
found in either of the two intervention groups compared to the habitual diet group. In addition, self-
reported whole grain intake was associated with plasma alkylresorcinol concentrations at baseline. 
Conclusion: Closer adherence to the current Danish official dietary guidelines, assessed by a DQI, 
was associated with a more beneficial cardio-metabolic risk profile in a Danish adult population 
with at least one self-reported risk factor for IHD (paper I).  
In the short-term the targeted substitution dietary guidelines were more effective than the Danish 
official dietary guidelines in changing the diet, resulting in a dietary composition of the overall diet 
being more cardio-protective compared with the habitual diet. The long-term effectiveness of the 
two sets of dietary guidelines was similar (paper II). This was supported by the observed short and 
long term increase in DQI score, indicating increased adherence to both sets of dietary guidelines.  
However, neither the targeted substitution dietary guidelines nor the Danish official dietary 
guidelines showed any overall beneficial effects on IHD risk factors compared with the habitual diet 
(paper III).  
The findings of the three papers included in this thesis will add to the understanding of the impact 
of applying dietary guidelines on dietary intake and IHD risk factors and will be of importance in 
future revisions of dietary guidelines.  
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Sammendrag 
Baggrund og formål: Iskæmisk hjertesygdom (IHS) er den førende årsag til morbiditet og 
dødelighed i verden med omkring 7,4 millioner dødsfald som følge af IHS i 2015. Fokus på 
modificerbare risikofaktorer så som kost kan hjælpe med at forebygge IHS. 
Det overordnede formål med denne afhandling var at undersøge effekterne af målrettede 
substitutionskostråd på kostindtag og risikofaktorer for IHS i en voksen dansk befolkning. De 
specifikke forskningsmål var: i) at undersøge sammenhængen mellem efterlevelse af de nuværende 
officielle danske kostråd, vurderet ved hjælp af et kostindex (DQI), og udvalgte kardiometaboliske 
risikofaktorer (artikel I), og ii) at undersøge de kort- og langsigtede effekter af målrettede 
substitutionskostråd på kostindtag (artikel II) og risikofaktorer for IHS (artikel III). 
Metoder: En 6-måneders enkeltblindet, parallelt randomiseret kontrolleret undersøgelse (RCT) 
med en 6-måneders opfølgning blev gennemført i en ”real-life setting” i en voksen dansk 
befolkning med mindst én selvrapporteret risikomarkør for IHS. Ved baseline blev deltagerne 
randomiseret i enten en kontrolgruppe, der blev henvist til at følge deres sædvanlige kost, eller til en 
af to interventionsgrupper, der enten modtog målrettede kostråd eller de officielle danske kostråd. 
Ved baseline og efter 6 og 12 måneder blev information om kostindtaget blandt deltagerne 
indsamlet ved hjælp af en 7-dages, web-baseret kostdagbog, og en DQI-score blev beregnet som en 
markør for efterlevelse af kostrådene i hver interventionsgruppe. Fastende blodprøver blev taget og 
analyseret for lipid- og glykæmiske biomarkører samt alkylresorcinoler. Blodtryk, puls, 
antropometriske målinger og baggrundsspørgsmål blev indsamlet, og lineære regressionsanalyser 
anvendt. 
Resultater: I alt blev 222 deltagere inkluderet med en median alder på 51 år, hvoraf 59% var 
kvinder, og 73% var overvægtige eller fede. 
I tværsnitsstudiet (artikel I) baseret på baseline data fra RCT’en var DQI-scoren signifikant invers 
associeret med lavdensititets lipoprotein kolesterol/højdensititets lipoprotein kolesterol (HDL-c)-
ratio og triglycerid og positivt associeret med HDL-c. For mænd var DQI-scoren omvendt 
associeret med body mass index, kropsfedt, high sensitivity C-reaktivt protein, haemoglobin A1c, 
insulin og insulin resistens. Hos kvinder var DQI positivt associeret med systolisk blodtryk. 
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De samlede resultater af RCT’en (artikel II og artikel III) viste, at gruppen, der modtog målrettede 
substitutionskostråd, statistisk set signifikant øgede deres indtag af fuldkorn, kostfibre og fine 
grøntsager og statistisk set signifikant sænkede deres procentdel af energi (E%) indtaget fra mættet 
fedt statistisk set signifikant sammenlignet med den habituelle kostgruppe, fra baseline til 6 
måneder. I samme periode sænkede gruppen, der modtog de officielle danske kostråd, E% -indtaget 
fra mættet fedt statistisk set signifikant sammenlignet med den habituelle kostgruppe. Fra baseline 
til 12 måneder forøgede begge interventionsgrupper deres indtag af fuldkorn og fisk statistisk set 
signifikant, og gruppen, der modtog de officielle danske kostråd, sænkede deres E% indtag fra 
mættet fedt sammenlignet med den habituelle kostgruppe. Yderligere analyser viste, at fra baseline 
til både 6 og 12 måneder steg DQI-scoren statistisk set signifikant i begge interventionsgrupper 
sammenlignet med den habituelle kostgruppe.  
Der blev ikke fundet nogen overordnede statistisk set signifikante forskelle i ændringer i 
kardiometabolske risikofaktorer i nogen af interventionsgrupperne sammenlignet den habituelle 
kostgruppe. 
Hertil kommer, at selvrapporteret fuldkornsindtag var associeret med plasma alkylresorcinoler ved 
baseline. 
Konklusion: Bedre efterlevelse af de nuværende danske officielle kostråd, vurderet ved et DQI, var 
forbundet med en mere fordelagtig kardiometabolisk risikoprofil i en voksen dansk befolkning med 
mindst en selvvurderet risikofaktor for IHS (artikel I). 
På kort sigt var de målrettede substitutionskostråd mere effektive til at ændre kosten end de 
officielle danske kostråd, hvilket resulterede i, at kostsammensætningen af den samlede kost var 
mere hjertebeskyttende end kosten i den habituelle kostgruppe. De langsigtede effekter af de to sæt 
kostråd var sammenlignelige (artikel II). Dette blev understøttet af den observerede kort- og 
langsigtede forøgelse i DQI-score, hvilket indikerer en øget efterlevelse af begge sæt kostråd. 
Dog viste hverken de målrettede substitutionskostråd eller de officielle danske kostråd generelle 
gavnlige effekter på risikofaktorer for IHS sammenlignet med en habituel kost (artikel III). 
Resultaterne af de tre artikler, der indgår i denne afhandling bidrager til forståelsen af effekten 
kostråd på kostindtaget og IHS-risikofaktorer, og bør have betydning for eventuelle revideringer af 
kostrådene. 
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1 Introduction 
 Rationale for this thesis  
The research described in this PhD thesis concerns the impact of targeted substitution dietary 
guidelines for the prevention of the most common cardiovascular disease (CVD), namely ischaemic 
heart disease (IHD). 
IHD arises from a combination of genetic and behavioural risk factors. Addressing behavioural 
risk factors, such as an unhealthy diet, may help improve some of the clinical conditions 
contributing to the development of IHD, including hypertension, diabetes, hyperlipidaemia, 
overweight and obesity (1–4). Therefore, identifying the optimal diet for prevention of IHD in the 
general population is crucial. 
Dietary guidelines worldwide, including the Danish official dietary guidelines, are typically 
based on systematic literature reviews of the association between food intake and different 
relevant diet-related diseases in the target group of the recommendations (5–7). However, targeted 
dietary guidelines addressing one specific nutrition-related lifestyle disease, such as IHD, might 
be even more effective in preventing IHD than dietary guidelines targeting all relevant nutrition-
related diseases, as in the case of the Danish official dietary guidelines. 
Previously, dietary research has focused mainly on single foods or nutrients to evaluate the 
association between diet and disease outcomes. Yet this does not resemble real-life situations as 
people consume foods and nutrients in combination. During recent decades, therefore, research 
on diet–disease associations have focused on the overall quality of dietary patterns and national 
dietary guidelines (8–11). However, the optimal intake of foods and nutrients in combination to 
prevent IHD is still unclear. 
When individuals change their intake of specific nutrients or foods, they primarily change their 
dietary composition rather than their total energy intake (12). Therefore, the changes that 
individuals must make toward achieving a healthy dietary pattern are important, and the foods or 
nutrients used by individuals as substitutes, to achieve a healthy dietary pattern, are not 
insignificant; indeed, this substitution aspect is important. 
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 Aim and objectives 
The overall aim of this thesis research was to study the effects of targeted substitution dietary 
guidelines on dietary intake and IHD risk factors in an adult Danish population.  
The specific research objectives were: 
– To investigate the associations between adherence to the current Danish official dietary 
guidelines, assessed by a diet quality index (DQI), and selected cardiometabolic risk factors 
(paper I). 
– To examine the short- and long-term effects of applying targeted substitution dietary 
guidelines on dietary intake (paper II) and IHD risk factors (paper III). 
The three manuscripts (paper I, paper II, and paper III) are included in this thesis as Appendix A. 
This PhD thesis is an integrated part of the large-scale research project entitled ´Diet and prevention 
of ischemic heart disease: a translational approach´ (DIPI; www.dipi.dk).  
The aim of DIPI was to study dietary patterns and optimal substitutions of energy-providing foods 
and macronutrients in relation to IHD development through observational studies, and to further 
translate this knowledge into food-based dietary guidelines targeting prevention of IHD, to be tested 
in a randomised controlled trial (RCT). 
Therefore, the focus of the research discussed in this thesis is the effects of food-based dietary 
guidelines on dietary intake and intermediate risk factors for IHD in a dietary RCT.  
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2 Background 
 Ischaemic heart disease 
2.1.1 Definition 
CVDs are the general term used for a group of disorders of the heart and blood vessels, including 
IHD (13). IHD is caused by inadequate oxygen as a result of reduced blood supply to the heart, 
often caused by atherosclerosis which causes narrowing or blocking of the coronary arteries (13, 
14). The main clinical manifestations of IHD are angina pectoris (chest pain or discomfort) and 
myocardial infarction (MI). 
IHD is sometimes referred to using other terms, such as coronary heart disease (CHD), coronary 
artery disease, and atherosclerotic heart disease. In this thesis, the term IHD is used to refer to 
IHD in general; when referring to previous studies on IHD and CVD risk factors or other 
subcategories of CVDs, the term used by the authors will be reported. 
2.1.2 Risk factors  
IHD arises from a combination of unmodifiable and modifiable behavioural risk factors (Table 
1). Modifiable behavioural risk factors include an unhealthy diet, smoking, high alcohol intake, 
and sedentary lifestyle (13, 15). Addressing these behavioural risk factors can help improve various 
clinical conditions including hyperlipidaemia, hypertension, overweight/obesity, and diabetes, 
which all contribute to the progression of atherosclerosis and therefore are major risk factors for 
the development of IHD (1–4).  
As serum lipids play an important role in the pathogenesis of atherosclerosis (see section 2.1.3), 
hyperlipidaemia is one of the most important risk factors for development of IHD. 
Hyperlipidaemia is defined as an abnormal lipid profile with elevated concentrations of total 
cholesterol, low-density lipoprotein (LDL), cholesterol or triglycerides (TAG), or low levels of 
high-density lipoprotein (HDL) cholesterol (4). In addition, C-reactive protein (CRP) serves as a 
marker for inflammation, which is present in all stages of atherosclerosis. Thus, managing CRP 
levels is a supportive measure for addressing IHD risk in clinical practise (16, 17).  
Hypertension or high blood pressure includes both measures of systolic blood pressure and 
diastolic blood pressure. Overweight/obesity is defined according to body mass index (BMI) and 
abdominal obesity, which is defined by measuring the waist circumference (4, 18).  
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Diabetes or prediabetes are terms used to describe a metabolic disorder characterized by chronic 
hyperglycaemia and impaired insulin secretion and or insulin action (19, 20). Haemoglobin A1c 
(HbA1c) levels serve as a measure of an individual’s average glucose level over the previous 3 
months (21). In addition, the homeostatic model assessment (HOMA) is widely used as a measure 
of changes in insulin resistance (HOMA-IR) that may increase the risk of development of 
diabetes and prediabetes (22, 23).  
In Table 1, unmodifiable and modifiable behavioural risk factors are collected and presented 
together with the recommended cut-off levels for defining the above-mentioned risk factors of 
IHD in clinical practise. 
Table 1 Unmodifiable and modifiable behavioural risk factors and recommended cut-off levels for the definition 
of risk factors for IHD in clinical practice. 
 
Unmodifiable 
risk factors 
Modifiable risk 
factors 
Clinical conditions accelerating atherosclerosis and 
definitions in clinical practise † 
Genetics 
Age 
Sex 
Unhealthy diet 
Smoking 
Excess alcohol 
intake 
Sedentary 
lifestyle  
 
 
 
Hyperlipidaemia 
  Total cholesterol > 5.0 mmol/L  
  LDL-c > 3.0 mmol/L  
  HDL-c: 
   men < 1.0 mmol/L 
   women < 1.2 mmol/L        
  TAG  level > 1.7 mmol/L 
   
Hypertension 
   
 
 
 
  SBP > 140 mmHg 
  DBP > 90 mmHg 
   
Overweight and 
obesity 
 
  BMI ≥ 25 kg/m2 and  
  BMI > 30 kg/m2 
   
 
Abdominal obesity 
 
 
 
 
Prediabetes and 
diabetes 
   
 
 
  WC: 
   men > 94 cm  
   women > 88 cm    
      
 
     Glucose > 7.0 mmol/L 
  HbA1c  > 6.5% 
  HOMA-IR > 2.29 §   
Abbreviations: IHD, ischaemic heart disease; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density 
lipoprotein cholesterol; TAG, triglyceride; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body 
mass index; WC, waist circumference; HbA1c, haemoglobin A1c; HOMA-IR, homeostatic model assessment insulin 
resistance.  
† According to European guidelines on cardiovascular disease prevention in clinical practice and the World Health 
Organization (4, 19). 
‡ A cut-off point for insulin resistance measured by HOMA-IR does not exist; however, a definition for low insulin 
resistance has been suggested as HOMA-IR > 2.29  (24). 
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Figure 1 Progression of changes in the arterial wall in response to injury. 1: Normal arteries, 2: 
Endothelial injury with adhesion of monocytes, 3: Migration of monocytes and smooth muscle cells 
(SMCs) into the intima, 4: Macrophage and SMC uptake of lipids, 5: Well-developed plaque. Illustration 
from Kumar et al. (14). 
2.1.3 Pathogenesis  
The primary cause of IHD is atherosclerosis, which is a slowly progressing arterial disease (Figure 
1) (25). 
The smooth layer of the artery wall that faces the 
arterial lumen is mainly made up of endothelial 
and smooth muscle cells, which serve as a semi-
permeable barrier where fluid, nutrients, and so on 
can be transported from the blood to the tissues 
(14).  
Briefly, the evolution of atherosclerosis is based 
on the ‘The Response to Injury’ theory, and 
begins with endothelial injury (14). Endothelial 
injury results from different internal or external 
insults, including haemodynamic disturbances, 
e.g. where arteries branch and development of 
vascular disorders such as hypertension, 
hyperlipidaemia, or chronically elevated blood 
glucose levels (14). 
Endothelial injury results in secretion of 
cytokines, causing a chronic inflammatory 
response. Furthermore, endothelial injury causes 
endothelial dysfunction with increased 
permeability where adhesion and migration of 
monocytes, smooth muscle cells, and lipoproteins 
(LDL and very low-density lipoprotein; VLDL) 
takes place (14, 25). Inside the intima, monocytes 
differentiate into macrophages and take up the 
LDL, which has undergone oxidation. The 
macrophages continue to take up oxidized LDL 
and eventually turn into ´foam cells´, until 
apoptosis occurs and the foam cells die. After 
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apoptosis, the lipids will accumulate, and thickening of the intima eventually creates fatty 
streaks, which can evolve into atherosclerotic plaques and cause reduced blood flow, resulting in 
oxygen inadequacy (14). 
Serum lipids play an especially important role in the pathogenesis of atherosclerosis because of 
the accumulated uptake by macrophages in the intima (25, 26). In addition, the increased 
oxidization of LDL inside the intima further stimulates release of cytokines, chemokines, and 
growth factors, resulting in increased recruitment of monocytes to the endothelial injury, leading 
to accelerated atherosclerosis plaque development (14, 26). 
2.1.4 IHD from a public health perspective 
As in most other Western countries, IHD is the leading cause of morbidity and mortality in 
Denmark. There were an estimated 7.4 million deaths worldwide owing to IHD in 2015 (13). In 
Denmark, the total incidence of IHD in 2015 was about 18,500, with a total prevalence of 
approximately 100,000 men and around 61,000 women (27). In total, IHD accounts for over 7% of 
all deaths in Denmark, making IHD one of the deadliest diseases (28). 
Despite this, the number of deaths due to IHD in Denmark and most other European countries 
has decreased during the period from 1995 to 2015 (27, 28). The decreased incidence of IHD, 
together with increasing survival of individuals with the disease, have contributed to the 
decrease in mortality (29). However, increased survival of IHD also increases the need for health 
care services for people living with the disease, resulting in a total annual cost for treatment and 
care of 1.760 billion DKK (28).  
 Evidence-based dietary guidelines 
To promote health and reduce the risk of diet-related diseases, including IHD, in the general 
population through improved nutrition and physical activity, health authorities in Denmark and 
most other Western countries have established dietary guidelines (6, 7, 30–32). These guidelines are 
based on the available body of scientific evidence on the association between food intake and 
physical activity and different diet-related diseases (5–7, 33, 34).  
In Denmark, the first set of dietary guidelines was launched in 1970, and the guidelines have 
been continuously revised since. The latest revision of the Danish official dietary guidelines was 
published in 2013, based on a systematic literature update of the scientific literature on the 
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associations between food intake and physical activity and different diet-related diseases and the 
Nordic Nutrition Recommendations 2012 (5, 35). The official dietary guidelines contain 10 
recommendations for foods and physical activity (Table 2) (36). The purpose of the Danish 
official dietary guidelines is to translate the nutrient requirements of the population into dietary 
recommendations, which requires consideration of the usual Danish dietary intake and physical 
activity level as well as Danish food culture and availability (5). However, adherence to the 
Danish official dietary guidelines remains low, with around 90% of Danish adults who do not eat 
the recommended daily amount of fruit and vegetables and 82% who do not eat the 
recommended daily amount of fish (37, 38).  
Table 2 The ten Danish official dietary guidelines (36). 
Danish official dietary guidelines 
Eat a variety of foods, but not too much, and be physically active 
Eat fruits and many vegetables (600 g/10MJ/day) † 
Eat more fish (350 g/week) 
Choose whole grains (min 75 g/10MJ/day) 
Choose lean meats and cold meats (max 500 g/week) 
Choose low-fat dairy products 
Eat less saturated fat 
Eat foods with less salt 
Eat less sugar  
Drink water 
† At least half should be vegetables (5). 
2.2.1 Promoting dietary guidelines 
Many initiatives have been implemented in the past decade to promote the Danish official 
dietary guidelines among the general population, to facilitate making healthier choices. These 
initiatives include partnerships, such as the Keyhole and the Whole Grain partnerships (39, 40). 
Both aim to make it easier for consumers to find and choose healthier foods and to follow the 
national dietary guidelines. Among other approaches, this is done through food labelling, 
ensuring that foods labelled with the Keyhole or Whole Grain logo meet specific requirements 
for whole grain, fibre, fat, sugar, and salt content.  
2.2.2 Targeted dietary guidelines and rationale of including specific substitutions  
The evidence base for the Danish official dietary guidelines presents a convincing or probable 
causal relationship between a lower risk of IHD and CVD and the intake of fish, fruit and 
vegetables, dietary fibre, whole grains, and the substitution of saturated fat with polyunsaturated 
fat (5). These foods and nutrients were the main focus when developing the five targeted dietary 
guidelines investigated in this thesis research.  
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These targeted substitution dietary guidelines were further developed with recommendations for 
specific substitutions, as it is well established that when individuals change their intake of 
specific nutrients or foods, they primarily change their dietary composition rather than their total 
energy intake (12). Therefore, the shifts that individuals need to make toward achieving a healthy 
dietary eating pattern are important, and the specific foods or nutrients used as substitutes by 
individuals to achieve a healthy dietary pattern are crucial. Therefore, the rationale in this study 
for establishing specific substitutions was to guide and motivate participants’ changes in foods 
or nutrients toward those that are the most cardioprotective.   
 Foods and nutrients relevant to IHD prevention 
The current Danish official dietary guidelines are based on a systematic literature update of the 
scientific literature up to 15 October 2012, which, as mentioned, showed a convincing or 
probable causal relationship between the intake of fish, fruit and vegetables, dietary fibre, whole 
grains, substitution of saturated fat with polyunsaturated fat, and lower risk of IHD and CVD (5).  
In addition, the author of this thesis conducted literature searches in PubMed on the selected 
food groups or nutrients, including substitutions, and IHD, from October 2012 to January 2018. 
Reference lists of the papers identified in these searches were read through, to search for 
additional relevant articles. 
The focus of the literature search was primarily meta-analyses. Thus, in the following paragraphs 
recent relevant meta-analyses, including RCTs and observational studies as well as selected 
supplementary single cohort studies, all aiming to investigate the above-mentioned foods and 
nutrients, including red meat (owing to its high-saturated fat content) in relation to IHD will be 
presented.  
2.3.1 Fish 
In this thesis and the included papers, fish refers to fresh, frozen, smoked, or canned fish and 
shellfish. Fish contains n-3 polyunsaturated fatty acids (PUFAs) and is an important source of 
vitamin D and selenium. The cardioprotective effect of fish consumption has been suggested to 
be mainly ascribable to the content of n-3 fatty acids (5).  
The suggested cardioprotective effects of n-3 PUFAs include modulation of serum lipids, 
regulation of blood pressure, reducing arrhythmia (irregular heartbeat), endothelial function 
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improvement, and inhibiting inflammation, thereby producing a protective effect against 
diseases characterised by low-level chronic inflammation, such as diabetes and obesity (41–43). 
In two recent meta-analyses of prospective cohort studies and case-control studies, an 
association between fish intake and lower risk of IHD and heart failure were observed (44, 45). 
Furthermore, a recent prospective cohort study suggested that replacing red meat, poultry, or 
lean fish with fatty fish was associated with a lower risk of MI (46). This is supported by results 
based on the same cohort, where a 12% lower relative risk of MI in men was found when the 
highest and lowest quintiles of fatty fish intake were compared; in addition, a 22% lower risk 
was found in women (47). In a recent review of clinical trials, fish consumption had a positive 
effect on relevant risk factors, such as TAG, HDL, and platelet aggregation (48). 
Nevertheless, some inconsistencies exist in the findings regarding fish consumption and risk of 
IHD. In two studies, including three cohort studies, no association was found between fish intake 
and IHD risk (49, 50); these results are supported by those of another study in which fish, instead 
of red meat, was not associated with a lower risk of CHD (51). 
2.3.2 Red meat 
In this thesis and the included papers, red meat refers to beef, veal, pork, lamb, and offal. Red 
meat also includes both raw and processed meat, the latter often preserved by salting, smoking, 
or by the addition of other preservatives such as nitrates (5, 37).  
Red meat consumption comprises intake of important nutrients like protein, B-vitamins (B12 and 
B6), iron, zinc, and selenium. However, the potential adverse effects of consuming red meat and 
processed meats involve large intakes of saturated fat (SFA), cholesterol, heme iron, and sodium, 
all of which have been suggested to produce harmful effects on serum lipids, oxidative stress, 
inflammation, and blood pressure (43, 52, 53). 
There are inconsistencies in the recent literature regarding the association between red meat 
consumption and IHD. However, processed meats have been constantly associated with IHD. In 
a meta-analysis of prospective cohorts, processed meat consumption was associated with a 
higher risk of CHD, and unprocessed meat consumption was associated with a higher increase or 
no risk (52). This was supported by another meta-analysis of prospective cohort studies 
suggesting that a high consumption of red meat, especially processed red meat, was associated 
with the risk of stroke (54). However, no association between consumption of red or processed 
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meat and IHD mortality was found in a meta-analysis of prospective cohort studies, although 
consumption of both red and processed meat was associated with CVD (55). 
2.3.3 Dietary fat 
Dietary fat includes different fatty acids such as SFA and trans fatty acids that, as previously 
described, are primarily found in animal products, such as meat, monounsaturated fatty acids 
(MUFAs), and PUFAs, and that (in addition to the aforementioned n-3 fatty acids found 
primarily in fish) also include n-6 PUFAs, found primarily in vegetable oils and nuts (56). 
Recent results from meta-analyses including RCTs and cohort studies provide strong evidence 
that replacing SFA with PUFAs is beneficial for cardiovascular health (43, 57–59). A systematic 
review including regression analysis of 84 RCTs found that when 1 E% (energy percentage) 
from SFA was replaced with an equal amount of PUFAs, reductions were seen in total 
cholesterol, LDL cholesterol, HDL cholesterol, TAG, the LDL cholesterol to HDL cholesterol 
ratio, and TAG to HDL cholesterol ratio (57). In addition, a meta-analysis including 13 
prospective cohort studies concluded that SFA should be replaced with n-6 PUFAs in the 
recommendations for primary prevention of CHD (58). Moreover, in a systematic review 
including 15 RCTs, a reduction in cardiovascular risk was suggested when SFA is replaced by 
PUFAs, but not by MUFAs, carbohydrates, or protein (59).  
2.3.4 Fruit and vegetables 
Fruit and vegetables include several nutrients, dietary fibre, and phytochemicals. Furthermore, 
they generally have low energy density (60).  
The association between a higher intake of fruit and vegetables and IHD risk has been 
investigated intensively (61–65). In a recent meta-analysis of prospective cohort studies, fruit and 
vegetable consumption was associated with a 17% lower relative risk of CVD, found for the 
highest versus the lowest categories of fruit and vegetable intake (62). In addition, a dose–
response analysis showed that participants who ate 800 g/d of fruit and vegetables had the lowest 
risk of CVD (62). This is supported by the results of another meta-analysis where the relative risk 
of stroke was 21% lower for the highest versus the lowest categories of fruit and vegetable 
intake, and the risk of stroke decreased 32% and 11% for every 200 g/d increase in consumption 
of fruit and vegetables, respectively (61). This protective association was also revealed in a 
prospective study including two large cohorts (66). However, no strong evidence was found for a 
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cardioprotective effect in individual RCTs with provision of fruit and vegetables, according to a 
meta-analysis that included 10 RCTs (65). Despite this, the authors concluded that because the 
studies included in the meta-analysis were all short-term, and only limited amounts of fruit and 
vegetables were provided, an increased intake of fruit and vegetables should be advised because 
single interventions have showed beneficial effects on CVD risk factors. The authors further 
concluded that additional RCTs are needed to confirm this (65). 
2.3.5 Whole grains and dietary fibre 
A whole grain kernel includes all the edible parts of the kernel, including the bran, germ, and 
endosperm. Whole grains are the main source of dietary fibre and also contain vitamins, 
minerals, antioxidants, and phytochemicals (43, 67). When the grain is refined, most of the bran 
and germ is removed, leaving the starchy endosperm to be further ground into white flour (67). 
The standard definition of whole grain and whole grain products varies slightly from country to 
country. In Denmark, whole grains are defined as whole kernels and processed kernels, 
including the bran, germ, and endosperm in the same proportions as the whole kernel. Whole 
grain products are defined according to the amount of whole grain in the product. Flour and 
grain must be 100% whole grain to receive the Whole Grain label. For whole grain products that 
include other ingredients, the content of whole grain must be at least 35% for bread and 55% 
breakfast cereals, crisp bread, dry pasta, and noodles (68). 
Extensive research has been done on the relationship between whole grain and fibre intake and 
CVDs, including IHD. In several recent meta-analyses and systematic reviews of both 
prospective cohort studies and RCTs, a high intake of whole grains was found to be associated 
with lower risk of IHD (67, 69–73).  
 Assessment of dietary intake 
An essential component in dietary intake-related research is the availability of appropriate methods 
for dietary assessment. Many different dietary assessment methods exist, including 24-hour dietary 
recall, the diet record method, diet histories, and food frequency questionnaires (FFQ). The FFQ is 
the most commonly used method for measuring dietary exposures in epidemiologic studies (74).  
The level of detailed information about food and nutrient intake varies considerably among dietary 
assessment methods and can play a role in the accuracy of estimating dietary intake. The method 
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used in any study should therefore be based on the foods or nutrients of interest and the capacity of 
the target population to provide the necessary details.  
Diet histories and FFQs are retrospective recall methods designed to estimate the usual dietary 
intake over a longer period; 24-hour dietary recall involves detailed recollection of the dietary 
intake over the previous 24 hours. An FFQ is used to obtain the intake frequency of specific foods 
whereas diet histories are used to capture more detailed information about dietary intake (74). 
The diet record method, on the other hand, involves prospective recording of dietary intake on 
typically 2 or more specific days. In addition, the dietary record method captures very detailed 
information about the foods and nutrients consumed over a specific stretch of time (74).  
Increased use of modern technology to collect dietary information via computers, cameras, and 
mobile phones is a huge advance (75), as these new digital methods of dietary assessment make data 
collection much faster and cheaper (75); however, these methods require individuals to have internet 
access and/or a mobile phone. 
 Dietary quality indices  
Previously, nutritional research has been focused on single foods and nutrients and their related 
health effects. However, isolating nutrients and foods may not provide a realistic picture of what 
people eat in combination and the health effects thereof. The health effects may be the result of 
an additive or synergetic effect of many different components in the diet, which nutritional 
research focused on single food and nutrient components does not capture. Thus, increasing 
attention has recently been given to healthy dietary patterns and their relationship to disease 
outcomes such as IHD (8, 11, 76). In addition, accumulated evidence supports an association 
between healthy dietary patterns and a decreased risk of CVDs (34).  
Adherence to dietary patterns or dietary guidelines is often measured using indices or scores 
designed to capture the essential food or nutrient components of a relevant healthy diet or dietary 
guidelines (77). A wide range of these dietary scores and quality indices have been developed (9, 
11, 76, 78). To calculate a single score for adherence, additional points are given for higher intake of 
foods and nutrients with health-promoting effects and lower intake of foods or nutrients with 
health-harming effects.  
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Some of the most commonly used scores and indices are the Mediterranean Diet Score, 
indicating compliance with the traditional dietary pattern followed by Mediterranean 
populations, and the American Healthy Eating Index (HEI), which assesses adherence to the 
Dietary Guidelines for Americans (79). Both observational studies and RCTs have found a 
protective effect against development and mortality of CVD with greater adherence to a 
Mediterranean diet and the Dietary Guidelines for Americans (80–87).  
 Healthy dietary patterns or national dietary guidelines and IHD  
In the two following sections, the most relevant studies with respect to background and discussion 
of this thesis research on healthy dietary patterns or national dietary guidelines and IHD are 
summarised. The studies have been selected based on literature searches conducted in PubMed and 
by reviewing the reference lists of the relevant literature. 
In the first section (section 2.6.1) relevant Nordic and Danish observational studies investigating the 
association between healthy dietary pattern and national dietary guidelines, using dietary indices or 
scores and IHD are summarised.  
In the second section (section 2.6.2) a summary of relevant dietary RCTs is given. The trials are 
divided according to study design on interventions with food provision and interventions without or 
with limited food provision. 
2.6.1 Observational studies 
In Europe, the Mediterranean diet has been widely promoted; however, adherence to the 
Mediterranean diet in countries outside the Mediterranean region remains low (88). Differences in 
food culture, preferences, and availability of local sources might limit adherence to the 
Mediterranean diet outside that region. Therefore, several indices reflecting the food culture and 
dietary guidelines of Nordic countries, including Denmark, have been developed (89–93).  
One example is the healthy Nordic food index, which is based on a 192-item FFQ including foods 
originating in the Nordic climate and reflecting the traditional Nordic diet. The included foods are 
fish, rye bread, oatmeal, cabbages, apples, pears, and root vegetables (93).  
In two prospective studies by Gunge et al. (94) and Hansen et al. (95) based on the same cohort, the 
Danish Diet, Cancer and Health cohort including around 56,000 adult men and women, the 
association between adherence to a healthy Nordic diet and MI and stroke was investigated. When 
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comparing individuals with the highest healthy Nordic food index scores and those with the lowest 
index scores, lower risks of MI (men: hazard ratio (HR) 0.77, 95% CI 0.62 to 0.97; women: HR 
0.55, 95% CI 0.37 to 0.82) and stroke (HR 0.86, 95% CI 0.76 to 0.98) were found (94, 95). Another 
prospective cohort based on the Danish Diet, Cancer and Health cohort also found an inverse 
association between adherence to a healthy Nordic diet, assessed by the healthy Nordic food index, 
and type 2 diabetes (men: HR 0.62, 95% CI 0.53 to 0.71, women: HR 0.75, 95% CI 0.61 to 0.92), 
when individuals with the highest healthy Nordic food index scores were compared with those 
having the lowest index scores (96).  
Despite this, results are inconsistent regarding a cardioprotective association of adherence to a 
healthy Nordic diet, as assessed by the healthy Nordic food index. In two prospective cohort studies 
by Roswall et al. based on the same cohort, the prospective Swedish Women´s Lifestyle and Health 
cohort including around 44,000 adult women, no overall association was found between the healthy 
Nordic food index and overall risk of CVD, IHD, and cardiovascular mortality (97, 98).  
Examples of indices reflecting the Danish official dietary guidelines are the Dietary Quality 
Score (DQS) and Diet Quality Index (DQI), both developed to measure adherence to 2005 
Danish dietary guidelines (90, 91).  
The DQS was developed and validated in a cross-sectional study by Toft et al. (90), who also 
investigated the association between the DQS, as a measure of adherence to the 2005 Danish 
official dietary guidelines, and CVD risk factors (90). The DQS was developed based on a 48-
item FFQ, using a 3-point scoring system for each of four food groups: fish, fruits, vegetables, 
and fats, reflecting the Danish official dietary guidelines for 2005 (90). The DQI was further 
validated against a 198-item FFQ. The study included 6542 healthy adult men and women. In the 
study, Toft et al. found that a higher DQS was inversely associated with total cholesterol, TAG, 
LDL cholesterol, homocysteine, and absolute risk of IHD (using the Copenhagen risk score) (90).  
In addition, in a recently published prospective cohort study by Hansen et al. based on the 
Danish Diet, Cancer and Health cohort, adherence to the Danish official dietary guidelines 2013 
as assessed by an updated DQI, called the Danish Dietary Guidelines Index Score, and risk of 
MI was investigated (95). The updated DQI was based on a 192-item FFQ and included six foods 
and nutrients: whole grains, fish, fruit and vegetables, red and processed meats, and E% from 
saturated fat and added sugar. In all, 55,021 adult men and women were included. A higher 
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Danish Dietary Guidelines Index Score was associated with lower risk of MI among both men 
(HR 0.87, 95% CI 0.78 to 0.96) and women (HR 0.76, 95% CI 0.63 to 0.93) (99). 
Although different in their description and composition, the dietary scores and indices reflect 
different healthy diets or national dietary guidelines all capture the essential elements of a 
healthy diet.  
2.6.2 Randomised controlled trials  
2.6.2.1 Interventions with food provision  
The controlled feeding trial is one method used to test the effects of healthy dietary patterns or 
national dietary guidelines on IHD risk factors through RCTs. In a controlled feeding trial, 
participants are provided with all foods during the period of the intervention. The results of these 
studies allow for a more straightforward interpretation of dietary exposure.  
A classic example of a controlled feeding trial is an RCT conducted by Appel et al. investigating the 
effect of the Dietary Approaches to Stop Hypertension (DASH) diet on blood pressure (100). The 
study included 459 healthy adults, who were randomly assigned to either a control group or to a 
group following one of two DASH diets: a diet rich in fruits and vegetables or an extended diet rich 
in fruits, vegetables, and low-fat dairy products, and with reduced saturated and total fat (100, 101). 
The participants were provided with all foods free of charge. Appel et al. found an improvement in 
blood pressure among participants following both types of DASH diet in comparison with the 
control group (100). 
Nordic examples of more recently published controlled feeding trials are RCTs conducted by 
Adamsson et al. (102) and Poulsen et al. (103). Adamsson et al. investigated the effects of a healthy 
Nordic diet on cardiovascular risk factors. The study included 88 hypercholesteraemic participants 
who were randomly assigned to an ad libitum Nordic diet or a control diet (102). All meals and foods 
were provided free of charge to the group following the healthy Nordic diet; the control group did 
not receive any meals or foods. Compliance was assessed using a daily study checklist. Adamsson 
et al. found that participants receiving the healthy Nordic diet had improved lipid profiles and 
insulin resistance, measured by HOMA-IR and blood pressure, in comparison with participants who 
were assigned to the control diet (102).  
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In addition, Poulsen et al. investigated the health effects of the New Nordic Diet in an RCT (103). 
The study included 147 adult participants with increased waist circumference who were randomised 
to receive either the New Nordic Diet or an average Danish diet (control). Cookbooks and all foods 
were provided free of charge to both groups through a shop model. A cookbook including recipes 
and menu plans was developed for the intervention group and a cookbook with recipes for 
traditional Danish dishes was developed for the control group. Dietary compliance was assessed 
using 3-day dietary records at three occasions during the intervention. Poulsen et al. found that in 
comparison with the group eating an average Danish diet, participants following the New Nordic 
Diet had improved lipid profiles, fasting glucose and CRP concentrations, blood pressure, and had 
reduced weight (103).   
2.6.2.2 Interventions without or with limited food provision 
Another approach to testing the effects of healthy dietary patterns or national dietary guidelines on 
IHD risk factors through dietary RCTs is by using a setting that is closer to real-life than in 
controlled feeding trials. Here, the study participant only receives dietary advice and/or some of the 
appropriate foods, with the aim to increase participants’ motivation to adhere to the advice given. 
Otherwise, participants are completely empowered to modify their own dietary habits and patterns.  
A recent RCT by Jenkin et al. investigated the effects of dietary advice with and without food 
provision on weight loss and cardiovascular risk factors (104). The study included 919 healthy 
overweight adult men and women. The study participants were randomised to either a control group 
who received the Health Canada´s Food Guide and nothing else, or one of three intervention arms. 
In addition to the Health Canada’s Food Guide, received by all three intervention arms, the first 
intervention arm received dietary advice based on the DASH diet and the Portfolio diet (a dietary 
approach to lowering cholesterol); the second intervention arm was provided foods reflecting the 
same dietary advice each week (without receiving dietary advice); and the third intervention arm 
was provided both foods and dietary advice. Additional interventions included 20–30 minutes of 
telephone interviews conducted weekly during the first month and monthly during the last 5 months 
of the intervention. The duration of the intervention was 6 months, with a 12-month follow-up. 
Dietary assessment was done via a validated FFQ, which was expanded to capture whole grains and 
viscous fibre. The retention increased with the provision of foods. Apart from an increase in whole 
grain intake in all three groups, an increase in the intake of other recommended foods was found 
only in the groups receiving foods, compared with the control group. No difference in CVD risk 
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factors was seen from baseline to 6 months or from baseline to 18 months in any of the three 
intervention groups, in comparison with the control group (104). 
Another 12-week RCT, the CRESSIDA study by Reidlinger et al. (105), including 162 healthy 
middle-aged and older men and women, investigated the effects of adherence to the United 
Kingdom (UK) dietary guidelines on selected CVD risk factors (105). The study participants were 
randomised to a group following UK dietary guidelines or to a control group instructed to eat a 
traditional British diet. The UK dietary guidelines included recommendations for reduced intake of 
SFA, added sugars, and sodium and increased intake of oily fish, fruit and vegetables, and whole 
grains. Adherence was assessed through dietary interviews conducted by a dietitian, twice face-to-
face (baseline and week 4) and twice by e-mail or phone calls (weeks 6 and 8). Food provision to 
participants following UK dietary guidelines included low-saturated/trans-fat margarine and liquid 
vegetable oil (high-oleic sunflower oil). Food provision to participants in the control diet group 
included high-saturated/trans-fat butter-based spread and liquid hydrogenated vegetable oil (olein). 
All participants were further provided with other foods such as whole grain breakfast cereal, brown 
rice, snacks (e.g., nuts and chocolate bars), and tinned fish (tuna, mackerel). Adherence to the 
dietary advice was assessed through 4-day diet records and biomarkers of intake. The overall 
dietary changes in the group following UK dietary guidelines, compared with the control group, 
was an increased intake of whole grains, dietary fibre, and E% intake from protein; a decreased 
intake of sodium and E% intake from total fat, SFA, and trans-fatty acids; and an increased E% 
intake from MUFAs and PUFAs. In addition, Reidlinger et al. found a decrease in systolic blood 
pressure, serum lipids, CRP, and waist circumference in the group following UK dietary guidelines 
in comparison with the control group (105).  
In a RCT, the SYSDIET study, Uusitupa et al. (106) examined the effects of an isocaloric (to avoid 
weight loss) healthy Nordic diet on cardiometabolic risk factors (106). The 18- to 24-week study 
included 166 adult men and women with features of metabolic syndrome, who were randomly 
assigned to eat a healthy Nordic diet or a control diet (average Nordic diet). Key food items were 
provided free of charge in both groups. The healthy Nordic diet group received key products such 
as whole grain products, berry products, dietary fats including rapeseed oil and spreads based on 
vegetable oils, and fish or covered expenses for fish consumed. The control group received low-
fibre cereal products and dairy fat-based spread, e.g., butter. A dietitian introduced the diets to the 
groups at baseline and compliance was measured repeatedly thereafter using 4-day food records; in 
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addition, serum phospholipids were analysed for fatty acid composition. Overall dietary changes 
between the groups favoured the group that adhered to the healthy Nordic diet, with changes in 
carbohydrates, protein, total fat, SFA, PUFAs, dietary fibre, and salt and sodium between the 
groups. Uusitupa et al. found a decrease in non-HDL cholesterol (total cholesterol – HDL 
cholesterol), LDL-to-HDL cholesterol ratio, and apolipoprotein B/apolipoprotein A1 ratio in the 
healthy Nordic diet group, compared with the control group. No changes in insulin sensitivity or 
glucose tolerance was found (106). 
The investigated endpoints of the above-mentioned studies are all intermediate risk factors for IHD 
and CVD. Long-term dietary RCTs investigating the effects of healthy dietary patterns or national 
dietary guidelines on incidence of diseases such as IHD as the endpoint are rare and are often not 
feasible. In such long-term trials, compliance with the intervention diets will likely decline during 
the intervention period, and they require a larger study population and longer duration than 
intermediate-term trials; this results in prohibitive costs of conducting long-term trials.  
However, one example of such a long-term dietary RCT is the PREDIMED study (107). In the 
PREDIMED study, Estruch et al. investigated the effects of two different Mediterranean diets, 
compared with a low-fat diet, on the incidence of major cardiovascular events (107). In all, 7447 
middle-aged men and women with high cardiovascular risk were included in the study, with a 
median follow-up of 4.8 years. Participants were randomised to a Mediterranean diet supplemented 
with mixed nuts, a Mediterranean diet supplemented with extra-virgin olive oil, or a control group 
advised to follow a low-fat diet. Mixed nuts and extra-virgin olive oil were provided free of charge 
to the two intervention groups; the control group received small non-food gifts. Additional 
intervention in the two Mediterranean diet groups included dietary training with a dietitian in 
individual and group sessions at baseline and quarterly thereafter. The control group also received 
dietary training by a dietician at baseline; thereafter, participants received leaflets explaining the 
low-fat diet on a yearly basis for the first 3 years of the intervention. Dietary compliance was 
measured using a 137-item FFQ and biomarkers were assessed to determine intake of extra-virgin 
olive oil (urinary hydroxytyrosol levels) and mixed nuts (plasma alpha-linolenic acids). At the end 
of the intervention, the largest dietary changes were differences in the composition of fat subtypes, 
fish, and legumes consumed. Estruch et al. found a 30% and 28% lower risk of major 
cardiovascular risk in the groups assigned to the Mediterranean diets with extra-virgin olive oil and 
nixed nuts, respectively, compared with the low-fat diet group (107). 
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To sum up, of the presented dietary RCTs with or without limited provision of key food products, 
and conducted in a real-life setting, both the study by Reidlinger et al. (105) and that by Uusitupa et 
al. (106) enrolled a control group that was provided with foods high in SFA. In the PREDIMED study 
by Estruch et al., the control group did not receive any SFA-rich foods but instead were advised to 
eat low-fat products (107). The control group in the study by Jenkins et al. only received a leaflet with 
dietary guidelines, which was also provided to the three other intervention arms (104). In addition, the 
intervention groups in the studies by Reidlinger et al. (105), Uusitupa et al. (106), and Estruch et al. (107) 
were all provided food products high in unsaturated fat.  
There are differences regarding the dietary assessment methods followed in these studies. In the 
study by Jenkins et al. (104) and in the PREDIMED study by Estruch et al. (107), an FFQ was used to 
assess adherence. In contrast, both the CRESSIDA study by Reidlinger et al. (105) and the SYSDIET 
study by Uusitupa et al. (106) used 4-day dietary records. In addition, the PREDIMED, CRESSIDA, 
and SYSDIET studies all included biomarkers of intake (105–107). Finally, the intensity of the 
intervention in the presented RCTs with or without limited food provision, such as the extent of 
dietary counselling provided, also differed between these studies.  
   
 
 
 
 
 
 
 
 
 
 
20 
 
3 Methods 
 Study design  
From March 2014 to May 2015, a 6-month single-blinded parallel RCT with a 6-month follow-up 
was conducted in a real-life setting and included adult participants with a minimum of one self-
reported risk factor of IHD. At baseline participants were assigned to either a control group advised 
to follow their habitual diet or to one of two intervention groups receiving either targeted 
substitution dietary guidelines or the Danish official dietary guidelines.  
Short- and long-term effects of the guidelines were defined as the changes in diet and IHD risk 
factors from baseline to 6 months (end of the intervention) and from baseline to 12 months (follow-
up), respectively.  
This study was part of the research project ´Diet and Prevention of Ischemic Heart Disease – a 
Translational Approach´ (DIPI) (www.DIPI.dk). The study was conducted according to the 
guidelines laid down in the Declaration of Helsinki and was approved by The Capital Region of 
Denmark Ethics Committee (Journal no. H-1-2013-110) and by the Danish Data Protection Agency 
(Journal no. 2013-54-0571). Written informed consent was obtained from all study participants, and 
they received a small remuneration of around 34 GBP for their participation in the study. The study 
was registered at ClinicalTrials.gov (registry name “Diet and Prevention of Ischemic Heart Disease: 
a Translational Approach (DIPI)”, ID no. NCT02062424).  
 Study participants  
Potential participants were identified using a unique personal identification number assigned to all 
Danish citizens in the Civil Registration System (108). In total, 5000 men and women born during 
1949–1984 and living in a defined area of Greater Copenhagen were invited by letter to participate 
in the study. The number of invited participants was based on previous experience of a low 
response rate when recruiting participants for RCTs. Overall, 334 people responded to the invitation 
and were screened using a self-administered questionnaire that included questions on the inclusion 
and exclusion criteria (Figure 2). 
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Potential participants were asked to measure and report their height in metres, weight in kilograms 
(kg), their waist circumference at a height 2 cm above the umbilicus, and whether they were 
physically active for more than 15 min/wk. Furthermore, the self-administered questionnaire 
included questions on the exclusion criteria. Eligible participants were invited to an informational 
meeting, which included an introduction to the web-based dietary assessment software.  
Figure 2 Flow chart of participant recruitment 
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3.2.1 Inclusion and exclusion criteria 
The inclusion criteria were age between 30 and 65 years, and a minimum of one self-reported risk 
factor for IHD: overweight or obesity (BMI ≥ 25), waist circumference ≥ 80 cm for women and ≥ 
94 cm for men, and/or physical inactivity defined as being moderately physically active during 
leisure time for 15 minutes or less per week. 
Exclusion criteria were current smoking, pregnancy or plans to become pregnant within the next 12 
months, breastfeeding, history of CVD, type 2 diabetes, chronic diseases/disorders that could affect 
the results of the study (chronic diseases reported by participants were evaluated by the physician in 
charge), drug abuse within the last 12 months, regular alcohol consumption > 21 units/week for 
men or > 14 units/week for women1, allergies or intolerance of the food groups included in the 
dietary guidelines, consumption of dietary supplements with high doses of nutrients that could have 
a potential effect on IHD risk factors (e.g., fish oils), and/or no access to a computer or the internet. 
 Randomisation and intervention 
A schematic overview of the study design is presented in Figure 3. After the baseline examination, 
participants were randomly assigned to one of the three study groups using a computer 
randomisation plan (www.randomization.com) for men and women separately, to ensure that the 
randomisation was balanced by sex. 
 
Figure 3 Schematic overview of the study design. 
                                                 
1 One unit (DK) is 12 g of pure alcohol. 
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The guidelines given to participants in the targeted substitution dietary guidelines group focused on 
5 of the 10 Danish official dietary guidelines related to foods or nutrients (Table 3) where the 
scientific evidence for a relationship between a dietary factor and an IHD outcome was found to be 
convincing or probable (5). Moreover, exact substitutions were specified. 
The guidelines given to participants in the Danish official dietary guidelines group included all 10 
official guidelines on foods, beverages, and physical activity (Table 3). The official dietary 
guidelines were updated based on a systematic literature update of the scientific literature on the 
associations between food intake and physical activity and different diet-related diseases, on 
knowledge of Danish food habits and the Nordic Nutrition Recommendations 2012 (5). 
Table 3 Targeted substitution dietary guidelines and Danish official dietary guidelines.  
Substitution dietary guidelines Official dietary guidelines 
 Eat a variety of foods, but not too much, and be 
physically active 
Eat fruit instead of candy and cake 
Eat coarse vegetables instead of fine 
vegetables† 
Eat fruits and many vegetables 
Eat fish instead of red meat Eat more fish 
Eat whole grain products instead of products 
with no whole grains 
Choose whole grains 
 Choose lean meats and cold meats 
 Choose low-fat dairy products 
Eat unsaturated fat instead of saturated fat Eat less saturated fat 
 Eat foods with less salt 
 Eat less sugar  
 Drink water 
† Vegetables are classified by type (e.g., all types of cabbage, root vegetables, and onions are classified as coarse 
vegetables and all vegetables with a high water content, like tomatoes and salad greens, are classified as fine 
vegetables). 
The two study groups assigned to receive either the targeted substitution dietary guidelines or the 
Danish official dietary guidelines were provided information about the guidelines via a letter, which 
included a leaflet containing the respective guidelines, and also via a website 
(www.dipi.food.dtu.dk). The participants were given a personal password to the website where they 
could find leaflets and recipes. The leaflets and recipes for the targeted substitution dietary 
guidelines and the Danish official dietary guidelines were identical in design, structure, and 
number; only the content varied according to the dietary guidelines each participant was randomly 
assigned to follow. All recipes given to the intervention groups were developed by the Danish 
Veterinary and Food Administration and were Keyhole nutrition labelled (40). To increase the 
participants’ motivation and compliance with the respective dietary guidelines, an e-mail with two 
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new recipes per intervention group was sent out to participants biweekly during the intervention 
period. In the group following the targeted substitution dietary guidelines, only recipes for fish 
dishes were sent. To increase motivation and compliance in the habitual diet group, participants 
were also sent an e-mail every second week, including a ‘thank you for still participating’ greeting.  
At the end of the intervention after 6 months, participants were told that the intervention portion of 
the study was finished but that they would be re-invited to a follow-up examination in another 6 
months (Figure 3). 
 Measures 
3.4.1 Dietary assessment 
Study participants recorded their dietary intake for 7 consecutive days, using a self-administered 
web-based dietary assessment software (109). The software is based on a validated diet recording 
method including a 7-day food record, which has been used for the past two decades in the Danish 
National Survey of Dietary Habits and Physical Activity (37, 110). The web-based dietary assessment 
software was originally developed and validated for children aged 8–11 years and has been 
customised to fit the adult participants in the DIPI study (109, 111, 112). A user manual for the software 
was given to study participants at baseline. At least 4 days of food reporting had to be completed for 
participants to be included in the analysis (110).   
The dietary assessment software was structured according to a typical Danish meal pattern covering 
breakfast, lunch, dinner and three in-between meals. The participants could estimate the amount 
consumed by selecting the closest portion size from among four different digital images in an 80-
photograph series. Reminders for frequently overlooked foods (e.g., spreads, sugar, sauces, 
dressings, snacks, candy, and beverages) were included. Furthermore, participants reported the 
intake of nutritional supplements and whether each day represented the usual or an unusual intake, 
and included reasons for unusual intake, such as illness. If a participant failed to report on one day, 
they were sent a reminder e-mail the following day (109).  
Intakes of food items, energy, and nutrients were calculated for each study participant as an average 
of 7 days using the software General Intake Estimation System (GIES) version 1.000.i6 and the 
Danish Food Composition Databank version 7.0 (National Food Institute, Technical University of 
Denmark). 
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3.4.1.1 Under- and over-reported energy intake 
Under- and over-reported energy intake was defined as a ratio of reported mean energy intake to 
basal metabolic rate and classified using cut-offs suggested by Black (113, 114). Under-reported 
energy intake was defined as; ratio of reported mean energy intake to basal metabolic rate ≤ 1.05 
and over-reported energy intake was defined as; ratio of reported mean energy intake to basal 
metabolic rate ≥ 2.28, using a physical activity level 1.55 (data not shown). Basal metabolic rate 
was calculated using the equations by Henry (115).  
3.4.1.2 Calculation of DQI  
Adherence to the Danish official dietary guidelines was evaluated based on a previous DQI, 
updated to the current Danish official dietary guidelines (91, 116), which include intake of whole 
grains (min 75 g/10 MJ/d), intake of fish (min 350 g/wk), intake of fruits and vegetables (min 600 
g/10MJ/d), energy from saturated fat (max 10 E%), and energy from added sugar (max 10 E%). The 
DQI was based on intake adjusted to 10 MJ as this is the unit used in the dietary guidelines (5). 
A DQI score for each study participant was calculated as the ratio of the actual intake and the 
recommended intake of each of the five guidelines included in the index (adapted from Knudsen et 
al. (91)). For example, if a study participant had an intake of 60 g/10 MJ/d of whole grains, the score 
was 60/75 = 0.8. For the included guidelines with an upper limit for a recommended intake, the 
DQI was calculated as 1−[(intake−recommended)/recommended]; thus, for a study participant with 
an intake of 13% E from added sugar, the DQI was calculated as 1−[(13−10)/10] = 0.7. 
In contrast to the original DQI, we did not have a maximum score for individuals with an intake 
exceeding the cut-off values (91). The total score was calculated as the sum of the five scores, with a 
higher score indicating a greater degree of adherence to the Danish official dietary guidelines. 
3.4.2 Blood samples (paper III) 
Fasting blood samples from venepuncture were analysed for concentrations of TAG, total 
cholesterol, HDL cholesterol, high-sensitivity C-reactive protein (hsCRP), glucose, HbA1c, and 
insulin. The blood samples were collected and handled according to hospital routines. TAG, total 
cholesterol, HDL cholesterol, and glucose were measured in plasma by reflection spectroscopy, 
with peaks at 540 nm; hsCRP was measured in the same way, with peaks at 660 nm (VITROS 5,1 
FS; Ortho Clinical Diagnostics, Bridgend Pencoed, United Kingdom). HbA1c was measured in 
plasma using high-performance liquid chromatography (D-100; Bio-Rad, Copenhagen, Denmark). 
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Fasting plasma insulin was measured using the sandwich enzyme-linked immunosorbent assay 
(ELISA) analysis principle (ADVIA Centaur XP; Siemens, Ballerup, Denmark). Within-run 
variation (coefficient of variation; CV%) for the biochemical measurements was 0.7%–11%. VLDL 
cholesterol was calculated from TAG using the following equation: plasma VLDL cholesterol = 
plasma TAG × 0.45. LDL cholesterol was calculated using the Friedewald equation (117).  
HOMA-IR was used to estimate insulin resistance and was calculated using the following formula: 
HOMA-IR = [glucose (nmol/L) × insulin (mU/mL)/22.5], using fasting values (22).  
3.4.2.1 Plasma alkylresorcinol concentrations (paper II) 
Total alkylresorcinol concentrations were extracted and purified from plasma samples and analysed 
using gas chromatography–mass spectrometry (Finnigan TRACE GC Ultra Gas Chromatograph 
coupled to a Finnigan TRACE DSQ II mass detector; Thermo Fisher Scientific, Waltham, MA, 
USA), according to a method described elsewhere in detail (118).    
3.4.3 Blood pressure and heart rate (papers I to III) 
Blood pressure and heart rate were measured in duplicate on the left arm, with the participant seated 
and after a 5-minute rest, using an electric sphygmomanometer according to standard procedures. 
Participants were asked to empty their bladder before measurement and were not allowed to 
converse during the measurements or to have their legs crossed. If the diastolic blood pressure 
differed more than 5 mmHg between measurements, further readings were taken until diastolic 
blood pressure differed ≤ 5 mmHg between at least two consecutive measurements. Average values 
of the two blood pressure and heart rate measurements were calculated. 
3.4.4 Anthropometric measurements (papers I to III) 
Height was measured to the nearest 0.5 cm using a wall-mounted stadiometer (seca, Hamburg, 
Germany). Fasting body weight in kg and abdominal obesity were registered on a body composition 
analyser (BC-418MA; Tanita, Tokyo, Japan). Waist- and hip circumference were measured twice 
using an anthropometric tape (seca 201) and the average was reported. BMI was defined as weight 
in kg divided by squared height in meters (kg/m2).  
3.4.5 Background questionnaires (papers I to III) 
Lifestyle questionnaires were used to obtain information about the participant’s education level 
(primary school/high school, associate degree, undergraduate degree, graduate degree) and level of 
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physical activity during leisure time (extremely active, moderately active, sedentary, or inactive). 
The question addressing physical activity level queried participants’ physical activity during leisure 
time in the previous 6 months and was based on the Danish National Health Profile questionnaire 
(119).  
 Statistical method 
For a parallel design, statistical power calculations based on evidence from previous similar studies 
(120–122) were used to estimate that 62 participants in each intervention arm was sufficient to detect a 
difference of 0.25 mmol/L LDL cholesterol (SD, 0.49) (α = 0.05, β = 0.8). To allow for a dropout 
rate of 20%, the number of participants was set to a total of 225. Using a paired t-test, self-reported 
weight (kg), waist circumference, and BMI from the screening self-administered questionnaire were 
compared with weight, waist circumference, and BMI measured at baseline. Baseline characteristics 
and dietary intake of the participants were summarized for men and women using medians and 80% 
central range for continuous variables and proportions for categorical variables. 
Baseline differences in dietary intake endpoints and IHD risk factors between the randomised 
groups were evaluated using analysis of variance (ANOVA) for continuous variables and the 
Kruskal–Wallis test for categorical variables (data not shown). 
For papers I and II, sensitivity analyses excluding under- and over-reporters were conducted to 
investigate the impact of under- and over-reported energy intake on the results of these papers. 
All statistical analyses in the three papers were carried out using RStudio 
Version 0.99.441 (RStudio, Inc., Boston, MA, USA). Statistical significance was set at p < 0.05.  
3.5.1 Paper I 
Linear regression analyses were applied to evaluate the association between DQI and 
cardiometabolic risk factors. Three models were used: a simple model adjusted for sex and age (< 
50 or ≥ 50 years) (model 1a); a multivariate model further adjusted for education level (primary 
school/high school, associate degree, undergraduate or graduate degree) and physical activity 
during leisure time (extremely active, moderately active, sedentary, or inactive) (model 1b); and a 
final multivariate model adjusted as in model 1b plus BMI (model 2). Furthermore, sensitivity 
analysis excluding under- and over-reporters was done to investigate the impact of under- and over-
reporters on the associations between DQI and cardiometabolic risk factors. 
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All models were tested for statistically significant interactions between DQI and sex and DQI and 
age. These interactions were tested to investigate if the associations were different for men and 
women and for participants aged < 50 or ≥ 50 years. If an interaction was significant, the DQI 
estimates for men and women and DQI estimates by age were given.  
To check the model assumptions, the standardized residuals of the final models were examined for 
normality, variance homogeneity, and linearity. BMI, waist-to-hip ratio, hsCRP, VLDL cholesterol, 
TAG, glucose, insulin, and HOMA-IR were all logarithm 10 transformed to normalize the 
distribution and to improve variance homogeneity. For the above-mentioned variables that were log 
transformed, the estimates and 95% confidence intervals (95% CI) are presented as percent 
difference. 
3.5.2 Papers II and III 
Two multiple linear regression models were applied to evaluate changes from baseline to 6 or 12 
months in dietary intake endpoints, DQI score, and IHD risk factors in the targeted substitution 
dietary guidelines group and the official dietary guidelines group, compared with the habitual diet 
group. Model 1 was adjusted for baseline value of the outcome variable, and model 2 was further 
adjusted for sex, age group (< 50 and ≥ 50 years), and BMI group (BMI 18.5–25 as normal weight, 
> 25–30 overweight, and > 30 obese). In Model 2 interactions between the intervention group and 
sex, the intervention group and age group, and the intervention group and BMI group were 
additionally tested for statistically significance.  
These interactions were tested to investigate whether the intervention had different effects for men 
and women; for participants above or below age 50 years; or for normal weight, overweight, or 
obese study participants. If an interaction was statistically significant, separate results were 
provided according to the level of the effect modifier.  
To check the model assumptions, the standardised residuals of the final models were examined for 
normality, variance homogeneity, and linearity.  
3.5.2.1 Statistical method for analysis with alkylresorcinols (paper II) 
Whole grain intake and total alkylresorcinol concentration in plasma were grouped into quartiles, 
and cross-tabulation for total whole grain intake and alkylresorcinol concentrations in plasma was 
done to examine the agreement between quartiles using the baseline data. To validate the whole 
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grain intake estimated using the web-based dietary assessment, a simple linear regression model 
was used to test the association between whole grain intake and total alkylresorcinol concentrations 
in plasma at baseline. To normalise the distribution of the residuals and to improve variance 
homogeneity, alkylresorcinol concentrations and whole grain intake were logarithm 2 transformed.  
3.5.3 Statistical analysis of within group differences 
Paired t-tests were applied to investigate changes in dietary intake endpoints and IHD risk factors in 
the randomised groups, from baseline to 6 months and from baseline to 12 months. 
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4 Results 
A summary of the results of the three papers (I to III), as well as data not included in the papers, is 
presented in this section (Tables 4–10). Details of the results for all statistical models in the three 
papers are found in Appendix A. 
 Baseline characteristics of the study participants 
A total of 222 participants met the inclusion and exclusion criteria and were enrolled in the study, 
accounting for 67% of the initially screened potential study participants. Participants’ self-reported 
weight and waist circumference were significantly higher (p < 0.05) than the measured weight and 
waist circumference at baseline; however, no difference in BMI was found. In all, 17% of women 
and 7% of men did not meet the inclusion criteria when measured at baseline (Table 4). 
Table 4 Weight (kg), body mass index (kg/m2), and waist circumference,  
self-reported and measured at baseline. 
 Self-reported 
Mean (SD) 
Measured 
Mean (SD) p-value† 
Weight (kg) 84 (16) 83 (16) 0.042 
BMI (kg/m2) 27 (4) 27 (4) 0.193 
Waist circumference (cm) 94 (12) 93 (12) 0.034 
†Paired t-test 
A full baseline examination was missing for three participants; these individuals were therefore 
excluded from the analysis (see flow chart in Figure 4). Baseline characteristics of the remaining 
219 study participants are presented in Table 5, by sex (for baseline characteristics of the study 
participants according to randomised intervention group, see papers II and III). Of the 219 study 
participants, 90 were men and 129 were women. The median (p10–p90) age of the study 
participants were 51 (37–61) years. Most study participants were overweight or obese according to 
BMI. No differences were found in either of the dietary intake endpoints or the cardiometabolic risk 
factors between the interventions groups at baseline (data not shown). 
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Table 5 Baseline characteristics of the study participants according to sex; medians (p10-p90)  
or percentages (n) 
Participant characteristics All (n=219) Men (n=90) Women (n=129) 
Age (years)  51 (37-61) 51 (36-61) 51 (37-61) 
Metabolic markers    
   Weight (kg)  83 (65-104) 88 (79-117.5) 75 (62.3-92.8) 
   BMI † 27 (23-34) 27 (24-34) 26 (23-33) 
   Weight status †:    
      Normal weight, % (n) 27 (60) 16 (14) 36 (46) 
      Overweight, % (n) 53 (116) 66 (60) 43 (56) 
      Obese, % (n) 20 (43) 18 (16) 21 (27) 
   Waist circumference (cm)  92 (80-105) 97 (91-118) 87 (77-100) 
   Hip circumference (cm) 107 (99-120) 107 (102-119) 108 (99-120) 
   Systolic BP (mm Hg) ‡ 130 (110-154) 135 (119-164) 125 (108-149) 
   Diastolic BP (mm Hg) ‡ 80 (69-94) 82 (72-98) 78 (68-92) 
   hsCRP (mg/L) ¨  1.4 (0.2-6.3) 1.0 (0.2-5.4) 1.9 (0.2-8.3) 
Lipid biomarkers ^    
   Total cholesterol (mmol/L) 5.3 (4.1-6.8) 5.5 (4.4-6.9) 5.2 (4.0-4.5) 
   LDL cholesterol (mmol/L) 3.2 (2.2-4.5) 3.5 (2.5-4.7) 3.1 (2.1-4.5) 
   HDL cholesterol (mmol/L) 1.4 (1.0-3.9) 1.2 (0.9-1.9) 1.6 (1.1-2.3) 
   LDL/HDL-ratio 2.3 (4.1-6.8) 2.8 (1.7-4.3) 2.0 (1.2-3.0) 
   VLDL cholesterol (mmol/L) 0.5 (0.3-1.0) 0.6 (0.3-1.2) 0.4 (0.3-0.8) 
   TAG (mmol/L) 1.1 (0.6-2.3) 1.3 (0.7-2.6) 0.9 (0.6-1.8) 
Glycaemic biomarkers §    
   Glucose (mmol/L) 5.5 (5.0-6.3) 5.6 (5.1-6.4) 5.4 (4.9-6.1) 
   HbA1c (%) 5.0 (4.5-5.5) 5.0 (4.6-5.5) 5.0 (4.5-5.5) 
   Insulin (pmol/L) 58 (30-100) 59 (31-127) 58 (30-94) 
   HOMA-IR 2.0 (1.0-3.8) 2.2 (1.0-4.6) 2.0 (1.0-3.6) 
Educational level    
   Primary school or high school, % (n) 25 (55)  29 (26)  23 (30) 
   Associate degree, % (n) 8 (18) 6 (5)  10 (13) 
   Undergraduate school, % (n) 40 (87) 31 (28) 46 (59) 
   Graduate school, % (n) 27 (58) 34 (31) 21 (27) 
Abbreviations: BMI, Body Mass Index; BP, blood pressure; hsCRP, high-sensitivity C-reactive protein; LDL, low density 
lipoprotein-cholesterol; HDL, high density lipoprotein-cholesterol; VLDL, very low density lipoprotein-cholesterol;  TAG, 
triglycerides; HbA1c , haemoglobin A1c;  HOMA-IR, homeostatic model of insulin resistance          
† BMI is calculated as weight in kilograms divided by the square of height in meters (kg/m2). 18.5-25 = Normal weight, 25-30 
= Overweight, >30 = Obese 
‡ All; n=216, men; n=89, women; n=127, after exclusion of those using BP-lowing medication 
¨ All; n=204, men; n= 87, women; n=117, due to lack in biochemical analyses of hsCRP 
^ All; n=214, men; n=85, after exclusion of those using cholesterol lowing medication 
§ All; n=218, women; n=128, as it was not possible to draw enough blood to the glycaemic biomarker analysis from one of 
the female study participants. 
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  Completers 
Altogether, 203 study participants completed the examination at 6 months and 199 also completed 
the dietary recording at 6 months, yielding compliance rates of 93% and 90%, respectively. At 12 
months, 196 study participants completed the examination and 186 participants completed the 
dietary recording. The dropout proportion was not higher than the expected approximately 20% in 
each group, and did not differ between the groups. Reasons for non-completers are given in the flow 
chart (Figure 4).   
Figure 4 Flow chart of the study 
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 Results of paper I 
The results of paper I are based on the baseline data. Table 6 presents the median (p10–p90) DQI 
score and individual DQI scores for the five included foods and nutrients, energy (MJ/d), diet 
composition (g/10 MJ/d), and energy contribution (E%) of macronutrients and dietary fibre (g/MJ) 
for study participants.  
The median (p10–p90) DQI for the entire study population was 4.5 (3.0–6.5). The median DQI 
score was higher for women than for men. In Table 1 of Appendix B, supplementary material is 
presented on the dietary intake endpoints of the study population, according to tertiles of the DQI 
score. 
Table 6 Overall Diet Quality Index (DQI) score and individual DQI scores for the five included foods and 
nutrients, energy (MJ/d), diet composition (g/10 MJ/d), and energy contribution (E%) of macronutrients and 
dietary fibre (g/MJ) for study participants; medians (p10-p90). 
Participant  Recommended† All  
(n=219) 
Men  
(n=90) 
Women (n=129) DQI score 
Overall DQI  4.5 (3.0, 6.5) 4.2 (2.7, 6.2) 4.6 (3.0, 6.6)  
Energy MJ/d  8.6 (5.8, 12.4) 10.1 (7.2, 13.7) 7.8 (5.2, 10.5)  
Diet composition  
(g/10MJ/d): 
     
Bread and cereals‡  218 (141, 301) 215 (149, 291) 220 (136, 307)  
  Whole grains  75 g/d 61 (31, 111) 56 (30, 117) 66 (34, 108) 0.8 (0.4, 1.5) 
Meat‡ < 70 g/d 139 (59, 249) 166 (85, 282) 124 (45, 224)  
Fish‡ ¨ 50 g/d 46 (5, 111) 41 (5, 109) 48 (5, 125) 0.9 (0.1, 2.2) 
Poultry‡^  32 (0, 102) 31 (0 , 103) 32 (0, 99)  
Fruit and vegetables‡ 600 g /d§ 388 (177, 690) 324 (144, 508) 452 (243, 749) 0.6 (0.3, 1.2) 
Fruit‡  143 (43, 331) 100 (23, 245) 180 (64, 362)  
Vegetables‡   220 (110, 425) 194 (84, 348) 237 (132, 469)  
  Vegetables, coarse ‖   97 (29, 208) 83 (23, 191) 104 (39, 215)  
  Vegetables, fine ‖  114 (49, 228) 95 (37, 167) 122 (68, 255)  
Potatoes‡  57 (7, 138) 73 (15, 152) 47 (2, 126)  
Milk‡   243 (68, 513) 213 (68, 484) 272 (70, 531)  
Cheese‡ Choose low fat 45 (11, 129) 36 (5, 97) 50 (16, 156)  
Edible fats  31 (18, 46) 30 (16, 48) 31 (18, 45)  
Sugar and candy Reduce intake 35 (10, 77) 31 (10, 76) 38 (14, 77)  
Energy distribution      
   Protein,  E% 10-20  17 (14, 22) 17 (14, 21) 17 (14, 22)  
   Fat,  E% 25-40 35 (29, 42) 35 (28, 40) 36 (29, 43)  
   SFA, E% < 10 13 (11, 17) 13 (10, 17) 13 (11, 16) 0.7 (0.4, 0.9) 
   MUFA, E% 10-20 13 (10, 17) 13 (10, 16) 14 (11, 18)  
   PUFA,  E% 5-10 5 (4, 7) 5 (4, 6) 5 (4, 7)  
   Carbohydrate E% 45-60 44 (35, 53) 43 (34, 53) 45 (35, 53)  
   Added sugar E% < 10 7 (2,13) 7 (2, 15) 7 (3, 13) 1.3 (0.7, 1.8) 
   Dietary fibre, g/MJ >3 g/MJ 2 (2,3) 2 (2, 3) 3 (2, 4)  
   Alcohol,  E%¶ < 5 5 (1,14) 7 (1, 16) 4 (0, 10)  
Abbreviations: g, gram; MJ, mega joule; SFA, Saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, 
polyunsaturated fatty acids 
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† recommended according to the official Danish food based dietary guidelines (5) and the Nordic Nutrition 
Recommendations, NNR 2012 (35) 
‡ including products made of the related food group 
¨All; n=201, men; n=83, women; n=118 after exclusion of those who did not eat fish 
^ All; n=180, men; n=76, women; n=104 after exclusion of those who did not eat poultry 
§ Eat 6 a day - equivalent to about 600 g vegetables and fruit. At least half should be vegetables 
‖ Vegetables are classified from type of food groups (e.g. all types of cabbage, rooted vegetables and onions are 
classified as coarse vegetables and all vegetables with a high water content like tomatoes and salad are classified as fine 
vegetables). 
¶ All; n=194, men; n=81, women; n=113 after exclusion of those who did not drink alcohol. 
4.3.1  Associations between DQI and cardiometabolic risk factors  
Table 7 summarises the associations between DQI score and cardiometabolic risk factors in the 
study population. Only results from the multivariate model 1b (adjusted for sex, age, education, and 
physical activity during leisure time) are presented. For the results of the simple linear regression 
model (model 1a, only adjusted for sex and age) and the multivariate model (model 2, additionally 
adjusted for BMI), see paper I.  
Overall, an inverse association was found between DQI and the lipid risk factors: LDL/HDL ratio 
and TAG (−0.089 per unit, 95% CI −0.177 to −0.002, p = 0.031 and −5% per unit, 95% CI −9% to 
0%, p = 0.029, respectively); DQI was positively associated with HDL cholesterol (0.047 mmol/L 
per unit, 95% CI 0.007 to 0.088 mmol/L, p = 0.021).  
For men, the DQI was inversely associated with BMI (−3% per unit, 95% CI −5% to −1%, p = 
0.012), trunk fat (−1% per unit, 95% CI −2% to −1%, p = 0.001), hsCRP (−30% per unit, 95% CI 
−41% to −16%, p = 0.002), HbA1c (−0.09% per unit, 95% CI −0.14% to −0.04%, p < 0.001), 
insulin (−13% per unit, 95% CI −19% to −7%, p < 0.001), and HOMA-IR (−14% per unit, 95% CI 
−21% to −7%, p < 0.001). In women, DQI was positively associated with systolic blood pressure 
(2.6 mmHg per unit, 95% CI 0.6 to 4.6 mmHg, p = 0.021). 
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Table 7 Linear regression of the associations between adherence to the Danish official dietary guidelines assessed 
by a DQI and cardiometabolic risk factors in an adult Danish population with minimum one self-reported risk 
factor for IHD (β-coefficients per unit DQI and 95% confidence intervals (CI), n=219). 
 Model 1b† β (95% CI) 
Metabolic markers   
BMI (kg/m2) (%) 0 (-1, 2) 
      Men  -3** (-5, -1) 
      Women  0 (-1, 2) 
Waist/hip-ratio (%) -1 (-1, 0) 
Trunk fat (%) 0 (-1, 1) 
      Men -1*** (-2, -1) 
      Women 0.02 (-0.69, 0.73) 
Systolic BP (mm Hg)¨ 1.15 (-0.36, 2.67) 
      Men -0.68 (-3.04, 1.68) 
      Women 2.6* (0.63, 4.58) 
Diastolic BP (mmHg)¨ 0.92 (-0.3, 2.13) 
      Men -1.33 (-2.78,  0.12) 
      Women 0.92 (-0.3,  2.13) 
hsCRP (mg/l) (%)^ -16** (-25, -6) 
      Men -30*** (-41, -16) 
      Women -5 (-18, 9) 
Lipid biomarkers §   
Total cholesterol (mmol/l)  -0.009 (-0.104, 0.087) 
LDL-c (mmol/l)  -0.027 (-0.110, 0.055) 
HDL-c (mmol/l)  0.047* (0.007, 0.088) 
      <50 years   
      >50 years   
LDL/HDL-ratio -0.089* (-0.177, -0.002) 
VLDL-c (mmol/l) (%) -5 (-9, 0) 
TAG (mmol/l) (%) -5* (-9, 0) 
Glycaemic biomarkers #   
Glucose (mmol/l) (%) 0 (-1, 1) 
HbA1c (%) 0.02 (-0.02, 0.06) 
      Men  -0.09*** (-0.14, -0.04) 
      Women 0.02 (-0.02, 0.06) 
Insulin (pmol/L) (%) -2 (-7, 5) 
      Men (%) -13*** (-19, -7) 
      Women (%) -7 (-7, 5) 
HOMA-IR (%) -1 (-7, 6) 
      Men (%) -14*** (-21, -7) 
      Women (%) -1 (-7, 6) 
DQI, diet quality index; IHD, Ischaemic heart disease; BMI, Body Mass Index; BP, blood pressure; hsCRP, high-
sensitivity C-reactive protein; LDL-c, low density lipoprotein-cholesterol; HDL-c, high density lipoprotein-cholesterol; 
VLDL-c, very low density lipoprotein-cholesterol;  TAG, triglycerides; HbA1c , haemoglobin A1c;  HOMA-IR, 
homeostatic model of insulin resistance    
Levels of significance are marked as: * p<0.05, ** p=<0.01, *** p=0.001 
† Multiple linear regression analysis adjusted for sex, age, education, physical activity at leisure time 
‡ Multiple linear regression analysis adjusted for sex, age, education, physical activity at leisure time and BMI 
¨ n = 216, after exclusion of those using BP-lowing medication 
^ n = 204 due to lack in biochemical analyses of hsCRP 
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§ n=214 at baseline, n=196 at 6 month and n=193 at 12 month after exclusion of those using cholesterol lowering 
medication 
# n=218 at baseline, 201 at 6 month and n=195 at 12 month as it was not possible to draw enough blood for the 
glycaemic biomarkers analysis 
 Results of paper II  
4.4.1 Dietary differences from baseline to 6 months  
Table 8 presents the between-group differences for changes in dietary intake endpoints from 
baseline to 6 months and from baseline to 12 months. Only results from the main model, the 
multiple liner regression model (model 2, adjusted for baseline intake of the outcome variables, sex, 
age group, and BMI) are presented. For results of the simple model, see paper II in Appendix A. 
4.4.1.1 Targeted substitution dietary guidelines compared with the habitual diet 
Compared with the habitual diet group, the group following the targeted substitution dietary 
guidelines increased their intakes of whole grains (17 g/10 MJ/d, 95% CI 6 to 28 g/10 MJ/d, p = 
0.002), dietary fibre (men: 0.31 g/MJ/d , 95% CI 0.04 to 0.58 g/MJ/d, p = 0.045 and women: 0.23 
g/MJ/d, 95% CI 0.002 to 0.45 g/MJ/d, p = 0.024), fine vegetables (41 g/10 MJ/d, 95% CI 5 to 77 
g/10 MJ/d, p = 0.024), and decreased their percentage of energy intake from SFA (−1.51 E%, 95% 
CI −2.31 to −0.70 E%, p < 0.001). In addition, women in the group increased their overall intake of 
vegetables (69.98 g/10 MJ/d, 95% CI 19.37 to 120.58 g/10 MJ/d, p = 0.007), and normal weight 
participants in the group increased their E% intake from PUFAs (1.55 E%, 95% CI 0.73 to 2.36 
E%, p < 0.001).   
4.4.1.2 Danish Official dietary guidelines compared with the habitual diet 
Compared with the habitual diet, the group following the Danish official dietary guidelines 
decreased their E% intake from SFA (−0.89 E%, 95% CI −1.69 to −0.09 E%, p = 0.029). 
Furthermore, the women in the group increased their overall intake of vegetables (60.31 g/10 MJ/d, 
95% CI 10.16 to 110.45 g/10 MJ/d, p = 0.019). Men in the group decreased their intake of coarse 
vegetables (−40 g/10 MJ/d, 95% CI −78 to −2 g/10 MJ/d, p = 0.040).   
4.4.2 Dietary differences from baseline to 12 months 
4.4.2.1 Targeted substitution dietary guidelines compared with the habitual diet 
Compared with the habitual diet, the group following the targeted substitution dietary guidelines 
continued to have an increased intake of whole grains from baseline to 12 months (16 g/10 MJ/d, 
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95% CI 6 to 27 g/10 MJ/d, p = 0.002) and increased intake of fish (23 g/10 MJ/d, 95% CI 3 to 43 
g/10 MJ/d, p = 0.022). Obese study participants in the group increased their vegetable intake in 
general (166 g/10 MJ/d, 95% CI 45 to 287 g/10 MJ/d, p = 0.007). Participants in the group 
increased their intake of sugar and candy (9 g/10 MJ/d, 95% CI 0.2 to 17 g/10 MJ/d, p = 0.046) and 
those aged ≥ 50 years increased their E% intake from carbohydrates (2.67 E%, 95% CI 0.15 to 5.19 
E%, p = 0.038). 
4.4.2.2 Danish official dietary guidelines compared with the habitual diet 
Compared with the habitual diet, from baseline to 12 months, the group following the Danish 
official dietary guidelines had increased intakes of whole grains (13 g/10 MJ/d, 95% CI 3 to 23 g/10 
MJ/d, p = 0.012) and fish (24 g/10 MJ/d, 95% CI 5 to 44 g/10 MJ/d, p = 0.016), and they continued 
to have a decreased E% intake from SFA (−0.84 E%, 95% CI −1.69 to −0.001 E%, p = 0.050). 
Participants aged ≥ 50 years in the group increased their E% intake from carbohydrates (2.95 E%, 
95% CI 0.45 to 5.46 E%, p = 0.021). 
4.4.3 Differences in DQI score from baseline to 6 and 12 months  
Table 9 presents the between-group differences in changes of DQI score from baseline to 6 months 
and from baseline to 12 months (not included in paper II). 
Compared with the habitual diet group, both the group receiving the targeted substitution dietary 
guidelines and the group receiving the Danish official dietary guidelines increased their DQI scores 
from baseline to 6 months (0.6 units, 95% CI 0.2 to 1.0 units and 0.4 units, 95% CI 0.02 to 0.9 
units, respectively) and from baseline to 12 months (0.7 units, 95% CI 0.3 to 1.2 units and 0.9 units, 
95% CI 0.4 to 1.3 units, respectively). 
4.4.4 Within group differences in dietary intake endpoints and IHD risk factors  
In Tables 2 and 3 of Appendix B, mean changes (95% CI) in dietary data and IHD risk factors in 
the randomised groups, from baseline to 6 months and from baseline to 12 months are presented 
(not included in paper II). 
4.4.5 Association between whole grain intake and plasma alkylresorcinols at baseline 
From the cross-classification between reported whole grain intake and alkylresorcinol 
concentrations, 36% of study participants were classified in the same quartile, 70% were classified 
in the same or an adjacent quartile, 22% were two quartiles apart, and 9% were misclassified in the 
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opposite quartile (data not shown). A statistically significant association between whole grain intake 
and plasma alkylresorcinols was observed at baseline (p < 0.0001).  
 Results of paper III 
4.5.1 Differences in IHD risk factors  
In Table 10 the between-group differences in IHD risk factors from baseline to 6 months and from 
baseline to 12 months are presented. Only results from the main model, the multiple liner regression 
model (model 2, adjusted for baseline intake of the outcome variables, sex, age group, and BMI) are 
presented. For results from the simple model, see paper III in Appendix A. 
Overall, no differences were found in cardiometabolic risk factors for either of the two dietary 
guideline groups when compared with the habitual diet. A significant decrease was found in waist 
circumference (−4.41 cm, 95% CI −7.93 to −0.88 cm, p = 0.015) from baseline to 12 months among 
obese study participants following the Danish official dietary guidelines, compared with the 
habitual diet group.  
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Table 8 Between-group differences in changes in energy adjusted diet composition (g/10 MJ/d), total energy (MJ/d),  
energy contribution (E%) of macronutrients, dietary fibre (g/MJ) from baseline to 6 months and from baseline to 12 months  
(means and 95% confidence intervals (CI), n=219 at baseline, n= 199 at 6 month and n= 186 at 12 months). 
 Model 2† 
From baseline to 6 months 
Model 2† 
From baseline to 12 months 
                                              
SUB DG vs. habitual 
Mean between group 
difference, 95%CI 
OFF DG vs. habitual 
Mean between group 
difference, 95%CI 
SUB DG vs. habitual 
Mean between group 
difference, 95%CI 
OFF DG vs. habitual 
Mean between group 
difference, 95%CI 
Diet composition (g/10 MJ/d):         
Bread and cereals 6 (-14, 26) -2 (-22, 18) 10 (-10, 31) 7 (-14, 27) 
   Whole grains 18** (7, 28) 7 (-4, 17) 16** (6, 27) 13* (3, 23) 
Meat and meat products -16 (-39, 6) -15 (-38, 7) -22 (-47, 2) -24 (-48, 0.3) 
Poultry and poultry products  -4 (-36, 27) -10 (-39, 20) 2 (-17, 20) 15 (-3, 33) 
Fish and fish products 12 (-7, 30) 15 (-4, 33) 23* (3, 43) 24* (5, 44) 
Fruit and fruit products 26 (-12, 64) 23 (-15, 62) -4 (-42, 34) -1 (-39, 36) 
Vegetables and vegetables 
products 
45* (5, 84) 16 (-23, 55) -20 (-69, 30) -11 (-61,  38) 
   Women 70** (19, 121) 60* (10, 110)     
   Men 8 (-52, 69) -48 (-109, 12)     
   Normal weight     -92 (-183,   0.1) -71 (-156,  15) 
   Overweight     -36 (-101, 29) 6 (-60,  72) 
   Obese     166** (45, 287) 61 (-62, 185) 
Vegetables, coarse‡ 9 (-15,  334) -3 (-27, 22) -14 (-45,  17) -8 (-38,  23) 
   Women 18 (-14, 50) 23 (-9, 54)     
   Men -4 (-42, 34) -40* (-78, -2)     
Vegetables, fine‡ 41* (5,  77) 34 (-2, 70) -8 (-39,  24) -9 (-41,  22) 
Potatoes and potatoes products -9 (-30, 11) 5 (-15, 25) -7 (-33, 20) 14 (-11, 39) 
   Women     14 (-20, 48) 4 (-28, 36) 
   Men     -37 (-77, 3) 29 (-8, 66) 
Milk and milk products -6 (-65,  53) 38 (-21, 96) 19 (-33, 71) -4 (-54, 47) 
Cheese and cheese products -18 (-37, 1) -18 (-36, 1) -23 (-48, 2) -4 (-29, 21) 
Edible fats -4 (-8, 1) -3 (-7, 2) 0.1 (-4, 5) -2 (-6, 3) 
Sugar and candy 5 (-3, 13) 3 (-5, 11) 9* (0.2, 17) 3 (-5, 12) 
Total energy, energy 
contribution of macronutrient, 
dietary fibre  
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Energy, MJ -0.84 (-3.73, 2.05) 1.53 (-1.28, 4.34) 0.13 (-0.45, 0.71) 0.31 (-0.27,.89) 
Energy from protein, % -0.50 (-1.34, 0.34) -0.17 (-1.01, 0.66) -0.44 (-1.46 , 0.57) 0.42 (-0.59, 1.43) 
Energy from carbohydrate, % 1.77 (-0.23, 3.78) 1.83 (-0.16, 3.81) 1.03 (-0.95,  3.02) 0.90 (-1.07,  2.87) 
<50 years     -1.29 (-4.40,  1.83) -2.18 (-5.28, 0.92) 
≥50 years     2.67* (0.15,  5.19) 2.95* (0.45,  5.45) 
Energy from added sugar, % 0.02 (-1.08, 1.12) 0.09 (-1.01, 1.19) 0.86 (-0.24, 1.96) 0.07 (-1.02, 1.17) 
Energy from total fat, % -1.35 (-3.05, 0.36) -1.03 (-2.72, 0.66) 0.05 (-1.60, 1.69) -0.63 (-2.26, 1.00) 
Energy from SFA, % -1.51*** (-2.3, -0.70) -0.89* (-1.69, -0.09) -0.73 (-1.59,  0.12) -0.84* (-1.69, -0.001) 
Energy from MUFA, % -0.22 (-1.13, 0.70) -0.19 (-1.10, 0.72) 0.44 (-0.51, 1.38) 0.06 (-0.87,  1.00) 
Energy from PUFA, % 0.47* (0.04,  0.91) 0.03 (-0.40, 0.46) 0.19 (-0.24, 0.61) 0.24 (-0.18, 0.66) 
   Normal weight 1.55*** (0.73, 2.36) 0.05 (-0.71, 0.81)     
   Overweight -0.06 (-0.64, 0.51) -0.03 (-0.61, 0.55)     
   Obese 0.60 (-0.42, 1.63) 0.11 (-0.95, 1.18)     
Energy from alcohol, % 0.50 (-0.67, 1.67) -0.48 (-1.67, 0.70) -1.15 (-2.37, 0.07) -1.11 (-2.33, 0.11) 
Dietary fibre, g/MJ/d 0.26** (0.09,  0.44) 0.08 (-0.09, 0.25) 0.08 (-0.10, 0.26) 0.10 (-0.08, 0.28) 
   Women 0.23* (0.01,  0.45) 0.22 (-0.01, 0.44)     
   Men  0.31* (0.04, 0.58) -0.12 (-0.39, 0.15)     
Abbreviations: SUB DG, targeted substitution dietary guidelines; habitual, habitual diet; OFF DG, Danish official dietary guidelines; g, gram; MJ,  
mega joule; SFA, Saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids 
Levels of significance are marked as: * p<0.05, ** p=<0.01, *** p=0.001 
†multiple liner regression model adjusted for baseline intake of the outcome variable, sex, age group (<50 and ≥50), BMI group  
(18.5-25 = Normal weight, >25-30 = Overweight, >30 = Obese) and interactions between intervention group and sex, intervention  
group and age group, and intervention group and BMI group 
‡ Vegetables are classified from type of food groups (e.g. all types of cabbage, rooted vegetables and onions are classified as coarse  
vegetables and all vegetables with a high water content like tomatoes and salad are classified as fine vegetables). 
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Table 9 Between-group differences in changes in DQI score from baseline to 6 months and from baseline to 12 months  
(means and 95% confidence intervals (CI), n=219 at baseline, n= 199 at 6 month and n= 186 at 12 months). 
 Model 2† 
From baseline to 6 months 
Model 2† 
From baseline to 12 months 
                                              
SUB DG vs. habitual 
Mean between group 
difference, 95%CI 
OFF DG vs. habitual 
Mean between group 
difference, 95%CI 
SUB DG vs. habitual 
Mean between group 
difference, 95%CI 
OFF DG vs. habitual 
Mean between group 
difference, 95%CI 
DQI score 0.6** (0.2, 1.0) 0.4* (0.02, 0.9) 0.7** (0.3, 1.2) 0.9*** (0.4, 1,3) 
Abbreviations: DQI, Diet quality index; SUB DG, targeted substitution dietary guidelines; habitual, habitual diet; OFF DG, Danish official dietary guidelines 
 
 
Table 10 Between-group differences in cardio-metabolic risk factors from baseline to 6 month and from baseline to 12 months 
(means and 95% confidence intervals (CI), n=219 at baseline, n= 203 at 6 month and n= 196 at 12 months). 
 Model 2† 
From baseline to 6 months 
Model 2† 
From baseline to 12 months 
 SUB DG vs. habitual 
Mean between group 
difference, 95%CI 
OFF DG vs. habitual  
Mean between group 
difference, 95%CI 
SUB DG vs. habitual 
Mean between group 
difference, 95%CI 
OFF DG vs. habitual 
Mean between group 
difference, 95%CI 
Weight (kg) -0.40 (-1.40, 0.60) -0.67 (-1.67, 0.32) -0.19 (-1.40, 1.03) -0.47 (-1.68, 0.73) 
BMI (kg/m2)  -0.13 (-0.47, 0.20) -0.24 (-0.58, 0.09) -0.06 (-0.47, 0.35) -0.17 (-0.58, 0.23) 
Waist circumference (cm)  -0.29 (-1.62, 1.05) 0.11 (-1.22, 1.45) -0.92 (-2.33, 0.48) -0.08 (-1.49, 1.32) 
   Normal weight -0.27 (-2.75, 2.20) -1.07 (-3.44, 1.30) -0.94 (-3.55,1.67) -0.43 (-2.88, 2.02) 
   Overweight -1.14 (-2.93, 0.64) 1.13 (-0.67, 2.93) -1.31 (-3.15, 0.53) 1.27 (-0.58,3.13) 
   Obese 2.45 (-0.67, 5.57) -0.98 (-4.19, 2.24) 0.28 (-3.06, 3.63) -4.41*** (-7.93,-0.88) 
Hip circumference (cm) -0.61 (-1.64, 0.41) -0.09 (-1.11, 0.93) -0.07 (-1.24, 1.11) -0.27 (-1.43, 0.90) 
   Normal weight     0.06 (-2.15, 2.27) -1.20 (-3.27, 0.86) 
   Overweight     -0.8 (-2.34, 0.76) 0.46 (-1.10, 2.03) 
   Obese     2.27 (-0.56, 5.11) -1.05 (-3.99, 1.90) 
Waist/hip-ratio 0.003 (-0.009, 0.02) -0.00009 (-0.01, 0.01) -0.007 (-0.02, 0.005) 0.0008 (-0.01, 0.01) 
Body fat (%) 0.08 (-0.54, 0.70) -0.10 (-0.72, 0.5) 0.59 (-0.20, 1.38) -0.04 (-0.82, 0.74) 
Trunk fat (%) 0.12 (-0.62, 0.87) -0.12 (-0.86, 0.62) 0.75 (-0.16, 1.67) -0.03 (-0.93, 0.88) 
Systolic BP (mm Hg)‡ 1.25 (-1.95, 4.45) -1.28 (-4.46, 1.89) -0.42 (-3.69 2.86) -2.99 (-6.26, 0.28) 
Diastolic BP (mm Hg)‡ 1.37 (-0.32, 3.05) -0.73 (-2.40, 0.93) 0.24 (-1.63, 2.12) -1.22 (-3.09, 0.65) 
hsCRP (mg/L)^ 0.18 (-0.23, 0.58) -0.04 (-0.44, 0.36) 0.07 (-0.4, 0.60) -0.03 (-0.56, 0.50) 
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Lipid biomarkers§         
   Total cholesterol -0.12 (-0.29, 0.06) -0.08 (-0.26 0.10) 0.07 (-0.17, 0.32) -0.14 (-0.38, 0.10) 
   LDL-HDL ratio 0.007 (-0.14, 0.16) 0.04 (-0.11, 0.19) 0.06 (-0.13, 0.26) -0.06 (-0.25, 0.14) 
   LDL cholesterol (mmol/L) -0.08 (-0.23, 0.08) -0.03 (-0.19, 0.12) 0.12 (-0.10, 0.33) -0.10 (-0.31, 0.11) 
   HDL cholesterol (mmol/L) -0.001 (-0.06, 0.06) -0.01 (-0.07, 0.05) 0.03 (-0.04, 0.10) -0.01 (-0.08, 0.07) 
   VLDL cholesterol (mmol/L) -0.04 (-0.12, 0.04) -0.02 (-0.10, 0.07) -0.06 (-0.16, 0.04) -0.01 (-0.11, 0.08) 
   TAG (mmol/L) -0.09 (-0.28, 0.10) -0.03 (-0.22, 0.15) -0.15 (-0.37, 0.07) -0.04 (-0.25, 0.18) 
Glycaemic biomarkers§         
   Glucose (mmol/L) 0.06 (-0.05, 0.18) 0.03 (-0.08, 0.15) -0.01 (-0.13, 0.10) 0.04 (-0.07, 0.16) 
   eAG (mmol/L) -0.008 (-0.13, 0.12) 0.014 (-0.11, 0.14) 0.001 (-0.11, 0.12) 0.09 (-0.02, 0.21) 
   HbA1c (%) -0.001 (-0.08, 0.07) 0.01 (-0.07, 0.08) 0.003 (-0.07, 0.08) 0.06 (-0.01,0.13) 
   HOMA-IR -0.06 (-0.44, 0.32) -0.04 (-0.42, 0.34) -0.08 (-0.48, 0.32) 0.11 (-0.29, 0.51) 
   Insulin (pmol/L) -2.56 (-12.37, 7.25) -2.29 (-12.00, 7.42) -2.09 (-11.66, 7.48) 3.58 (-5.95, 13.10) 
   C-peptid -2.49 (-41.32, 6.34) 1.04 -37.49, 39.58) 1.01 (-38.52, 40.54) 39.00 (-0.45, 78.46) 
Abbreviations: SUB DG, targeted substitution dietary guidelines; habitual, habitual diet; OFF DG, Danish official dietary guidelines; BMI,  
Body Mass Index; BP, blood pressure; hsCRP, high-sensitivity C-reactive protein; LDL, low density lipoprotein-cholesterol; HDL, high density  
lipoprotein-cholesterol; VLDL, very low density lipoprotein-cholesterol;  TAG, triglycerides; HbA1c , haemoglobin A1c;  HOMA-IR,  
homeostatic model of insulin resistance          
† multiple liner regression model adjusted for baseline intake of the outcome variable, sex, age group (<50 and ≥50), BMI group (18.5-25 = Normal weight,  
>25-30 = Overweight, >30 = Obese) and interactions between intervention group and sex, intervention group and age group, and intervention group and BMI group 
‡ n=216 at baseline, n= 201 at 6 month and n= 190 at 12 month after exclusion of those using BP-lowering medication 
¨ n= 204 at baseline, n=196 at 6 month and n= 185 at 12 month due to lack in biochemical analysis of hsCRP 
^ n=214 at baseline, n=196 at 6 month and n=193 at 12 month after exclusion of those using cholesterol lowering medication 
§ n=218 at baseline, 201 at 6 month and n=195 at 12 month as it was not possible to draw enough blood for the glycaemic biomarkers analysis 
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 Under-and over-reporting and medication users (papers I to III) 
4.6.1 Under- and over-reporters 
At baseline, at 6 months, and at 12 months, 21%, 35%, and 31% of the participants, respectively, 
were classified as under-reporters. In addition, 1% were classified as over-reporters at baseline, 6 
months, and 12 months. Of the under-reporters, 86%–90% were overweight or obese, and 41%–
44% were men; all the over-reporters were men.  
In paper I, the associations between DQI and most of the included variables were the same whether 
under- and over-reporters were or were not included in the analysis. In paper II, excluding under- 
and over-reporters for the sensitivity analysis did not change the findings for the two sets of dietary 
guidelines, compared with the habitual diet. 
4.6.2 Medication users  
Participants who were taking medications to lower cholesterol (n = 5 at baseline, n = 7 at 6 months, 
and n = 3 at 12 months) and/or blood pressure (n = 3 at baseline, n = 2 at 6 months, and n = 6 at 12 
months) were excluded from the statistical analysis of lipid biomarkers and blood pressure, 
respectively.   
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5 Discussion 
 Main results 
Firstly, in the cross-sectional study of paper I, a closer adherence to the current Danish official 
dietary guidelines, assessed by a DQI, was found to be associated with a more beneficial 
cardiometabolic risk profile in an adult Danish population with a minimum of one self-reported risk 
factor for IHD. The overall results showed an inverse association between DQI score and lipid risk 
factors (LDL/HDL ratio and TAG) and a positive association with HDL cholesterol. For male 
participants, an inverse association between DQI and BMI, trunk fat, hsCRP, and glycaemic risk 
factors was found. Furthermore, for women, we found a positive association between DQI and 
systolic blood pressure. 
Secondly, the main results of the DIPI RCT showed that, compared with the habitual diet, during 
the intervention period from baseline to 6 months, the targeted substitution dietary guidelines were 
more effective than the Danish official dietary guidelines in changing the number of dietary 
components, resulting in a dietary composition of the overall diet that was more cardioprotective. 
However, when including follow-up, from baseline to 12 months, the effectiveness in changing the 
dietary composition in this manner was similar for both the targeted substitution dietary guidelines 
and the Danish official dietary guidelines, compared with the habitual diet (paper II). This was 
supported by the observed positive changes in DQI score, indicating an increased adherence to both 
sets of dietary guidelines throughout the intervention and follow-up periods, compared with the 
habitual diet.  
Even though both sets of dietary guidelines were effective in changing dietary composition towards 
a more cardio-protective dietary pattern, neither applying the targeted substitution dietary guidelines 
nor the Danish official dietary guidelines showed any overall effects on the included intermediate 
risk factors for IHD, from baseline to 6 or 12 months (paper III). 
 Paper 1: Comparison with other observational studies 
The findings of the cross-sectional study of paper I are in line with those of the cross-sectional 
study by Toft et al. including 6542 healthy adult Danish men and women, comparable with the 
study population of the DIPI RCT. In the study Toft et al. found that a higher DQS, indicating 
closer adherence to the 2005 Danish official dietary guidelines, was associated with a more 
beneficial CVD risk factor profile (90). 
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The observed positive associations between a higher dietary score and better cardiometabolic risk 
profile found in both paper I and in the study by Toft et al. could potentially be used for prevention 
of cardiovascular-related diseases. This is supported by findings of the recently published 
prospective cohort study of Hansen et al. including 55,021 adult Danish men and women (95). In that 
study, greater adherence to the 2013 Danish official dietary guidelines, assessed by another updated 
DQI called the Danish Guidelines Index Score, was associated with a 13% and 24% lower risk of 
MI in men and women, respectively. 
The sex-specific inverse associations between DQI and BMI, trunk fat, hsCRP, and glycaemic risk 
factors for male participants found in paper I are also in line with the results of two cohort studies, 
by Drewnowski et al. (123) and Frazier-Wood et al., both investigating the association between diet 
quality, as indexed by the HEI, originally developed to assess adherence to the Dietary Guidelines 
for Americans, and cardiovascular risk factors (124).  
In the cross-sectional study by Drewnowski et al. including 5,081 middle-aged French men and 
women with low CVD risk, an inverse association between HEI and BMI and blood pressure was 
found in men only (123). Also in the cross-sectional study by Frazier-Wood et al.(124) including 9,797 
adult American men and women with at least one CVD risk factor, comparable with the study 
population of the present research, the HEI score was inversely associated with insulin, HOMA-IR, 
HDL cholesterol, TAG, and CRP in men only (125). Yet, in contrast to our results, when Frazier-
Wood et al. adjusted for BMI, the results were no longer significant. In paper I, when further 
adjustments for BMI were made, the associations between DQI score and glycaemic biomarkers 
remained significant; however, the associations between DQI score and LDL/HDL ratio, TAG, and 
trunk fat were attenuated and no longer statistically significant. These results and those of Frazier-
Wood et al. suggest that BMI might be an important factor in cardiovascular disease prevention 
(125).  
The sex difference of inverse associations between DQI and BMI, trunk fat, hsCRP, and glycaemic 
risk factors for male participants found in the results of paper I, could be explained by the higher 
number of overweight men than women. In addition, we only found an inverse significant 
association between DQI and BMI in men. Also, the link between BMI, trunk fat, and hsCRP is 
supported by the recognised inverse relationship between BMI and CRP. Moreover, it is known that 
CRP is further elevated with increased adiposity (126).  
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5.2.1 Methodological considerations: Paper I, the cross-sectional study 
5.2.1.1 The DQI 
In contrast to the more traditional approach of focusing on single foods and nutrients, use of the 
DQI to assess adherence to the Danish official dietary guidelines and the associations with IHD risk 
factors allowed us to combine information on multiple dietary data into this single indicator of 
adherence and to catch potential additive or synergistic effects of the different components of the 
diet.  
The predefined DQI is based on five food and nutrient guidelines of the 10 Danish official dietary 
guidelines. Originally, the DQI was developed for the purpose of evaluating the overall diet quality 
based on the 2005 Danish official dietary guidelines and not for evaluation of the potential health 
effects of the included foods and nutrients (91). Therefore, the items included in the DQI are not 
weighted according to their expected health effects; it is therefore not plausible to expect an 
association with all the outcomes included in the present study. 
In addition, the DQI does not include intakes of meat and salt, which have both been associated 
with low cardiometabolic health (52, 54, 127–130). Especially, an excessive intake of salt/sodium have 
been associated with an elevated blood pressure in some people (128–130), and intake of salt could be 
related to the surprising and unexpected finding of a positive association between the DQI and 
systolic blood pressure in women, which is not in line with previous studies of dietary patterns and 
blood pressure. In a meta-analysis of 17 RCTs investigating the effect of dietary patterns on blood 
pressure in adults, it was found that healthy dietary patterns such as those of the Nordic, 
Mediterranean, and DASH diets decreased systolic and diastolic blood pressure (131).  The primary 
reason that salt was not included in the DQI is that estimation of sodium chloride with the dietary 
record method that was used to collect dietary intake information would involve excessive 
uncertainty. 
However, the index used in the present study includes whole grains, fish, fruits and vegetables, 
energy from saturated fat, and energy from added sugar, all of which have been associated with 
either a reduced risk of IHD or an increased risk of IHD (5, 43, 64, 69, 132). Therefore, it was expected 
that a higher DQI score would be associated with a better cardiometabolic risk profile. 
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5.2.1.2 Internal and external validity 
The results of paper I were based on baseline data from the DIPI RCT, of which the internal and 
external validity is discussed in details in section 5.3.1.  
A strength of this cross-sectional study was the availability of detailed dietary intake data, collected 
using a web-based 7-day dietary record, limiting measurement errors. In addition, sub-analysis 
excluding under- and over-reporters was also conducted, which made it possible to consider the 
potential information-bias of under- and over-reporting in the self-reported dietary data. 
Furthermore, different liner regression models were applied in order to consider potential 
confounders; unmeasured confounding cannot be ruled out, however. In addition, interaction effects 
were examined to determine whether the associations between DQI and the outcome variables were 
different between sexes and age groups.  
A limitation of this study was the observational design of the cross-sectional study, which does not 
allow for conclusions to be made about cause and effect relationships. Furthermore, the power of 
the study, which was originally calculated for the DIPI RCT, must be considered quite low for a 
cross-sectional study, with only 219 included study participants. Considering these limitations, and 
especially the fact that the study was underpowered, both the internal and external validity of the 
study must be considered quite low, and generalisation based on the results should be made with 
caution. 
 Paper II and III: Comparison with other dietary RCT 
The results of the DIPI RCT are in line with results of the previously described RCT by Jenkins et 
al. (104). Comparable with the findings of increased whole grain intake in the DIPI RCT, Jenkins et 
al. also observed an increase in whole grain intake in their intervention group receiving only dietary 
advice. However, in contrast to the DIPI RCT, Jenkins et al. only observed increased intake of other 
recommended foods in the intervention groups that were provided with free foods; they did not note 
any other changes in dietary intake endpoints in the intervention group only receiving dietary 
advice. Nevertheless, in line with results of the present study, Jenkin et al. did not find any short- or 
long-term difference in CVD risk factors among any of the three intervention groups, in comparison 
with the control group. 
Two other previously presented dietary RCTs, both conducted in a real-life setting, comparable to 
the DIPI RCT are the CRESSIDA study by Reidlinger et al. (105) and the SYSDIET study by 
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Uusitupa et al. (106). Like the DIPI RCT, these studies found a beneficial dietary effect of both the 
UK dietary guidelines, which are broadly similar to the Danish official dietary guidelines, and the 
healthy Nordic diet. However, in contrast to the DIPI RCT and the RCT by Jenkins et al. (104) both 
the study by Reidlinger et al. (105) and that by Uusitupa et al. (106) found beneficial effects of 
providing advice on selected CVD risk factors, potentially leading to prevention of CVD.  
In contrast to the DIPI RCT, in a sub-study of the aforementioned long-term dietary RCT, the 
PREDIMED study, Estruch et al. found short-term beneficial effects on CVD risk factors in both 
groups following the two Mediterranean diets that were provided with either olive oil or nuts, in 
comparison with a low-fat diet (120). The sub-study included 772 participants and measured dietary 
compliance and CVD risk factors after 3 months. Apart from an increase in E% intake from the 
provided foods, Estruch et al. observed an increase in E% intakes from total fat, MUFAs, and 
PUFAs, and a decrease in E% intake from carbohydrates in the Mediterranean diet group provided 
with nuts, compared with the low-fat group. Estruch et al. did not report other dietary changes in 
either of the two Mediterranean diet groups, in comparison with the low-fat diet. However, long-
term beneficial dietary changes were found in both Mediterranean diet groups provided with olive 
oil or nuts, and a concomitant 30% and 28% lower risk of major cardiovascular events, respectively, 
compared with the low-fat diet group (107). 
In the studies by Reidlinger et al. (105), Uusitupa et al. (106), and Estruch et al. (107, 120), the primary 
dietary changes were found in fat subtypes, all of which reflect the fat content of the provided food 
items. When compared with a control group, Reidlinger et al. (105) found a 7.2 E% decrease from 
SFA and a 1.9 E% increase from PUFAs in the group following the UK dietary guidelines. In 
addition, Uusitupa et al. (106) found a decrease of 4.3 E% from SFA and an increase of 2.1 E% from 
PUFAs in the group following the healthy Nordic diet, when compared to the control group. In the 
PREDIMED study, Estruch et al. found short- and long-term increases of 3.0 E% and 2.0 E% from 
PUFAs, respectively, in the group following a Mediterranean diet plus nuts, and a long-term 
increase of 0.2 E% from SFA and 0.6 E% from PUFAs for those on the Mediterranean diet plus 
olive oil, when compared with the group following the low-fat diet (107, 120). 
In the DIPI RCT, when compared with the control group, the short-term changes in fat subtypes in 
both the group following the targeted substitution dietary guidelines and in the group following the 
Danish official dietary guidelines were a decrease in energy percentage from SFA of 1.5 E% and 
0.9 E%, respectively. In addition, normal-weight participants in the targeted substitution dietary 
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guideline group increased their energy percentage from PUFAs with 1.6 E%. The long-term 
changes in fat subtypes were that the group assigned to follow the Danish official dietary guidelines 
decreased their energy percentage from SFA with 0.8 E%, when compared with the control group. 
The differences in dietary intake (including fat subtypes) between the DIPI RCT and the three 
above-mentioned studies by Reidlinger et al. (105), Uusitupa et al. (106), and Estruch et al. (107, 120) (all 
of which found an effect of the investigated dietary guidelines or healthy diets on CVD risk factors 
and major cardiovascular events) might be due to the fact that, contrary to the present study, the 
participants in the other studies were all provided with key foods according to UK dietary 
guidelines, the healthy Nordic diet, or the Mediterranean diet (105–107, 120). This provision of key 
foods might also be the most important difference between these studies and the DIPI RCT.  
The inconsistency between results of the DIPI RCT and the studies by Reidlinger et al. (105), 
Uusitupa et al. (106), and Estruch et al. (107) might also be due to other differences in the intensity of 
the interventions, apart from the provision of key foods. The intervention/communication format 
used in the DIPI RCT (leaflets, a website including information on dietary guidelines and recipes, 
and biweekly e-mails with new recipes) was chosen to reflect how information about dietary 
guidelines is normally transmitted in real life. Contrary to this, in the study by Jenkins et al., the 
group that only received dietary advice was provided with leaflets but also had 20–30 minutes of 
telephone interviews weekly in the first months and monthly in the final 5 months of the 
intervention (104). Likewise, adherence to both the UK dietary guidelines investigated by Reidlinger 
et al. (105) and the Mediterranean diet investigated by Estruch et al. (107) was achieved through dietary 
advice provided in face-to-face meetings with a dietitian. Both telephone interviews and face-to-
face meetings might be assumed to be more motivating informational methods for study 
participants than the less-interactive media used in the present study  (105, 107). One can speculate that 
if similar intervention tools had been utilized in the DIPI RCT, this might have resulted in a higher 
adherence to the dietary guidelines and a concomitant effect on the risk factors for IHD. 
That said, the effect of the intensity of the intervention was exactly what Jenkin et al. was aiming to 
test in the previously mentioned study (104). However, despite including three intervention groups 
with different intensity (receiving either advice, food provision or advice plus food provision) no 
measured effect on CVD risk factors was found in either of the groups, when compared to a control 
group. This indicates that the intensity of the intervention may not impact the results, however, 
more research is needed in order to draw any conclusions. 
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The baseline health status of study participants might also be of significance when measuring risk 
factors for IHD. In the present study, we recruited participants with a minimum of one self-reported 
risk factor for IHD, but, although most were overweight or obese and had an elevated waist 
circumference, the study participants were generally healthy non-smokers and were not taking 
blood pressure-lowering or anti-hyperlipidaemia medication, and the baseline LDL cholesterol 
levels of the participants were only slightly elevated. This was similar to the study participants in 
the studies by Jenkins et al. (104) and Reidlinger et. al. (105), where only Reidlinger et al. found an 
effect of the investigated UK dietary guidelines on CVD risk factors (105). However, in contrast to 
the baseline health status of the study participants in the DIPI RCT both the RCTs by Estruch et al. 
(107, 120) and Uusitupa et al. (106), included men and women with higher cardiovascular risk, and here 
both studies found a cardioprotective effect of the investigated diets (106, 107, 120). The differences 
between the results of the DIPI RCT and these studies may therefore to a certain extent be due to 
differences in the study participants baseline health status.  
The study participants’ habitual intake of key foods and nutrients included in both sets of dietary 
guidelines could also have contributed to the fact that we did not find any changes in IHD risk 
factors. When compared with the habitual diet, we found the largest dietary changes for intake of 
whole grains, fish, and SFA in both dietary guideline groups. A higher intake of both whole grains 
and fish containing high amounts of PUFAs has been associated with reduced risk of IHD (5). In 
addition, there is strong evidence that consuming PUFAs in place of SFA reduces IHD (57–59). 
However, the participants’ median baseline/habitual intake of whole grains and fish was already 
relatively high, nearly reaching the recommended 75 g/10 MJ/d and 50 g/10 MJ/d, respectively (5). 
By comparison, the mean baseline intake of whole grains in the studies by Jenkins et al. (104), 
Reidlinger et al. (105), and Estruch et al. (107) was only 1.0–1.5 servings/d (1 serving, 30 g) or 
approximately 30–45 g/d (whole grain intake was not presented in Uusitupa et al.’s study). In a 
meta-analysis including dose–response analysis of whole grain intake and CVD mortality, a 
nonlinear effect was found (133). From the dose–response analysis of that meta-analysis, each 28 g/d 
of whole grain intake was associated with a 14% lower risk of CVD mortality; however, when 
comparing the higher range of whole grain intake, the curve appeared steeper at the lower range of 
whole grain intake (133). This finding supports the recommendation for a whole grain intake of 
around 75 g/d. 
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Conversely, study participants in the DIPI RCT had a median baseline/habitual intake of meat and 
meat products (prepared weight) that was much higher (139 g/10 MJ/d) than the recommended 
maximum of 70 g/10 MJ/d (5) and a lower intake of fruit and vegetables (388 g/10 MJ/d) than the 
recommended 600 g/10 MJ/d (5). No significant differences in changes for meat or fruit and 
vegetable intake were observed in the DIPI RCT.  
Closer adherence to the dietary guidelines, with an additional significant reduction in meat intake 
and higher intake of fruit and vegetables, might have led to a change in IHD risk factors. Although 
too small to have a beneficial effect on IHD risk factors, the dietary changes found in both the 
targeted substitution dietary guideline and official dietary guideline groups nearly all constituted 
improvements, compared with the habitual diet. This is also supported by the finding of an 
increased DQI score in both dietary guidelines groups, compared with the habitual diet group, 
throughout both the intervention and the follow-up period, indicating a higher adherence to both 
sets of dietary guidelines. 
The results of the above-mentioned dietary RCTs reveal the many challenges that are related to 
imposing dietary changes, which may influence the disease course of IHD. Therefore, addressing 
other modifiable risk factors, such as smoking and physical activity, might be a plausible 
contribution to the prevention of IHD. Several RCTs have been conducted with the purpose of 
primary prevention of CVD through investigating multiple behavioural risk factors such as smoking 
cessation, healthy food choices, and increased physical activity (134–137). However, these multiple 
risk factor interventions that use counselling and education appear to only have a small effect on 
CVD risk factors and appear to have no effect on CVD events in the general population (134, 135, 137).  
One example of such a large-scale multiple health behaviour change intervention study is the 
Danish INTER99 study, which investigated the effect of screening and multiple lifestyle 
counselling on the incidence of IHD and stroke (138). The study was a 5-year parallel RCT, where 
study participants were randomly assigned to an intervention group including 6,091 adult men and 
women and a control group including 3,324 adult men and women. The intervention consisted of 
counselling based on the participants’ lifestyle and degree of IHD risk. Comparable to the results of 
the DIPI RCT, the INTER99 study also found some favourable changes in dietary endpoints in the 
intervention group, compared with the control group (139, 140), but no significant difference in IHD or 
stroke was seen between the intervention and control groups after 10 years (138).  
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5.3.1 Methodological considerations: Papers II and III, the DIPI RCT 
5.3.1.1 Internal validity 
5.3.1.1.1 Design 
To test the effects of the targeted substitution dietary guidelines we chose a RCT. A key factor in a 
RCT is the allocation of participants by chance to receive one or several interventions so that the 
only systematic difference between the groups is the intervention, making the RCT the gold 
standard with regard to internal validity (141). In the present RCT no differences in key endpoints 
were found at baseline, indicating that the randomisation was successfully conducted.  
The DIPI RCT was conducted in a real-life setting where participants were free-living and 
empowered to modify their dietary pattern, which must be considered a strength as it reflects the 
“real-world” thereby making the application of the results more straight-forward than controlled 
feeding trials. However, this type of study also increases the chance of the intervention being 
blurred by confounders. 
The design of the DIPI RCT included a standard control group that was not provided with any form 
of intervention; a primary intervention group that received the targeted substitution dietary 
guidelines; and a second intervention group that received the Danish official dietary guidelines. 
This made it possible to investigate the effects of the two intervention groups, when compared to 
the control group.  
Even though the DIPI RCT was designed and conducted to fulfil the criteria for a RCT to the 
highest possible degree, the study still has some limitations. 
First of all, the design of the study made it impossible to blind participants, which may bias the 
results as this increased the risk of deteriorating motivation within the control group due to 
dissatisfaction with being assigned to the control group and not receiving any dietary guidelines. At 
the same time the control group were free to search information elsewhere and had access to the 
Danish official dietary guidelines via official homepages and other channels. However, as the 
intervention was conducted only 6 months after the release of the 2013 Danish official dietary 
guidelines, the assumption was that the study participants were not yet very aware of the updated 
official dietary guidelines. Supporting this assumption is the fact that only a small decrease in 
energy intake was observed in the control group from baseline to 6 months, indicating that the 
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control group did in fact not follow the dietary guidelines on their own accord (Tables 2 and 3 of 
Appendix B). 
Secondly, in the design of the DIPI RCT the power calculation was based on LDL cholesterol, one 
of the major modifiable risk factors for IHD (142). However, even though dietary effects of both sets 
of dietary guidelines compared with the habitual diet was found, only small statistically 
insignificant differences in changes in LDL cholesterol in both intervention groups, compared with 
the control group was observed. This “negative/null finding” could be due to insufficient power 
resulting in type II errors (143, 144).  Freiman et al. reviewed the power calculations of 71 RCTs with 
"negative/null" results and found that the estimation of the sample size may assume an 
unrealistically large intervention effect (144).  In the DIPI RCT the intervention effect was set to a 
difference in LDL cholesterol of 0.25 mml/L. However, retrospectively taking the intensity of the 
intervention into consideration (further discussed below in section 5.1.1.1.3) this might have been 
too high.  
5.3.1.1.2 The study population: Selection and drop-outs 
Due to fact that examinations took place at Gentofte Hospital, recruitment of study participants 
were limited to the areas of Greater Copenhagen surrounding the hospital, for practical and cost 
related reasons. In total, 5000 men and women living in the defined area of Greater Copenhagen, 
who were identified using a unique personal identification number assigned to all Danish citizens in 
the Civil Registration System (108), were invited by letter to participate in the study. Of the 5000 
possible participants invited, only 7% responded to the invitation and were screened, which may 
induce sample bias.  
Inclusion criteria were made to define the target population. The aim was to include an adult 
population with at least one risk factor for IHD. Due to prohibitive cost, it was not possible to 
analyse blood samples for lipid biomarkers such as LDL cholesterol, and self-measured risk factors 
was therefore selected. As it turned out, however, the study participants’ self-reported weight and 
waist circumference were statistically significantly higher than the measured weight and waist 
circumference at baseline – possibly because the motivation of the responders to be a part of the 
study was high; however, no difference in BMI was found. This resulted in 17% of women and 7% 
of men not meeting the inclusion criteria when measured at baseline. Also exclusion criteria were 
applied to limit the influence of confounding participant characteristics. 
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A major source of bias in RCTs is related to intervention dropouts. Therefore, in the statistical 
methods of the DIPI RCT intention-to-treat analysis was used. This approach ensures that 
participants are analysed according to their original allocation. However, of the included 
participants 90% and 84% completed the intervention and follow up, respectively, which may be 
considered as high proportion of completers. In addition, there were no differences in the number of 
drop-outs between the groups; therefore it was assumed that the missing data was completely 
random. 
5.3.1.1.3 The intervention 
A fact that may have contributed to the observed null results on the IHD risk factors was the 
relatively low intensity of the intervention (provision of dietary guidelines to the study participant 
through leaflets and a website), that may have been too low to ensure the necessary adherence in the 
two intervention groups that would allow detection of the expected effects of the dietary guidelines 
on IHD risk factors. In contrast, other studies which did find effects of the dietary guidelines on 
cardiometabolic risk factors included higher intensity intervention measures like food provisioning 
and dietary advice through face-to-face meetings with dietitians (105, 106, 120).  
5.3.1.1.4 Statistic, analysis and confounding  
In the statistical analyses of papers II and III, two multiple liner regression models were applied to 
consider known or potential confounding factors which strengthens the interpretability of the 
results. Furthermore, interactions were tested to investigate whether the intervention had different 
effects between sexes, age groups, and BMI. However, confounding from unknown or unmeasured 
factors cannot be excluded.   
A general strength of this thesis research is the availability of detailed dietary intake data collected 
using a web-based 7-day dietary record (37, 110). Also, validation of the dietary method used and 
evidence for compliance with the intervention were provided through an objective biomarker of 
intake. In addition, sub-analysis excluding under- and over-reporters was also applied, which made 
it possible to consider the potential information-bias of under- and over-reporting in the self-
reported dietary data. 
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5.3.1.2 External validity 
Some issues regarding generalisability of the results should be considered.  
First of all, the criteria for inclusion were that the participants should have a minimum of one self-
reported risk factor for IHD. However, although the majority of the participants were overweight or 
obese and had an elevated waist circumference, the study participants were generally healthy, and in 
that regard comparable with the general Danish population. A newly published report found that 
51%  and 16.8 % of the Danish population is overweight or obese (38), comparable with the 
proportion of overweight and obese study participants of the DIPI RCT.  
A second issue regarding generalisability is that the study participants resided in areas of Greater 
Copenhagen with a higher level of education compared with the general Danish population (37).   It 
is well known that higher educational levels is associated with a healthier lifestyle and as such it 
may be more challenging to bring about dietary changes in populations with lower educational 
levels who may be assumed to be less health conscious than the study participants (38). 
 Dietary assessment method and objective markers for intake 
Availability of an appropriate and valid method for assessing dietary intake is an essential 
component in the investigation of diet and disease. The method used in any study should therefore 
be based on the foods or nutrients of interest and the capacity of the target group to provide the 
needed details.  
Long-term food recording methods like the FFQ, which is widely used in observation studies, rely 
on recall by the respondent and inherently gives rise to measurements errors but are simple and 
inexpensive to use, and the burden on the respondent is low.  
In contrast to the FFQ, the dietary recording method used in the research of the present thesis does 
not depend on the respondent’s memory and allows for collection of more detailed information 
about foods. However, both the cost and burden on the respondent are much higher than with the 
FFQ. Therefore, we only collected dietary intake on three occasions in the DIPI RCT: at baseline, 
after 6 months of intervention, and again after another 6 months of follow-up. 
When investigating changes in dietary intake over a period of 6 months, it is difficult to detect 
information on changes in the usual intake of the specific foods and nutrients included in the 
provided dietary guidelines. Repeatedly recording the dietary intake during the intervention and the 
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follow-up periods would have been too big of a burden to respondents and might have caused 
undesirable dropouts. 
Future development of dietary assessment methods to accurately measure dietary intake over a 
period of time is therefore crucial and these should include repeated measurements of dietary intake 
and use of multiple biomarkers for intake. 
In the present thesis research, estimated whole grain intake was validated against alkylresorcinol as 
an objective biomarker. Alkylresorcinol was chosen as a biomarker because of the high relevance of 
whole grains to human health. The results showed that self-reported whole grain intake was 
associated with plasma alkylresorcinol concentrations at baseline. Furthermore, from cross-
classification between reported whole grain intake and alkylresorcinol concentrations, it was found 
that 70% of participants were classified in the same quartile or an adjacent quartile, which is in 
agreement with findings from studies by Ross et al. (145) and Biltoft-Jensen et al. (112).  
It would have been interesting to include more biomarkers for further validation of dietary intake 
such as n-3 fatty acids, using phospholipids as a marker for usual fish intake (146) and serum 
carotenoids as a biomarker for fruit and vegetable intake (147). However, due to the prohibitively 
high cost of biomarker analyses, this was not possible.  
 Implications of the research results  
In paper I the use of a dietary index approach enabled us to describe associations between food and 
nutrient intake in individuals with dietary patterns that were more or less compatible with the 
current Danish official dietary guidelines and cardiometabolic risk factors. Overall, the cross-
sectional study of paper I adds to the growing body of evidence showing that adherence to different 
national dietary guidelines and diets that are rich in fruit and vegetables, whole grains, and fish and 
low in SFA and sweets are associated with a better cardiometabolic risk profile. However, the 
results of the present study need to be further tested and validated in both larger-scale observational 
studies with sufficient power and eventually in RCTs to enable conclusions to be made about cause 
and effect relationships.  
Along those lines, it is important to further investigate the inter-relationship between diet quality, 
IHD risk factors, and BMI. In paper I, when further adjustment for BMI was made, the observed 
inverse association between the DQI score and LDL/HDL ratio, TAG, and trunk fat was attenuated 
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and no longer statistically significant, which strengthens the importance of BMI as a factor in 
cardiovascular disease prevention. Therefore, one might question whether the association of closer 
adherence to Danish official dietary guidelines and a more beneficial cardiometabolic risk profile is 
due to the effect of the official Danish guidelines, expressed in the DQI, on BMI and body 
composition including trunk fat, or whether the association is independent. The results of this study 
further strengthen the need to conduct sex-stratified analyses in relation to investigation of primary 
prevention of IHD risk. 
In paper II, we found an increased intake of some of the recommend foods and nutrients 
included in both sets of dietary guidelines. This was supported by supplementary analysis of a 
short- and long-term increased DQI score, indicating increased adherence to both sets of dietary 
guidelines. As mentioned earlier, the purpose of the DQI originally developed by Knudsen et al. 
was to evaluate the overall diet quality based on the Danish official dietary guidelines in 2005 
and not the potential health effects associated with the included foods and nutrients, the aim of 
paper I (91). However, although the two sets of dietary guidelines investigated in the present study 
differ in terms of numbers and wording, the DQI still captures the essential elements of the 
targeted substitution dietary guidelines and can be used to indicate a change in adherence to both 
the targeted substitution dietary guidelines in this trial and the Danish official dietary guidelines 
and.   
The results of this thesis research demonstrate that by simply providing advice about dietary 
guidelines using leaflets and a website it is possible to impose some dietary changes in a 
population of adults. However, the intensity of the intervention (leaflets, a website including 
information on dietary guidelines and recipes, and biweekly e-mails with new recipes) may have 
been too weak, which may have contributed to the null results on the IHD risk factors.  
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6 Conclusion 
In conclusion, closer adherence to the current Danish official dietary guidelines was associated with 
a more beneficial cardiometabolic risk profile in a Danish adult population with at least one self-
reported risk factor for IHD. However, the results highlight the need to conduct sex-stratified 
analyses on IHD risk in this particular population. 
The results of the DIPI RCT showed that short-term, after 6 months of intervention, the targeted 
substitution dietary guidelines were more effective than the Danish official dietary guidelines in 
changing the diet, resulting in a dietary composition of the overall diet that was more 
cardioprotective compared with the habitual diet. However, after an additional 6 months of follow-
up, the long-term effects of the two sets of dietary guidelines were similar, when compared with the 
habitual diet. This was supported by the observed positive changes in DQI score, indicating an 
increased adherence to both sets of dietary guidelines throughout the intervention and follow-up 
periods, compared with the habitual diet.  
However, neither the targeted substitution dietary guidelines nor the Danish official dietary 
guidelines showed any overall short- or long-term effects on any of the included risk factors for 
IHD compared with the habitual diet. 
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7 Perspective 
As a worldwide leading cause of morbidity and mortality, IHD is a primary consideration in the 
development of evidence-based dietary guidelines. Enhancing the understanding and knowledge of 
the association between nutrition and health will continue to progress, as the optimal strategy for 
prevention of IHD through diet is still far from being defined. The findings of the three papers 
included in this thesis will add to this knowledge and will be of importance in the revision of future 
dietary guidelines and prevention of IHD.  
However, the present results also demonstrate the challenges in promoting dietary guidelines that—
when followed—have the potential to reduce the risk of IHD among the general population in an 
effective way. Behavioural changes are preferred over pharmacological or surgical interventions as 
these could lead to adverse effects, but implementing and ensuring adherence to the former are 
more challenging.  
Future studies could therefore focus on addressing the need for innovative ways to promote and 
ensure adherence to dietary guidelines. In line with this, many new initiatives using computer or 
mobile phone technologies have been developed to promote healthy lifestyles, and how use of these 
new technologies may help in improving adherence to dietary guidelines is an important topic of 
future research. 
Human behaviour is influenced at many different levels. In some dietary RCTs, a beneficial change 
in IHD risk factors was observed in participants who were provided with foods free of charge. In 
addition, considering the missing results on IHD morbidity and mortality of many multiple risk 
factor intervention studies, another approach could be to focus on the effects of different structural 
initiatives such as encouraging the consumption of healthy foods by imposing additional taxes on 
unhealthy foods and legislation, for example, to alter the fat content of foods and better labelling, all 
of which could help individuals to adopt healthier dietary patterns and could potentially lead to 
prevention of IHD. Such structural initiatives could target the entire population, including children 
and adolescents. 
Future research could therefore be focused on the complexity of human behaviour in relation to 
imposing changes to dietary patterns, including behavioural theories, and the effects of structural 
initiatives like promotion of healthy foods and introduction of taxes and legislation to advocate 
healthy dietary patterns. 
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Abstract
Diet is recognised as one modiﬁable lifestyle factor for ischaemic heart disease (IHD). We aimed at investigating the associations between
adherence to the Danish Food-Based Dietary Guidelines (FBDG) indicated by a Dietary Quality Index (DQI) and selected cardiometabolic risk
factors in a cross-sectional study with 219 Danish adult participants (59%women; age 31–65years) with a minimum of one self-rated risk
marker of IHD. Information regarding diet was obtained using web-based dietary assessment software and adherence to the Danish FBDG
was expressed by a DQI calculated from 5 food and nutrient indicators (whole grain, ﬁsh, fruit and vegetables, energy from saturated fat and
from added sugar). Background information, blood samples and anthropometrics were collected and blood pressure was measured. Linear
regression analyses were used to evaluate the association between DQI and cardiometabolic risk factors. DQI was inversely associated with
LDL:HDL ratio and TAG (−0·089 per unit; 95% CI −0·177, −0·002 and −5% per unit; 95% CI −9, 0, respectively) and positively associated with
HDL-cholesterol (0·047mmol/l per unit; 95% CI 0·007, 0·088). For men, DQI was inversely associated with BMI (−3%per unit; 95% CI −5, −1),
trunk fat (−1% per unit; 95% CI −2, −1), high-sensitivity C-reactive protein (−30% per unit; 95% CI −41, −16%), HbA1c (−0·09% per unit;
95% CI −0·14, −0·04), insulin (−13% per unit; 95% CI −19, −7) and homoeostatic model assessment-insulin resistance (−14% per unit;
95% CI −21, −7). In women, DQI was positively associated with systolic blood pressure (2·6mmHg per unit; 95% CI 0·6, 4·6). In conclusion,
higher adherence to the current Danish FBDG was associated with a more beneﬁcial cardiometabolic risk proﬁle in a Danish adult population
with a minimum of one self-rated risk factor for IHD.
Key words: Dietary patterns: Diet quality: Diet index: Cardiovascular risk factors: Cross-sectional studies
Ischaemic heart disease (IHD) is one of the major causes of
morbidity and mortality worldwide(1,2). Diet is recognised as
one of several modiﬁable lifestyle factors for the prevention
of IHD(1,3,4).
During the past decades, research on diet–disease associa-
tions has focused on measurements of overall quality of diets
and dietary patterns as opposed to the traditional approach in
dietary research with focus on single nutrients and foods(5–8).
This change in research focus is justiﬁed by the notion that
people eat composite diets and meals with nutrients and foods
in combination.
Several dietary scores and dietary quality indices have been
developed to assess adherence to different healthy food
patterns and national Food-Based Dietary Guidelines
(FBDG)(6,9,10). Some of the most commonly used are The
Mediterranean diet score indicating compliance with the tradi-
tional dietary pattern followed by Mediterranean populations,
and the American Healthy Eating Index (HEI), which assesses
adherence with the Dietary Guidelines for Americans(11). Both
observational and intervention studies have shown a protective
effect on the development and mortality of CVD with a higher
compliance to the Mediterranean diet and the Dietary Guide-
lines for Americans(12–16).
The Mediterranean diet score and the American HEI are
considered most suitable for the Mediterranean countries and
the Americans and for countries with similar food cultures,
Abbreviations: BP, blood pressure; DQI, Dietary Quality Index; DQS, Dietary Quality Score; E%, energy contribution; FBDG, Food-Based Dietary Guidelines;
HEI, Healthy Eating Index; HOMA-IR, homoeostatic model of insulin resistance; hsCRP, high-sensitivity C-reactive protein; IHD, ischaemic heart disease; OR,
over-reporters; UR, under-reporters; WC, waist circumference.
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respectively. In the Nordic countries, including Denmark, a
different food culture exists with a dietary pattern relatively
abundant in certain fruit and vegetables (especially berries,
cabbages, root vegetables and legumes), potatoes, whole-grain
cereals, dairy and meat products(17). The Danish food culture
and food preferences were included as an integrated part in the
development of the current Danish FBDG when translating the
scientiﬁc evidence regarding the association between diet and
risk of diseases into quantiﬁed FBDG(18).
In Denmark, two dietary quality indices have been developed
to measure adherence to the Danish FBDG from 2005(19,20). One
is the Dietary Quality Score (DQS), which is based on a forty-
eight-item FFQ, and uses a three-point scoring system for each of
four food groups: ﬁsh, fruit, vegetables and fats. The DQS has
been found to be inversely associated with serum lipids,
homocysteine and absolute risk of IHD in men and women aged
30–60 years(19). The other, the Diet Quality Index (DQI), is based
on dietary data from a 7-d pre-coded food diary, and uses a sum
of six scores of food and nutrients based on the 2005 FBDG
relating to dietary intake(20,21). In continuation of the update of
the Danish FBDG in 2013, an updated version of the DQI was
applied to reﬂect the changes in the FBDG(18,22). The updated
DQI is based on ﬁve food and nutrient indicators, including
whole grain, ﬁsh, fruit and vegetables and energy % from
saturated fat and from added sugar(20,22).
The objective of this study was to investigate associations
between adherence to the current Danish FBDG assessed by a
DQI and selected cardiometabolic risk factors in a Danish adult
population with a minimum of one self-rated risk factor of IHD.
Methods
Study design
The study was based on baseline data from the study Diet and
Prevention of Ischemic Heart Disease – a Translational
Approach (DIPI) (www.DIPI.dk), which included a 6-month
randomised, single-blinded parallel, dietary intervention study
in a real-life setting, with a 6-month follow-up. The study was
designed to assess the effects of dietary substitution guidelines
speciﬁcally aimed at the prevention of IHD on dietary intake
and IHD risk factors in the general adult Danish population.
This paper reports on the baseline cross-sectional data.
This study was conducted according to the guidelines laid
down in the Declaration of Helsinki and was approved by The
Capital Region of Denmark Ethics Committee (Journal no. H-1-
2013-110) and by the Danish Data Protection Agency (Journal
no. 2013-54-0571). Written informed consent was obtained from
all study participants, and they received a small remuneration of
about 34 GBP for their participation in the study. The study was
registered at ClinicalTrials.gov (registry name ‘DIPI’, ID no.
NCT02062424).
Study participants
Potential participants were identiﬁed using a unique personal
identiﬁcation number assigned to all Danish citizens in the Civil
Registration System(23). In total, 5000 men and women born in
1949–1984 and living in a deﬁned area of the greater
Copenhagen were invited by letter to participate in the study.
The number of invited participants was based on previous
experience of a low response rate when recruiting participants
for long-term interventions. Overall, 334 responded on the
invitation and were thus screened from a self-administered
questionnaire including questions on the inclusion and exclu-
sion criteria. The potential participants were asked in the
questionnaire to measure and report their height in metres,
weight in kg, their waist circumference (WC) 2 cm above their
belly button and whether or not they were physically active for
more than 15min/week. Furthermore, the self-administered
questionnaire included questions on the exclusion criteria; see
below. After screening, the eligible participants were invited to
an information meeting, which included an introduction to the
web-based dietary assessment software. Of the eligible partici-
pants who participated in the information meeting, 100%
agreed to participate and provided informed consent.
The inclusion criteria were age between 30 and 65 years, and
a minimum of one self-rated risk factor of IHD – that is over-
weight or obesity (BMI ≥ 25) – WC ≥ 80 cm for women and
≥94 cm for men, and/or physical inactivity deﬁned as being
moderately physically active in leisure time for 15min or less
per week.
The exclusion criteria were current smoking, pregnancy or
plans to become pregnant within the next 12 months, breast-
feeding, history of CVD, type 2 diabetes, chronic disease/
disorders that could affect the results of the study (the chronic
diseases that the subjects reported were evaluated by the
clinical physician in charge), drug abuse within the past
12 months, regular alcohol consumption >21 units/week for
men or >14 units/week for women, allergies or intolerance of
the food groups included in the dietary guidelines, consump-
tion of dietary supplements with high doses of nutrients that
could have a potential effect on IHD risk factors (e.g. ﬁsh oils)
and/or no access to a computer and internet.
Measures
Dietary intake and calculation of diet quality index. The
study participants recorded their dietary intake using a web-based
dietary assessment software for 7 consecutive days(24). The web-
based dietary assessment software was originally developed and
validated for children aged 8–11 years and slightly customised to
ﬁt the adult study population of the DIPI study(24,25). At least 4 d of
food reporting had to be completed by the study participant for
inclusion of the study participants in the analysis(21).
The dietary assessment software was structured according to a
typical Danish meal pattern covering breakfast, lunch, dinner and
three in-between meals. The participants could estimate the
amount consumed by selecting the closest portion size among
four different digital images in eighty photograph series. Internal
checks for frequently forgotten foods (spreads, sugar,
sauces, dressings, snacks, candy and beverages) were included.
Furthermore, the participants reported the intake of nutritional
supplements and whether a day represented usual or unusual
intake, including reasons for unusual intakes such as illness. If a
participant failed to report for a day, the participant was reminded
by an email the next day(24).
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Intakes of food items, energy and nutrients were calculated for
each study participant as an average of 7 d using the
software system General Intake Estimation System (GIES)
version 1.000.i6 (National Food Institute, Technical University of
Denmark) and the Danish Food Composition Databank
version 7.0 (National Food Institute Technical University of
Denmark, 2009).
Adherence to the Danish FBDG was evaluated based on a DQI
published earlier and updated to the current Danish FBDG(20,22),
including intake of whole grain (min 75 g/10MJ per d),
intake of ﬁsh (min 350g/10MJ per week), intake of fruit and
vegetables (min 600 g/10MJ per d), energy from saturated fat
(max 10 E%) and energy from added sugar (max 10 E%). The
DQI was based on intake adjusted to 10MJ, as this is the unit for
the FBDG(18).
A DQI for each study participant was calculated – adapted
from(20) – as the ratio of the actual intake and the recommend
intake of each of the ﬁve guidelines included in the index. For
example, if a study participant had an intake of 60 g/10 MJ per d
whole grain, the score was 60/75= 0·8. For the included guide-
lines with an upper limit of a recommended intake, the DQI was
calculated as 1− ((intake− recommended)/recommended), and
thus for a study participant with an intake of 13% energy from
added sugar the DQI was calculated as 1− ((13–10)/10)= 0·7.
In contrast to the original DQI, we did not have a maximum
score in individuals with an intake exceeding the cut-off
values(20). The total score was calculated as the sum of the ﬁve
scores, a higher score meaning a higher degree of compliance
with the FBDG.
Under- and over-reporters. Under- and over-reported energy
intake (EI) was deﬁned as a ratio of reported mean EI:BMR and
classiﬁed by cut-offs suggested by Black(26,27). Under-reporters
(UR) were deﬁned as EI:BMR ≤ 1·05 and over-reporters (OR)
were deﬁned as EI:BMR ≥ 2·28, using a physical activity level of
1·55 (data not shown).
Assessment of cardiometabolic risk factors
Blood samples. Fasting blood samples from venepuncture
were analysed for concentrations of TAG, total cholesterol,
HDL-cholesterol, high-sensitivity C-reactive protein (hsCRP),
glucose, HbA1c and insulin. The blood samples were collected
and handled according to the hospital routines. TAG, total
cholesterol, HDL-cholesterol and glucose were measured in
plasma by Reﬂection Spectroscopy at 540 nm and hsCRP was
measured in plasma by Reﬂection Spectroscopy at 660 nm
(Apparatus Vitros 5.1 FS; Ortho-Clinical Diagnostics). HbA1c
was measured in plasma with HPLC (D-100; Bio-Rad). Fasting
plasma insulin was measured using the sandwich ELISA ana-
lysis principle (ADVIA Centaur XP; Siemens). VLDL-cholesterol
was calculated from TAG, using the equation plasma VLDL-
cholesterol=plasma TAG× 0·45, and LDL-cholesterol was
calculated using the Friedewald equation(28).
The homoeostatic model assessment (HOMA) was used to
estimate insulin resistance (HOMA-IR). HOMA-IR was calcu-
lated using the formula HOMA-IR= (glucose (nmol/l)× insulin
(mU/ml)/22·5), using fasting values(29).
Anthropometric measurements (height, weight and waist
circumference). Height was measured to the nearest 0·5 cm,
on a wall-mounted stadiometer (SECA). Body weight was
measured in kg and trunk fat was registered on a fat analysis
weight (Tanita BC 418 MA). The subjects had to be fasting.
Waist and hip circumference was measured twice, with an
anthropometric tape (SECA 201), and the average was reported.
BMI was deﬁned as weight in kg divided by squared height in
metres (kg/m2).
Blood pressure and heart rate. Seated blood pressure (BP)
and heart rate (HR) were measured in duplicate after 5min of
rest in the subjects’ left arm, using an electric sphygmoman-
ometer according to standardised procedures. The subjects had
to empty their bladder before the measurement and were not
allowed to converse during the measurement, nor have their
legs crossed. If the diastolic BP differed more than 5mmHg,
further measurements were done, until at least in two mea-
surements the diastolic BP differed≤5mmHg. The average
value of the two BP and HR measurements was calculated.
Assessment of background questionnaires. Lifestyle ques-
tionnaires were used to obtain information about the partici-
pant’s education level (primary school/high school, associate
degree, under-graduate, graduate) and the level of physical
activity at leisure time (extremely active, moderately active,
sedentary or inactive). The question about the level of physical
activity was based on one question about the study participants’
physical activity during leisure time in the past 6 month and was
based upon the Danish National Health Proﬁle(30).
Statistical analysis
For a parallel design, statistical power calculations based on
evidence from previous similar studies(31–33) were used to
estimate that sixty-two subjects in each intervention arm were
sufﬁcient to detect a difference of 0·25mmol/l LDL-cholesterol
(SD 0·49) (α= 0·05, β= 0·8). To allow for a drop-out of 20%, the
number of participants was set to a total of 225. Self-rated
weight (kg), WC and BMI from the screening self-administered
questionnaire were compared with weight, WC and BMI
measured at baseline by a paired t test. Baseline characteristics
and dietary intake of the study participants were summarised
for men and women using medians and 80% central range for
continuous variables and proportions for categorical variables.
Linear regression analyses were used to evaluate the
association between DQI and cardiometabolic risk factors.
Three models were applied; a simple model adjusted for sex
and age (<50 or ≥ 50) (model 1a), a multivariate model further
adjusted for education (primary school/high school, associate
degree, under-graduate or graduate) and physical activity at
leisure time (extremely active, moderately active, sedentary or
inactive) (model 1b), and a ﬁnal multivariate model adjusted as
model 1b plus BMI (model 2). Furthermore, sensitivity analysis
excluding UR and OR was made to investigate the impact of UR
and OR on the associations between DQI and cardiometabolic
risk factors.
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All the models were tested for statistically signiﬁcant inter-
actions between DQI and sex and DQI and age. These inter-
actions were tested to investigate whether the associations were
different for men and women and for participants <50 years of
age or 50 years of age or above. If an interaction was signiﬁcant,
the DQI estimates for men and women and DQI estimates by
age were given. To check the model assumptions, the stan-
dardised residuals of the ﬁnal models were examined for nor-
mality, variance homogeneity and linearity. BMI, waist:hip-ratio,
hsCRP, VLDL-cholesterol, TAG, glucose, insulin and HOMA-IR
were all logarithm10 transformed to normalise the distribution
and to improve variance homogeneity. For the above-
mentioned variables, which were log-transformed, the esti-
mates and 95% CI are presented as percent difference.
The statistical analyses were carried out using RStudio (ver-
sion 0.99.441 – © 2009–2015; RStudio, Inc.). Statistical sig-
niﬁcance was established at P< 0·05.
Results
Baseline characteristics of study participants
A total of 222 participants met the inclusion and exclusion criteria
and were enrolled into the study, which was 67% of the initially
screened potential study participants. Signiﬁcant differences
(P< 0·05) in weight and WC were found between self-reported
and measured at baseline. The participants’ self-reported weight
and WC were higher than the measured weight and WC at
baseline. However, no difference in BMI was found. In all, 17%
of the women and 7% of the men did not meet the inclusion
criteria when measured at baseline (data not shown). For three
participants, a full baseline examination was missing, and they
were therefore excluded. Of the remaining 219 study partici-
pants, those who were taking cholesterol-lowering (n 5) and/or
BP-lowering (n 3) medications were excluded from the statistical
analysis of the association between DQI and lipid biomarkers
and DQI and BP, respectively. In addition, biochemical analysis
of hsCRP was not possible in ﬁfteen study participants; therefore,
for the statistical analysis of the association between DQI and
hsCRP, the number of participants was 204. Furthermore, it was
not possible to get sufﬁcient blood from one of the study parti-
cipants for the biochemical analysis of the glycaemic biomarkers,
and thus for the statistical analysis of the association between
DQI and glycaemic biomarkers (n 218).
Baseline characteristics of the 219 study participants included
in the statistical analysis are presented in Table 1. Of the 219
study participants, ninety were men and 129 were women. The
median age of the study participants was 51 years (10th–90th
percentile (p10–p90) 37–61).
Diet quality index, total energy intake and dietary
composition
For the whole study population the median DQI was 4·5
(p10–p90 3·0–6·5). The median DQI score was higher for
women than for men. Furthermore, the median individual DQI
score for added sugar was higher than the median DQI scores
for whole grain, ﬁsh, fruit and vegetables and saturated fat.
Median total EI for men was 10·1MJ (p10–p90 7·2–13·7) and for
women it was 7·8MJ (p10–p90 5·2–10·5) (Table 2). Medians
(p10–p90) of the Diet Quality Index score (DQI), energy
(MJ/d), diet composition (g/10MJ per d) and energy contribu-
tion (E%) of macronutrients and dietary ﬁbre (g/MJ) of the study
population divided in tertiles of the DQI are presented in the
online Supplementary Table S1.
Association between Dietary Quality Index and
cardiometabolic risk factors
Table 3 summarises the associations between DQI and cardi-
ometabolic risk factors in the study population. In the following
section, only results from model 1b will be presented.
We found an inverse association between DQI and the lipid
risk factors – LDL:HDL ratio and TAG (−0·089 per unit DQI; 95%
CI −0·177, −0·002 and −5% per unit DQI; 95% CI −9, 0, respec-
tively) – and a positive association between DQI and HDL-
cholesterol (0·047mmol/l per unit DQI; 95% CI 0·007, 0·088). For
men only, we found an inverse association between DQI and BMI
(−3% per unit DQI; 95% CI −5, −1), trunk fat (−1% per unit DQI;
95% CI −2, −1), hsCRP (−30% per unit DQI; 95% CI −41, −16) and
the glycaemic risk factors, HbA1c (−0·09% per unit DQI; 95%
CI −0·14, −0·04), insulin (−13% per unit DQI; 95% CI −19, −7)
and HOMA-IR (−14% per unit DQI; 95% CI −21, −7).
Furthermore, we found a positive association between DQI and
systolic BP in women (2·6mmHg per unit DQI; 95% CI 0·6, 4·6).
Under- and over-reporters
Overall, 21% of the participants were classiﬁed as UR and 1%
as OR. Of those classiﬁed as UR, 89% were overweight or
obese, 46% of the UR were men and all of the OR were men.
The associations between DQI and most of the variables
included were the same whether UR and OR were included in
the analysis or not. However, for the metabolic markers BMI,
trunk fat, systolic BP and hsCRP, the interaction between DQI
and sex was no longer signiﬁcant when excluding UR and OR.
Except for BMI, the association between DQI and these meta-
bolic markers was now signiﬁcant for the whole study popu-
lation (trunk fat: −1% per unit DQI; 95% CI −2, −0·4, systolic
BP: 1·7mmHg per unit DQI; 95% CI 0·08, 3·36, and hsCRP
−23% per unit DQI; 95% CI −32, −12). Furthermore, the
metabolic markers waist:hip-ratio changed from being non-
signiﬁcant to signiﬁcant (−1 per unit DQI; 95% CI −2, 0). In
addition, the observed positive association between DQI and
HDL-cholesterol was only signiﬁcant in study participants aged
50 years or above when excluding UR and OR from the analysis
(0·09mmol/L per unit DQI; 95% CI 0·034, 0·045).
Discussion
In the present study, a higher adherence to the current Danish
FBDG, assessed by a DQI, was associated with a more bene-
ﬁcial cardiometabolic risk proﬁle in a Danish adult population
with a minimum of one self-rated risk factor for IHD. The main
ﬁndings were the inverse associations between the DQI and the
lipid risk factors: LDL:HDL ratio and TAG and the positive
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association with HDL-cholesterol. For the male study partici-
pants, an inverse association between DQI and BMI, trunk fat,
hsCRP and the glycaemic risk factors, HbA1c, insulin and
HOMA-IR was observed. Furthermore, we found a positive
association between DQI and systolic BP in women.
When we controlled for the effect of BMI on cardiometabolic
risk factors, the associations between DQI and trunk fat, LDL:
HDL ratio and TAG were attenuated and no longer statistically
signiﬁcant, suggesting that BMI could be an important factor in
CVD prevention. Of that notion it is important to further
investigate whether the association of higher adherence to the
Danish FBDG and a more beneﬁcial cardiometabolic risk
proﬁle is due to the effect of the Danish FBDG, expressed by
DQI, on BMI and body composition, including trunk fat, or
whether the association is independent. We only found an
inverse signiﬁcant association between DQI and BMI in men,
suggesting that a higher DQI score (indication of a higher
adherence to the Danish FBDG) is only associated with a lower
BMI in men and not women. The fact that DQI and BMI was
only associated in men and not in women could be explained
by the higher number of normal-weight women than men, and
the higher number of overweight men than women. Moreover,
Table 1. Baseline characteristics of the study participants divided by sex
(Medians and 10th–90th percentiles (p10–p90); percentages and numbers)
All (n 219) Men (n 90) Women (n 129)
Participant characteristics Median p10–p90 Median p10–p90 Median p10–p90
Age (years) 51·0 37–61 50·5 36–61 51·0 37–61
Metabolic markers
Weight (kg) 82·6 65·3–103·6 88·4 79–117·5 74·6 62·3–92·8
BMI (kg/m2)* 26·7 22·9–33·6 27·0 23·9–33·9 26·3 22·6–32·9
Weight status*
Normal weight
% 27 16 36
n 60 14 46
Overweight
% 53 66 43
n 116 60 56
Obese
% 20 18 21
n 43 16 27
Waist circumference (cm) 92·4 79·8–105·2 97·4 90·8–118·3 87·0 76·8–99·5
Hip circumference (cm) 107·1 99·4–120·0 106·7 102·3–118·7 108·2 98·9–120·4
Systolic BP (mmHg)† 130 110–154 135 119–164 125 108–149
Diastolic BP (mmHg)† 80 69–94 82 72–98 78 68–92
hsCRP (mg/l)‡ 1·4 0·2–6·3 1·0 0·2–5·4 1·9 0·2–8·3
Lipid biomarkers§
Total cholesterol (mmol/l) 5·3 4·1–6·8 5·5 4·4–6·9 5·2 4·0–4·5
LDL-cholesterol (mmol/l) 3·2 2·2–4·5 3·5 2·5–4·7 3·1 2·1–4·5
HDL-cholesterol (mmol/l) 1·4 1·0–3·9 1·2 0·9–1·9 1·6 1·1–2·3
LDL:HDL ratio 2·3 4·1–6·8 2·8 1·7–4·3 2·0 1·2–3·0
VLDL-cholesterol (mmol/l) 0·5 0·3–1·0 0·6 0·3–1·2 0·4 0·3–0·8
TAG (mmol/l) 1·1 0·6–2·3 1·3 0·7–2·6 0·9 0·6–1·8
Glycaemic biomarkers||
Glucose (mmol/l) 5·5 5·0–6·3 5·6 5·1–6·4 5·4 4·9–6·1
HbA1c (%) 5·0 4·5–5·5 5·0 4·6–5·5 5·0 4·5–5·5
Insulin (pmol/l) 58 30–100 59 31–127 58 30–94
HOMA-IR 2·0 1·0–3·8 2·2 1·0–4·6 2·0 1·0–3·6
Educational level
Primary school or high school
% 25 29 23
n 55 26 30
Associate degree
% 8 6 10
n 18 5 13
Under-graduate school
% 40 31 46
n 87 28 59
Graduate school
% 27 34 21
n 58 31 27
BP, blood pressure; hsCRP, high-sensitivity C-reactive protein; HOMA-IR, homoeostatic model of insulin resistance.
* BMI is calculated as weight in kg divided by the square of height in m (kg/m2). 18·5–25kg/m2: normal weight, 25–30 kg/m2: overweight, >30 kg/m2: obese.
† All; 216, men; eighty-nine, women; 127, after exclusion of those using BP-lowering medication.
‡ All; 204, men; eighty-seven, women; 117, due to lack of hsCRP in biochemical analyses.
§ All; 214, men; eighty-five, after exclusion of those using cholesterol-lowering medication.
|| All; 218, women; 128, as it was not possible to draw enough blood to the glycaemic biomarker analysis from one of the female study participants.
Dietary guidelines and CVD risk factors 5
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114517003695
Downloaded from https://www.cambridge.org/core. DTU Library - Tech Info Ctr of Denmark, on 23 Jan 2018 at 09:11:21, subject to the Cambridge Core terms of use, available at
Table 2. Overall Diet Quality Index (DQI) score and DQI scores for individual components, energy (MJ/d), diet composition (g/10 MJ per d) and energy contribution (E%) of macronutrients and dietary fibre
(g/MJ) of the study participants
(Medians and 10th–90th percentiles (p10–p90))
Guidelines and
All (219) Men (n 90) Women (n 129) DQI score
Participants recommendations* Median p10–p90 Median p10–p90 Median p10–p90 Median p10–p90
Overall DQI 4·5 3·0–6·5 4·2 2·7–6·2 4·6 3·0–6·6
Energy (MJ/d) 8·6 5·8–12·4 10·1 7·2–13·7 7·8 5·2–10·5
Diet composition (g/10MJ/d)
Bread and cereals* 218 141–301 215 149–291 220 136–307
Whole grains 75 g/d 61 31–111 56 30–117 66 34–108 0·8 0·4–1·5
Meat and meat products <70 g/d 139 59–249 166 85–282 124 45–224
Fish and fish products† 50 g/d 46 5–111 41 5–109 48 5–125 0·9 0·1–2·2
Poultry and poultry products‡ 32 0–102 31 0 –103 32 0–99
Fruit and vegetables 600 g/d§ 388 177–690 324 144–508 452 243–749 0·6 0·3–1·2
Fruit and fruit products 143 43–331 100 23–245 180 64–362
Vegetables and vegetable products 220 110–425 194 84–348 237 132–469
Vegetables, coarse|| 97 29–208 83 23–191 104 39–215
Vegetables, fine|| 114 49–228 95 37–167 122 68–255
Potatoes and potato products 57 7–138 73 15–152 47 2–126
Milk and milk products 243 68–513 213 68–484 272 70–531
Cheese and cheese products Choose low fat 45 11–129 36 5–97 50 16–156
Edible fats 31 18–46 30 16–48 31 18–45
Sugar and candy Reduce intake 35 10–77 31 10–76 38 14–77
Energy distribution
Protein (E%) 10–20 17 14–22 17 14–21 17 14–22
Fat (E%) 25–40 35 29–42 35 28–40 36 29–43
SFA (E%) <10 13 11–17 13 10–17 13 11–16 0·7 0·4–0·9
MUFA (E%) 10–20 13 10–17 13 10–16 14 11–18
PUFA (E%) 5–10 5 4–7 5 4–6 5 4–7
Carbohydrate (E%) 45–60 44 35–53 43 34–53 45 35–53
Added sugar (E%) <10 7 2–13 7 2–15 7 3–13 1·3 0·7–1·8
Dietary fibre (g/MJ) > 3g/MJ 2 2–3 2 2–3 3 2–4
Alcohol (E%)¶ <5 5 1–14 7 1–16 4 0–10
* Guidelines and recommendations according to the official Danish Food-Based Dietary Guidelines(18) and the Nordic Nutrition Recommendations, 2012(8).
† All; n 201, men; eighty-three, women; 118 after exclusion of those who did not eat fish.
‡ All; 180, men; seventy-six, women; 104 after exclusion of those who did not eat poultry.
§ Eat 6 a day – equivalent to about 600 g of vegetables and fruit. At least half should be vegetables.
|| Vegetables are classified from type of food groups (e.g. all types of cabbage, root vegetables and onions are classified as coarse vegetables and all vegetables with a high water content like tomatoes and salad are classified as fine
vegetables).
¶ All; 194, men; eighty-one, women; 113 after exclusion of those who did not drink alcohol.
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the sex-speciﬁc association between DQI and systolic BP and
DQI and hsCRP was no longer present when we controlled for
the effect of BMI. Here a positive association between DQI and
Systolic BP and an inverse association between DQI and hsCRP
were seen for the whole study population. Additionally, in the
sensitivity analysis excluding UR and OR, a non-sex-speciﬁc
signiﬁcant association between DQI and trunk fat, systolic BP
and hsCRP was observed. These results suggest that the
observed sex-speciﬁc associations between DQI and the
metabolic biomarkers BMI, trunk fat, systolic BP and hsCRP
found in the analysis, including UR and OR, could be explained
by dietary report errors. However, the results of the sensitivity
analysis should be interpreted with caution, because of poten-
tial power issues when removing UR and OR from the analysis.
The inverse relationship between BMI and CRP is well
recognised, and, moreover, it has been recognised that with
increased adiposity CRP is further elevated(34). The link
between these risk factors is supported by the results of the
present study, where an inverse association between DQI and
BMI, trunk fat and hsCRP was found in men.
In addition, when controlling for the effect of BMI, the
observed positive association between DQI and HDL-
cholesterol was only signiﬁcant in study participants aged 50
years or above, suggesting that BMI is a more important med-
iator for HDL-cholesterol levels for people less than 50 years of
age. However, genetic studies have lately challenged the
common concept of raising HDL-cholesterol as a marker for
CVD risk reduction, and further studies are need to investigate
the role of HDL-cholesterol in CVD prevention(35,36).
A main advantage of this study is the detailed assessment of
the dietary data with the habitual diet measured during a 7-d
consecutive dietary record using a validated method used for
Table 3. Linear regression of the associations between adherence to the Danish Food-Based Dietary Guidelines (FBDG) assessed by a diet quality index
(DQI) and cardiometabolic risk factors in a Danish adult population with minimum one self-rated risk factor for Ischaemic heart disease
(β-Coefficients per unit DQI and 95% confidence intervals)
Model 1a† Model 1b‡ Model 2§
β 95% CI β 95% CI β 95% CI
Metabolic markers (n 219)
BMI (kg/m2) (%) 0 −2, 1 0 −1, 2
Men −3* −5, 1 −3** −5, −1
Women 0 −2, 1 0 −1, 2
Waist:hip-ratio (%) −1 −1, 0 −1 −1, 0 −1 −2, 0
Trunk fat (%) −1* −1, 0 0 −1, 1 0 −1, 0
Men −1*** −2, −1
Women 0·02 −0·69, 0·73
Systolic BP (mmHg)‖ 0·81 −0·7, 2·3 1·15 −0·36, 2·67 1·59* 0·11, 3·07
Men −0·68 −3·04, 1·68
Women 2·6* 0·63, 4·58
Diastolic BP (mmHg)‖ −0·24 −1·19, 0·71 0·92 −0·3, 2·13 0·3 −0·56, 1·17
Men −1·33 −2·78, 0·12
Women 0·92 −0·3, 2·13
hsCRP (mg/l) (%)¶ −16** −25, −6 −16** −25, −6 −12* −21, −2
Men −29*** −40, −15 −30*** −41, −16
Women −7 −19, 7 −5 −18, 9
Lipid biomarkers (n 214)
Total cholesterol (mmol/l) 0·005 −0·089, 0·099 −0·009 −0·104, 0·087 −0·006 −0·101, 0·090
LDL-cholesterol (mmol/l) −0·017 −0·098, 0·065 −0·027 −0·110, 0·055 −0·024 −0·106, 0·059
HDL-cholesterol (mmol/l) −0·052* 0·012, 0·092 0·047* 0·007, 0·088 −0·009 −0·071, 0·052
< 50 years −0·009 −0·071, 0·052
> 50 years 0·071** 0·021, 0·120
LDL:HDL-ratio −0·088* −0·175, −0·002 −0·089* −0·177, −0·002 −0·074 −0·158, 0·010
VLDL-cholesterol (mmol/l) (%) −5* −9, −1 −5 −9, 0 −4 −8, 0
TAG (mmol/l) (%) −5* −9, −1 −5* −9, 0 −4 −8, 0
Glycaemic biomarkers (n 218)
Glucose (mmol/l) (%) 0 −1, 1 0 −1, 1 0 −1, 1
HbA1c (%) 0·02 −0·03, 0·06 0·02 −0·02, 0·06 0·02 −0·03, 0·05
Men −0·09*** −0·13, −0·04 −0·09*** −0·14, −0·04 −0·07** −0·12, −0·02
Women 0·02 −0·03, 0·06 0·02 −0·02, 0·06 0·02 −0·02, 0·05
Insulin (pmol/l) (%) −4 −10, 2 −2 −7, 5 −3 −8, 3
Men (%) −12*** −19, −6 −13*** −19, −7 −9** −15, −3
Women (%) −4 −10, 2 −7 −7, 5 −3 −8, 3
HOMA-IR (%) −4 −10, 3 −1 −7, 6 −2 −8, 4
Men (%) −13*** −20, −6 −14*** −21, −7 −10** −16, −3
Women (%) −4 −10, 3 −1 −7, 6 −2 −8, 4
BP, blood pressure; hsCRP, high-sensitivity C-reactive protein; HOMA-IR, homoeostatic model of insulin resistance.
*P<0·05, ** P≤0·01, *** P=0·001.
† Simple linear regression model adjusted for sex and age.
‡ Multiple linear regression analysis adjusted for sex, age, education, physical activity at leisure time.
§ Multiple linear regression analysis adjusted for sex, age, education, physical activity at leisure time and BMI.
‖ n 216, after exclusion of those using BP-lowering medication.
¶ n 204 due to lack in biochemical analyses of hsCRP.
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the past two decades in the Danish National Survey of Dietary
Habits and Physical Activity(21,37). In addition, this study uses a
DQI based on ﬁve food and nutrients from the Danish FBDG
relevant for IHD risk, and thus a relatively easy way to measure
adherence to the overall current FBDG. A limitation of this
study is the observational design of the cross-sectional study, as
this design does not allow conclusions on cause and effect
relationships. Therefore, extrapolation of the results should only
be made with caution as the study participants resided in areas
of Greater Copenhagen with a relatively higher level of
education compared with the general Danish population(37).
The sex-speciﬁc results with an inverse association in men
only between DQI and the cardiometabolic risk factors BMI,
trunk fat, hsCRP, HbA1c, insulin and HOMA-IR are in line with
two cohort studies using the HEI(38,39). The cross-sectional
study by Drewnowski et al.(39) including 5081 men and women,
middle-aged French citizens with low CVD risk, investigated the
association between the HEI and cardiovascular risk factors.
Here an inverse association between the HEI and BMI was
found in men only. Furthermore, Frazier-Woods et al. observed
in another cross-sectional study containing 9797 adults men and
women, with at least one CVD risk factor, that in men only the
HEI score was inversely associated with insulin, HOMA-IR,
HDL-cholesterol, TAG and CRP(38). In contrast to our results,
when Frazier-Wood et al. adjusted for BMI, the results were no
longer signiﬁcant. This strengthens the importance of BMI as an
important factor in CVD prevention(38).
The sex-speciﬁc differences in the results in the present study
could be accounted for by alcohol intake of those of the study
participants who drank alcohol (n 194), as the men in the study
drank more alcohol than the women. The median alcohol
intake of the women was 3·9 E%, whereas the men had a
median alcohol intake of 6·5 E%. It could be that men with a
higher adherence to the Danish FBDG, expressed by a higher
DQI score, also had a lower alcohol intake equivalent to the
Danish recommendations of max seven drinks per week, cor-
responding to approximately 1 drink/d. A recent meta-analysis
of 84 prospective cohort studies found that alcohol consump-
tion of 2·5– 14·9 g/d (about ≤1 drink/d) was associated with a
lower risk of cardiovascular mortality, compared with abstain-
ing from alcohol(40). This is supported by the ﬁndings of the
present study, where we found that a higher DQI score was
associated with a more beneﬁcial cardiometabolic risk proﬁle.
One other cross-sectional study by Toft et al. investigated the
association between adherence to Danish FBDG, assessed by a
DQS and CVD risk factors(19). In this cross-sectional study
including 6542 healthy men and women aged 30–60 years, it
was found, in line with the ﬁndings of the present study, that
higher adherence to the Danish FBDG 2005 was associated
with a more beneﬁcial CVD risk factor proﬁle. In agreement
with our results, Toft et al. also found that the DQS was
inversely associated with TAG, but in contrast to our results the
DQS was inversely associated with total cholesterol and
LDL-cholesterol. However, Toft et al. did not ﬁnd a positive
association between the DQS and HDL-cholesterol like in the
present study.
Furthermore, our results are supported by the ﬁndings of
another cross-sectional study by Babio et al. investigating
adherence to a traditional Mediterranean diet (using a 14-point
score) and risk of metabolic syndrome, which is a cluster of
common CVD risk factors, including central obesity, hypergly-
caemia, low HDL-cholesterol levels, hypertension and hyper-
triglyceridaemia(41). The traditional Mediterranean diet
investigated by Babio et al. is characterised by a food pattern
high in fruit, vegetables, grains and unsaturated fat and low in
saturated fats(42). This food pattern is comparable with the ﬁve
food and nutrient indicators of the DQI used in this present
study to investigate adherence to the Danish FBDG. Babio et al.
found that a higher adherence to a traditional Mediterranean
diet was associated with lower odds of having metabolic
syndrome. In addition, Babio et al. found that subjects in the
fourth quartile of the Mediterranean diet adherence, when
compared with subjects in the lowest quartile of adherence to
the Mediterranean diet, had 47 and 54% lower odds of having
low HDL-cholesterol levels and high TAG levels, respectively.
However, in contrast to the low-risk middle-aged study
participants of the present study, Babio et al. included 808
elderly high cardiovascular risk participants of the Reus
PREDIMED Centre.
BP is known to be a variable measurement, and it can be
hard to measure accurately. The surprising and unexpected
ﬁnding of a positive association between the DQI and systolic
BP is not in line with previous studies. In a meta-analysis of
seventeen randomised controlled trials investigating the effect
of dietary patterns on BP in adults, it was found that healthy
dietary patterns such as the Nordic diet, the Mediterranean diet
and the Dietary Approaches to Stop Hypertension decreased
systolic and diastolic BP(43).
When comparing the results of the previously mentioned stu-
dies and the results of the present study, it is important to be
aware of differences between ﬁrst and foremost the study popu-
lations, as some were middle-aged with low CVD risk(39), and
some older with features of the metabolic syndrome and therefore
were at high CVD risk(41), all of which can have an effect on the
results on cardiometabolic risk factors. Moreover, awareness of
the different methods of dietary assessment is important, as it
could play a role for the accuracy of estimating dietary
intake(19,38,39,41). Furthermore, the DQI used in the present study
include various factors of more or less importance for cardiome-
tabolic risk factors. In particular, the score of whole-grain intake
included in the DQI is of importance, as a high whole-grain intake
is associated with lower risk of CVD(44). In addition, looking at the
individual scores of the ﬁve food and nutrients included in the
DQI, the median score for added sugar was higher than the other
median individual scores for whole grains, ﬁsh, fruit and
vegetables and saturated fat, indicating a higher compliance to this
speciﬁc dietary guideline of a reduced sugar intake.
Using a dietary index approach enabled us to describe
associations between food and nutrient intake in individuals
with dietary patterns more or less compliant with the current
Danish FBDG and cardiometabolic risk factors. Overall, the
present cross-sectional study adds to the growing body of
evidence that adherence to different national FBDG and diets
rich in fruit, vegetables, whole grains, legumes and ﬁsh and low
in meat and sweets are associated with a better cardiometabolic
risk proﬁle.
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In conclusion, higher adherence to the current Danish FBDG,
assessed by a DQI comprising of ﬁve components, was asso-
ciated with a more beneﬁcial cardiometabolic risk proﬁle in a
Danish adult population with a minimum of one self-rated risk
factor for IHD. The DQI was inversely associated with BMI,
trunk fat, hsCRP and glycaemic biomarkers in men.
The results substantiate the use of the DQI to measure
adherence to the current Danish FBDG and associations with
cardiometabolic risk factors, and indicate that adherence to the
Danish FBDG may be beneﬁcial for prevention of CVD. The
results of this study further highlight the need to conduct sex-
stratiﬁed analyses on CVD risk in this particular target group.
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Abstract 26 
Addressing modifiable risk-factors such as diet can help prevent ischemic heart disease. The 27 
objective was to examine short- and long-term dietary effects of applying Substitution Dietary 28 
Guidelines (DG) and Official DG in a Danish adult population. A 6-months randomised, single-29 
blinded parallel intervention study was conducted with 6 months follow-up. At baseline 219 30 
participants were randomly assigned to either I) Substitution DG, II) Official DG, or III) habitual 31 
diet. At baseline and at 6 and 12 months dietary records, plasma alkylresorcinols concentrations, 32 
anthropometrics, and background questionnaires were collected. Linear regression analyses were 33 
applied. Compared to the participants on habitual diet, the Substitution DG group increased their 34 
intake of whole grain (17g/10MJ/d, 95%CI:6, 28 g/10MJ/d), dietary fibre (0.26g/MJ/d, 35 
95%CI:0.09, 0.44g/MJ/d), fine vegetables (41g/10MJ/d, 95%CI:5, 7g/10MJ/d), and decreased 36 
their E% SFA (-1.51E%, 95%CI:-2.31,-0.70E%) and the Official DG group decreased E% SFA 37 
(-0.89E%, 95%CI: -1.69,-0.09E%). After 12 months, when compared to the habitual diet, both 38 
the Substitution DG group and the Official DG group increased intake of WG (16g/10MJ/d, 39 
95%CI: 6, 27g/10MJ/d and 13 g/10MJ/d, 95%CI: 3, 23g/10MJ/d, respectively) and fish 40 
(23g/10MJ/d, 95%CI: 3, 43g/10MJ/d and 24g/10MJ/d, 95%CI: 5, 44g/10MJ/d, respectively), the 41 
Official DG group decreased E% SFA (0.84E%, 95%CI:-1.69,-0.001E%). In conclusion from 42 
baseline to 6 months, when compared to the habitual diet, the Substitution DG was more 43 
effective than the Official DG in changing the number of dietary components, resulting in a 44 
dietary composition of the overall diet being more cardio-protective. However, from baseline to 45 
12 months the two DGs showed similar effectiveness.  46 
 47 
 48 
 49 
 50 
  51 
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Introduction 52 
Ischemic heart disease (IHD) is a leading cause of morbidity and mortality worldwide  with an 53 
estimated 7.4 million deaths due to IHD in 2015 (1). Addressing modifiable risk factors such as 54 
an unhealthy diet can help in the prevention of IHD (2–4).  55 
In the Nordic and European countries science based health messages including Dietary 56 
Reference Values and Dietary Guidelines (DG) are much alike (5). The guidelines, including the 57 
Danish Official DG are based on systematic literature reviews of the associations between food 58 
intake and relevant nutrition-related diseases in a general population. These DGs are thus 59 
targeted most public health relevant nutrition-related diseases. However, DG may also be 60 
developed to target only one specific nutrition-related disease, e.g. IHD.    61 
DG may be communicated in general terms, such as ´eat more or eat less´, with  an additional 62 
quantification of the food and nutrients included in the DG (6). Moreover, both cohort studies and 63 
randomised controlled studies have shown a lower risk of IHD when saturated fat (SFA) is 64 
substituted with polyunsaturated fat (PUFA)(7, 8). Also, it has been suggested that replacement of 65 
SFA with carbohydrates with low glycaemic index (GI) values may be associated with a lower 66 
risk of IHD, whereas replacing SFA with carbohydrates with high GI values may be associated 67 
with a higher risk of IHD (9). Furthermore, it is known that when individuals change their dietary 68 
intake of specific foods, they primarily change their dietary composition rather than their total 69 
energy intake (10). Therefore, the substitution aspect is important and emphasise the importance 70 
of in dietary guidelines also to explicitly specifying dietary substitutions.  71 
Since intake of food and nutrients vary between the dietary assessments methods, the validity of 72 
estimating the dietary intake may differ. The method of use for any study should be based on the 73 
food or nutrients of interest and the capacity of the target group to provide the needed details. 74 
The Danish diet is characterised by a relatively high intake of whole grain (WG) (11). 75 
Furthermore, consumption of WG as a part of a healthy diet has consistently been shown to be 76 
associated with a lower risk of developing several diseases including cardiovascular diseases 77 
(CVD) (12, 13). Alkylresorcinols (ARs) are phenolic lipids, that have been suggested as objective 78 
biomarkers for WG wheat and rye intake (14, 15). In addition, validation studies in adults have 79 
shown that plasma AR concentrations increase proportionally with AR and WG intake (16, 17) and 80 
therefore, AR have been used as biomarkers in endpoint studies (18, 19). Due to high relevance of 81 
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WGs in human health, it is relevant to validate estimated WG intake against an objective 82 
biomarker such as AR. 83 
The primary objective of this study was to examine the short- and long term dietary effects of 84 
applying Substitution DG and Official DG in a Danish adult population at risk of ischemic heart 85 
disease. A secondary objective was to validate the dietary assessment method for WG intake 86 
using an objective biomarker. 87 
Method 88 
Study design  89 
A 6-month randomised, single-blinded parallel intervention study was conducted from March 2014 90 
to May 2015 in a real-life setting with adult participants with a minimum of 1 risk marker of IHD, 91 
with a 6-month follow-up. At baseline participants were assigned to 1 of 3 study groups I) food-92 
based Substitution DG II) food-based Danish Official DG, or III) a habitual diet (Figure 1).  93 
Short- and long term dietary effects of the guidelines were defined as the changes in diet from 94 
baseline to 6 months (end of the intervention) and from baseline to 12 months (follow-up), 95 
respectively.  96 
The study was a part of the research project ´Diet and Prevention of Ischemic Heart Disease – a 97 
Translational Approach´ (DIPI) (www.DIPI.dk).  98 
The study was conducted according to the guidelines laid down in the Declaration of Helsinki and 99 
was approved by The Capital Region of Denmark Ethics Committee (Journal no. H-1-2013-110) 100 
and by the Danish Data Protection Agency (Journal no. 2013-54-0571). Written informed consent 101 
was obtained from all study participants and they received a small remuneration of around 34 102 
British pound (GBP) for their participation in the study. The study was registered at 103 
ClinicalTrials.gov (registry name “Diet and Prevention of Ischemic Heart Disease: a Translational 104 
Approach (DIPI)”, ID no. NCT02062424).  105 
Study participants  106 
Potential participants were identified using a unique personal identification number assigned to all 107 
Danish citizens in the Civil Registration System (20).  In total 5000 men and women born 1949-1984 108 
and living in a defined area of greater Copenhagen were invited by letter to participate in the study. 109 
The number of invited participants was based on previous experience of a low response rate when 110 
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recruiting participants for long term interventions. Overall, 334 responded to the invitation and were 111 
screened using a self-administered questionnaire including questions on the inclusion- and 112 
exclusion criteria. The potential participants were asked to measure and report their height in 113 
meters, weight in kilo grams (kg), their waist circumference 2 cm above their umbilicus, and 114 
whether or not they were physically active for more than 15 minutes per week. Furthermore, the 115 
self-administered questionnaire included questions on the exclusion criteria. The eligible 116 
participants were invited to an information meeting, which included an introduction to the web-117 
based dietary assessment software.  118 
The inclusion criteria were age between 30 and 65 years, and a minimum of 1 self-rated risk factor 119 
for IHD, i.e. overweight or obesity (BMI ≥ 25), waist circumference ≥80 cm for women and ≥94 120 
cm for men, and/or physical inactivity defined as being moderately physically active in leisure time 121 
for 15 minutes or less per week. 122 
The exclusion criteria were current smoking, pregnancy or plans to become pregnant within the 123 
next 12 month, breastfeeding, history of CVD, type-2 diabetes, chronic disease/disorders that could 124 
affect the results of the study (the chronic diseases that the subjects reported were evaluated by the 125 
physician in charge), drug abuse within the last 12 months, regular alcohol consumption >21 126 
units/week for men or >14 units/week for women, allergies or intolerance of the food groups 127 
included in the DG, consumption of dietary supplements with high doses of nutrients that could 128 
have a potential effect on IHD risk factors (e.g. fish oils) and/or no access to a computer and 129 
internet. 130 
Randomisation and intervention 131 
A schematic overview of the study design is presented in Figure 1. After the baseline examination 132 
the participants were randomly assigned to one of the 3 study groups using a computer 133 
randomisation plan (www.randomization.com) for men and women separately to ensure that the 134 
randomisation was balanced by sex. 135 
The guidelines given to the participants in the Substitution  DG group focused on 5 of the 10 136 
Danish Official DG (Table 1) where the scientific evidence for a relationship between a dietary 137 
factor and an IHD outcome was found to be convincing or probable  (21).  138 
The guidelines given to the participants in the Official DG group included 10 guidelines on food, 139 
beverages, and physical activity (Table 1). The Official DG were updated based on a systematic 140 
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literature review and on knowledge regarding Danish food habit and relevant nutrition-related 141 
diseases  (21). 142 
The two study groups assigned to receive either the Substitution DG or the Official DG, were given 143 
information about the DG via a letter including a leaflet with the respective guidelines and via a 144 
homepage (www.dipi.food.dtu.dk). The participants were given a personal password to the 145 
homepage where they could find leaflets and recipes. The leaflets and recipes for the Substitution 146 
DG and the Official DG were identical in design, structure and numbers, and therefore it was only 147 
the content that varied depending on which DG the participant was randomised to receive 148 
information about. All recipes given to the intervention groups were developed by the Danish 149 
Veterinary and Food Administration and Keyhole nutrition labelled (22) (a nutrition label developed 150 
to make it easier for Nordic consumers to select healthy products). To increase motivation and 151 
compliance to the respective DG, an email with two new recipes for each of the two study groups 152 
was send out to the participants biweekly during the intervention period. In the group receiving the 153 
Substitution DG, only recipes with fish dishes were sent out. To increase motivation and 154 
compliance in the habitual diet group the participants were also sent an email every second week, 155 
including a ‘thank you for still participating’ greeting.  156 
At the end of the intervention, after 6 months the participants were told that the intervention study 157 
was finished, but that they would be re-invited to a follow-up examination after further 6 months 158 
(Figure 1). 159 
Dietary assessment 160 
The study participants recorded their dietary intake using a web-based dietary assessment software 161 
for seven consecutive days (23). A user manual for the software was given to the participants at 162 
baseline. The web-based dietary assessment software was originally developed and validated for 163 
children aged 8-11-years and slightly customised to fit the adult study population of the DIPI study 164 
(23–25). At least four days of food reporting had to be completed for inclusion of the study 165 
participants in the analysis (26).  166 
The dietary assessment software was structured according to a typical Danish meal pattern covering 167 
breakfast, lunch, dinner and three in-between meals. The participants could estimate the amount 168 
consumed by selecting the closest portion size among four different digital images in 80 photograph 169 
series. Reminders for frequently forgotten foods (e.g. spreads, sugar, sauces, dressings, snacks, 170 
candy and beverages) were included. Furthermore, the participants reported the intake of nutritional 171 
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supplements and whether a day represented a usual or an unusual intake, including reasons for 172 
unusual intakes such as illness. If a participant failed to report for a day, the participant was 173 
reminded by an e-mail the next day (23).  174 
Intakes of food items, energy and nutrients were calculated for each study participant as an average 175 
of seven days using the software system General Intake Estimation System (GIES) version 1.000.i6 176 
(National Food Institute, Technical University of Denmark, Kgs. Lyngby, DK) and the Danish Food 177 
Composition Databank version 7.0 (National Food Institute Technical University of Denmark, 178 
2009). 179 
Under- and over-reporters 180 
Under- and over-reported energy intake was defined according to a ratio of reported mean energy 181 
intake to basal metabolic rate (EI;BMR) and classified by cut-offs suggested by Black (27, 28). Under-182 
reporters were defined as EI:BMR ≤ 1.05 and over-reporters was defined as EI:BMR ≥ 2.28, using 183 
a physical activity level 1.55 (data not shown).  184 
Anthropometric measurements (height, weight, and waist circumference) 185 
Height was measured to the nearest 0.5 cm on a wall mounted Stadiometer (SECA, Hamburg, 186 
Germany). Fasting body weight in kg and trunk fat was registered on a fat analysis weight (Tanita 187 
BC 418 MA, Tokyo, Japan). Waist- and hip circumference were measured twice, with an 188 
anthropometric tape (SECA 201, Hamburg, Germany) and the average was reported.  189 
Body mass index (BMI) was defined as weight in kg divided by squared height in meters (kg/m2).  190 
Background questionnaires 191 
Lifestyle questionnaires were used to obtain information about the participant’s education level 192 
(primary school/high school, associate degree, under-graduate, graduate) and the level of physical 193 
activity at leisure time (extremely active, moderately active, sedentary or inactive). The question 194 
about the level of physical activity was based on one question about the study participants physical 195 
activity during leisure time the past 6 month and was based upon the Danish National Health Profile 196 
questionnaire (29).   197 
Plasma alkylresorcinol concentrations 198 
Alkylresorcinol homologs (C17:0, C19:0, C21:0, C23:0, C25:0, and their sum) were extracted and 199 
purified from plasma samples and analysed by a gas chromatography–mass spectrometry (Finnigan 200 
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TM Trace GC Ultra Gas chromatograph coupled to a Finnigan Trace DSQ II mass detector, Thermo 201 
Fisher Scientific, Waltham, MA, USA)according to the method is described in detail elsewhere (30).     202 
Statistical method 203 
Statistical power calculations based on evidence from previous similar studies (31–33) were used to 204 
estimate that 62 subjects in each intervention arm was sufficient to detect a difference of 0.25 205 
mmol/L low-density lipoprotein (LDL) cholesterol (SD, 0.49) (α = 0.05, β = 0.8). In order to allow 206 
for a drop-out of 20 percent the number of participants was set to a total of 225. Baseline 207 
characteristics and dietary intake of the study participants were summarised for each intervention 208 
group using medians and 50 % central range for continuous variables and proportions for 209 
categorical variables. 210 
Changes in dietary composition, energy intake  and energy distribution in the Substitution DG 211 
group and the Official DG group, compared to the habitual diet from baseline to 6 months  and from 212 
baseline to 12 months  were based on two multiple liner regression models. Model 1 was adjusted 213 
for baseline intake of the outcome variable, and model 2 further adjusted for sex, age group (<50 214 
and ≥50) and BMI group (18.5-25 = Normal weight, >25-30 = Overweight, >30 = Obese). In Model 215 
2 we additionally tested for statistically significant interactions between intervention group and sex, 216 
intervention group and age group, and intervention group and BMI group. These interactions were 217 
tested to investigate whether the intervention had different effects for men and women, for 218 
participants above or below the 50 years of age or for normal weight, overweight or obese study 219 
participants. If an interaction was statistically significant, separate results according to the level of 220 
the effect modifier were provided. Furthermore, sensitivity analysis excluding under- and over-221 
reporters were made to investigate the impact of under- and over-reported energy intake on the 222 
changes in dietary composition and energy distribution in the two DG groups, when compared to 223 
the habitual diet. 224 
To check the model assumptions the standardised residuals of the final models were examined for 225 
normality, variance homogeneity and linearity.  226 
WG intake and total AR concentration in plasma were grouped into quartiles and cross-tabulation 227 
for total WG intake, and AR concentrations in plasma were presented to examine the agreement 228 
between quartiles using the baseline data. To validate the WG intake estimated form the web-based 229 
dietary assessment software a simple linear regression model was used to test the association 230 
between WG intake and total AR concentrations in plasma at baseline. To normalise the distribution 231 
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of the residuals and to improve variance homogeneity, AR concentrations and WG intake were 232 
logarithm2 transformed.  233 
The statistical analyses were carried out using RStudio (Version 0.99.441 – © 2009-2015 RStudio, 234 
Inc.). Statistical significance was established at p < 0.05.  235 
Results  236 
Baseline characteristics of the participants 237 
A total of 222 participants met the inclusion and exclusion criteria and were enrolled into the study, 238 
which was 67% of the initially screened potential study participants. Three participants dropped out 239 
of the study before randomisation (a full baseline examination was missing) and they were therefore 240 
excluded, see flow chart (Figure 2). Baseline characteristics of the remaining 219 study 241 
participants, by randomised intervention group are presented in Table 2. Altogether, 199 completed 242 
the intervention, corresponding to a compliance of 90 % and 186 participants completed the follow-243 
up. Reasons for non-compliance are given in the flow chart in Figure 2.  244 
Diet-differences from baseline to 6 months  245 
Table 3 shows the composition of the participant’s usual diets at baseline (median (p10- p90)) with 246 
all three groups combined and the between group differences in changes in diet from baseline to 6 247 
months. 248 
Substitution DG compared to the habitual diet 249 
Compared to the habitual diet, the group receiving the Substitution DG  increased their intake of 250 
WG (17 g/10 MJ/d, 95%CI: 6, 28  g/10MJ/d), dietary fibre (men; 0.31 g/MJ/d , 95%CI: 0.04, 0.58 251 
g/MJ/d, and women 0.23 g/MJ/d, 95%CI: 0.002, 0.45 g/MJ/d), fine vegetables (41 g/10MJ/d, 252 
95%CI: 5, 77 g/10MJ/d), and decreased their percentage of energy (E%) intake from SFA (-1.51 253 
E%, 95%CI:-2.31, -0.70 E%). In addition, women in the group increased their overall intake of 254 
vegetables (69.98 g/10MJ/d, 95%CI: 19.37, 120.58 g/10MJ/d) and normal weight study participants 255 
in the group increased their E% intake from PUFA (1.55 E%, 95%CI: 0.73, 2.36 E%).  256 
Official DG compared to the habitual diet 257 
Compared to the habitual diet, the group receiving the Official DG decreased their E% intake from 258 
SFA (-0.89 E%, 95%CI: -1.69, -0.09 E%). Furthermore, the women in the group increased their 259 
overall intake of vegetables (60.31 g/10MJ/d, 95%CI: 10.16, 110.45 g/10MJ/). Moreover, men in 260 
the group decreased their intake of coarse vegetables (-40 g/10MJ/d, 95%CI: -78, -2 g/10MJ/d).  261 
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Diet-differences from baseline to 12 months 262 
Table 4 shows the between group differences in changes in diet from baseline to 12 months. 263 
Substitution DG compared to the habitual diet 264 
Compared to the habitual diet, the group receiving the Substitution DG continued to have an 265 
increased intake of WGs from baseline to 12 months (16 g/10MJ/d, 95%CI: 6, 27g/10MJ/d) and 266 
increased their intake of fish (23 g/10MJ/d, 95%CI: 3, 43 g/10MJ/d). For vegetables intake in 267 
general, obese study participants in the group increased their intake (166 g/10MJ/d, 95%CI: 45, 287 268 
g/10MJ/d). Moreover, the group increased their intake of sugar and candy (9 g/10MJ/d, 95%CI: 0.2, 269 
17g/10MJ/d) and participants 50 years or above increased their E% intake from carbohydrate (2.67 270 
E%, 95%CI: 0.15, 5.19 E%). 271 
Official DG compared to the habitual diet 272 
Compared to the habitual diet, the group receiving the Official DG had from baseline to 12 months 273 
increased their intake of WG (13 g/10MJ/d, 95%CI: 3, 23 g/10MJ/d) and fish (24 g/10MJ/d, 274 
95%CI: 5, 44 g/10MJ/d) and they continued to have a decreased E% intake from SFA (-0.84 E%, 275 
95%CI: -1.69, -0.001 E%). Furthermore, participants 50 years or above in the group increased their 276 
E% intake from carbohydrates (2.95 E%, 95%CI: 0.45, 5.46 E%). 277 
Under- and over-reporters 278 
At baseline, at 6 months and at 12 months 21%, 35% and 31%, respectively of the participants were 279 
classified as under-reporters and 1%, respectively as over-reporters. Of the under-reporters 86-90% 280 
were overweight or obese, 41-44% of the under-reporters were men and all of the over-reporters 281 
were men.  282 
Excluding under- and over-reporters for the sensitivity analysis did not change the conclusion for 283 
the two sets of DG, when compared to the habitual diet. 284 
Association between whole grain intake and plasma AR at baseline 285 
From the cross-classification between reported WG intake and AR concentrations, 36% of the study 286 
participants were classified in the same quartile, 70% were classified in the same quartile or 287 
adjacent quartile, 22% were 2 quartiles apart, and 9% were misclassified in the opposite quartile 288 
(data not shown). A statistically significant association between WG intake and plasma AR was 289 
observed at baseline (p < 0.0001).  290 
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Discussion  291 
In the present study we found that from baseline to 6 months, when compared to the habitual diet, 292 
the Substitution DG was more effective than the Danish Official DG in changing the number of 293 
dietary components, resulting in a dietary composition of the overall diet being more cardio-294 
protective. However, from baseline to 12 months the effectiveness in changing the dietary 295 
composition towards a more cardio-protective diet was similar for both the Substitution DG and the 296 
Official DG in form of how many dietary components have changed, when compared to the 297 
habitual diet.  298 
Overall, from baseline to 6 months, the group assigned to follow the Substitution DG increased 299 
their intake of WG, dietary fibre and fine vegetables and decreased their E% intake from SFA, 300 
when compared to the habitual diet. Furthermore, women increased their overall vegetable intake 301 
and normal weight study participants increased their E% intake from PUFA, when compared to the 302 
habitual diet. The group assigned to follow the Official DG decreased their E% intake from SFA, 303 
when compared to the habitual diet. Further, women increased their intake of vegetables in general, 304 
like the women in the Substitution DG group, and men decreased their intake of coarse vegetables. 305 
From baseline to 12 months, the group receiving the Substitution DG continued to have an 306 
increased intake of WG. The group assigned to follow the Official DG had now, in contrast to from 307 
baseline to 6 months, also increased their intake of WG, when compared to the habitual diet. 308 
Changes in dietary fibre intake did not stay significant from baseline to 12 months in the 309 
Substitution DG group and besides an increased general intake of vegetables of obese study 310 
participants in the Substitution DG group, no other changes in total-, fine-, or coarse vegetables was 311 
found from baseline to 12 months in either of the two DG groups, when compared to the habitual 312 
diet.  313 
When compared to the habitual diet, the participants in both the two DG groups had from baseline 314 
to 12 months, in contrast to from baseline to 6 months, increased their intake of fish. One of the 315 
Substitution DG included the specific wording ´eat fish instead of red meat´, however, only a 316 
tendency towards a change in red meat intake was found in the Substitution DG group, when 317 
compared to the habitual diet.  The fact that we did not observe an increase in fish intake in either of 318 
the two DG groups from baseline to 6 months, even though both DG groups include advice to 319 
increase fish intake, could be explained by the fact that it may be difficult for people to exchange 320 
red meat with fish in many dishes. In many of the dishes including red meat, it would make little 321 
     
12 
 
sense to simply replace the meat with fish, and therefore participants are forced to change the whole 322 
dish instead of just one food component. It could be speculated that it will take some time to 323 
integrate new food/meal habits explaining why we only see an increase in fish intake from baseline 324 
to 12 months. 325 
As individuals usually change the dietary composition to maintain energy balance (10), the higher 326 
intake of the food groups found in the present study may be expected to replace other energy-327 
providing foods in the diet, which may have beneficial, neutral or detrimental effects. In the present 328 
study we did not find any decrease in certain food groups, even though we did not find any 329 
significant difference in total energy intake in either of the two DG groups, when compared to the 330 
habitual diet. However, we found that both the DG groups decreased their E% intake from SFA 331 
(corresponding to a 12 % and 7 % decreased intake from SFA from baseline, respectively) from 332 
baseline to 6 months. In addition, from baseline to 12 months the group assigned to follow the 333 
Substitution DG had a tendency towards a decreased E% intake from SFA and the group assigned 334 
to follow the Official DG had a decreased E% intake from SFA (corresponding to a 5 % and 6 % 335 
reduced intake from SFA from baseline, respectively). The decrease in SFA could be explained by 336 
the statistical tendency of a decreased meat intake in both the two DG groups and the tendency of a 337 
decreased cheese intake in the group assigned to the Substitution DG. Also, participants in the 338 
Substitution DG group with normal weight had increased their E% intake from PUFA from baseline 339 
to 6 months (corresponding to a 12 % increased intake form PUFA from baseline), when compared 340 
to the habitual diet; however from baseline to 12 months the increase in E% intake from PUFA was 341 
not significant anymore.  342 
Replacing dietary SFA with PUFA and WG have been shown in both prospective studies and 343 
randomized controlled trials to be beneficial for cardiovascular health (5, 8, 9, 34, 35). Mozaffarian et al. 344 
found in a meta-analysis of 8 RCT that when 5 E% from SFA was replaced by an equal amount of 345 
PUFA, LDL cholesterol and total cholesterol to high-density lipoprotein (HDL) cholesterol-ratio 346 
was reduced (8). This finding is supported by another systematic review including regression 347 
analysis of 84 RCT by Mensink et al. who found that when 1 E% from SFA was replaced with an 348 
equal amount of PUFA, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, LDL 349 
cholesterol to HDL cholesterol-ratio and triglyceride to HDL cholesterol ratio were reduced (34). 350 
Moreover, Mensink et al. showed that when 1 E% from SFA was replaced with carbohydrates, a 351 
decrease in total cholesterol, LDL cholesterol, HDL cholesterol and LDL cholesterol to HDL 352 
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cholesterol-ratio was seen, but they also found an increase in triglycerides. However, the source of 353 
carbohydrates is suggested to be important, as replacing SFA with refined starches/added sugars 354 
have shown not to be protective against CVD, whereas replacing SFA with WG have shown to be 355 
protective against CVD (5, 35).  356 
Li et al. suggest that when decreasing SFA intake, most people appear to increase the intake of low-357 
quality carbohydrates, such as refined starches and/or added sugar, rather than increase the intake of 358 
unsaturated fats (35). This suggestion by Li et al. is in line with findings of the present study where 359 
we found a decreased E% intake from SFA or a tendency towards a decreased E% intake from SFA 360 
in both DG groups from baseline to 6- and 12 months, when compared to the habitual diet. In 361 
addition, in the present study we also found that participants 50 years or above in both DG groups 362 
increased their E% from carbohydrates from baseline to 12 months, when compared to the habitual 363 
diet. Also, the group receiving the Substitution DG had from baseline to 12 months, in contrast to 364 
from baseline to 6 months, increased their intake of sugar and candy. A meta-analysis of 40 RCT 365 
found that higher intake of sugar significantly increased TAG, total-cholesterol, LDL-cholesterol 366 
and HDL-cholesterol (36).  367 
The substitution aspect of DGs is important because it approaches a real-life setting by specifying 368 
what to eat instead of a certain food or nutrient item. In addition, because the Substitution DG only 369 
consisted of 5 food and nutrient guidelines, they could be expected to be easier to follow and 370 
implement in the everyday life of the participants than the Official DG consisting of ten guidelines. 371 
However, the long term dietary effect from baseline to 12 months of both the Substitution DG and 372 
the Official DG were similar in form of changes in the numbers of dietary components, when 373 
compared to the habitual diet  374 
Misreporting as under- and over-reported energy intake in self-reported dietary assessment methods 375 
could be a potential source of bias (37). However, in the present study excluding under- and over-376 
reporters for the sensitivity analysis did not change the conclusion for the two sets of DG, when 377 
compared to the habitual diet. 378 
In the present study, self-rated WG intake was associated with plasma AR at baseline. Andersen et 379 
al. have suggested that plasma AR concentrations in fasting samples can be used as a biomarker of 380 
WG intake in free-living populations with a high and consistent WG intake, comparable with the 381 
study population in the present study (17). Furthermore, from cross-classification between reported 382 
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WG intake and AR concentrations we found that 70% were classified in the same quartile or 383 
adjacent quartile, which is in agreement with findings from two other studies by Ross et al. (14) and 384 
Biltoft et al. (23). 385 
Our study has some limitations. To some extent the present study does not present the direct/actual 386 
effects of the DGs on dietary composition, as ensuring adherence to DGs is difficult in long-term 387 
intervention trial, both because of prohibitive costs and of what you impose on the study 388 
participants in a long-term trial. However, the present study does provide evidence for the dietary 389 
effects of advising two different sets of DGs; one focusing on specific substitutions targeted 390 
primary prevention of IHD and one set of DGs with a wording more traditional in the European and 391 
Nordic countries, namely the Danish Official DG, which focuses on nutrition-related diseases 392 
relevant in Denmark. A strength of this study is the real-life setting, where participants were free-393 
living and empowered to modify their dietary pattern. Also, the study was conducted in a healthy 394 
adult population, including men and women, non-smoking, not taking blood pressure- or 395 
hyperlipidemia medication, which is a strength because evidence is lacking for primary prevention 396 
of CVD. In addition, although some of the found diet and nutritional changes are small, they are 397 
almost all in the direction of improvement. Moreover, the found improvements in dietary effects are 398 
the result of simply providing people with DG over a 12 month period. Last but not least, validation 399 
of the dietary method used and evidence for compliance to the intervention were provided through 400 
an objective biomarker of intake.  401 
In conclusion from baseline to 6 months, when compared to the habitual diet, the Substitution DG 402 
was more effective than the Danish Official DG in changing the number of dietary components, 403 
resulting in a dietary composition of the overall diet being more cardio-protective. However, from 404 
baseline to 12 months the effectiveness in changing the dietary composition towards a more cardio-405 
protective diet was similar for both the Substitution DG and the Official DG in form of changes in 406 
numbers of dietary components, when compared to the habitual diet. Furthermore, self-rated WG 407 
intake was associated with plasma AR at baseline, objectively validating WG-intake  408 
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Table 1: The Substitution dietary guidelines and the Danish Official dietary guidelines  549 
Substitution dietary guidelines Official dietary guidelines 
 Eat a variety of foods, but not too much, 
and be physically active 
Eat fruit instead of candy and cake 
Eat coarse vegetables instead of fine 
vegetables† 
Eat fruits and many vegetables 
Eat fish instead of red meet Eat more fish 
Eat wholegrain products instead of 
products with no wholegrain grains 
Choose whole grains 
 Choose lean meats and cold meats 
 Choose low-fat dairy products 
Eat unsaturated fat instead of saturated 
fat 
Eat less saturated fat 
 Eat foods with less salt 
 Eat less sugar  
 Drink water 
† Vegetables are classified from type of food groups (e.g. all types of cabbage, rooted vegetables and onions are classified as coarse 550 
vegetables and all vegetables with a high water content like tomatoes and salad are classified as fine vegetables) 551 
 552 
 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
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Table 2: Baseline characteristics of the study participants by randomised intervention group (n=219). 561 
Participants characteristics Habitual diet (n=73) Substitution DG (n=74) Official DG (n=72) 
 Median (p25-p75) Median (p25-p75) Median (p25-p75) 
Age (years) 51.0 (42.0, 55.0) 51 (42.3, 57.0) 52.5 (45.0, 58.0) 
Women, % (n) 59  (43) 58  (43) 60  (43) 
Weight (kg) 85.2 (71.8, 90.8) 82.2 (74.2, 88.8) 80.7 (70.5, 91.8) 
BMI† 26.0 (24.2, 29.3) 27.0 (25.6, 29.2) 26.8 (24.6, 29.4) 
Weight status†:       
   Normal weight, % (n) 33 (24) 22 (16) 28 (20) 
   Overweight, % (n) 51 (37) 56 (42) 51 (37) 
   Obese, % (n) 16 (12) 22 (16) 21 (15) 
Waist circumference (cm)  92.3 (85.7, 99.4) 92.3 (86.8, 98.2) 94.1 (83.1, 99.2) 
Hip circumference (cm) 106.9 (103.7, 112.4) 107.2 (104.5, 114.5) 107.1 (102.8, 112.7) 
Educational level       
Primary school or high school, % (n) 22 (16) 26 (19) 29 (21) 
Associate degree, % (n) 11 (8) 8 (6) 6 (4) 
Undergraduate school, % (n) 37 (27) 42 (31) 40 (29) 
Graduate school, % (n) 30 (22) 24 (18) 25 (18) 
DG, dietary guidelines; BMI, Body Mass Index. 562 
†BMI is calculated as weight in kilograms divided by the square of height in meters (kg/m2). 18.5-25 = Normal weight, 25-30 = 563 
Overweight, >30 = Obese. 564 
 565 
 566 
 567 
 568 
 569 
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Table 3: Between group differences in changes in energy adjusted diet composition (g/10MJ/day), total energy (MJ/day), energy 570 
contribution (E%) of macronutrients, dietary fibre (g/MJ) from baseline to after 6 months. 571 
 Model 1† Model 2‡ 
                                                        Baseline intake (n=219) 
                                                     Median (p10-p90) 
SUB DG vs. habitual  
Mean between group 
difference, 95%CI 
OFF DG vs. habitual  
Mean between group 
difference, 95%CI 
SUB DG vs. habitual    
Mean between group 
difference, 95%CI 
OFF DG vs. habitual   
Mean between group 
difference, 95%CI 
Diet composition (g/10MJ/day):           
Bread and cereals 218 (141-301) 6 (-15, 26) -3 (-23, 18) 6 (-14, 26) -2 (-22, 18) 
   Whole grains 61 (31-111) 17** (6, 28) 6 (-4, 17) 18** (7, 28) 7 (-4, 17) 
Meat and meat products 139 (59-249) -15 (-38, 8) -15 (-38, 8) -16 (-39, 6) -15 (-38, 7) 
Poultry and poultry products  32 (0-102) 10 (-7, 28) 4 (-13, 20) -4 (-36, 27) -10 (-39, 20) 
Fish and fish products 46 (5-111) 12 (-6, 30) 15 (-4, 33) 12 (-7, 30) 15 (-4, 33) 
Fruit and fruit products 143 (43-331) 25 (-13, 63) 22 (-16, 60) 26 (-12, 64) 23 (-15, 62) 
Vegetables and vegetables products 220 (110-425) 44* (5, 83) 16 ( -23, 55) 45* (5, 84) 16 (-23, 55) 
   Women       70** (19, 121) 60* (10, 110) 
   Men       8 (-52, 69) -48 (-109, 12) 
Vegetables, coarse§ 97 (29-208) 8 (-17 to 33) -4 (-28, 21) 9 (-15,  334) -3 (-27, 22) 
   Women       18 (-14, 50) 23 (-9, 54) 
   Men       -4 (-42, 34) -40* (-78, -2) 
Vegetables, fine§ 114 (49-228) 28* (1, 56) 15 (-12, 42) 41* (5,  77) 34 (-2, 70) 
Potatoes and potatoes products 57 (7-138) -9 (-30, 11) 6 (-14 , 26) -9 (-30, 11) 5 (-15, 25) 
Milk and milk products 243 (68-513) -4 (-63, 56) 38 (-21,  96) -6 (-65,  53) 38 (-21, 96) 
Cheese and cheese products 45 (11-129) -17 (-36, 2) -16 (-35, 2) -18 (-37, 1) -18 (-36, 1) 
Edible fats   -4 (-8, 1) -3 (-7, 2) -4 (-8, 1) -3 (-7, 2) 
Sugar and candy 35 (10-77) 4 (-4,  12) 2 (-6,  11) 5 (-3, 13) 3 (-5, 11) 
Total energy, energy contribution 
of macronutrient, dietary fibre  
          
Energy, MJ 8.6 (5.8-12.4) -0.12  (-0.76, 0.51) 0.06 (-0.58, 0.70) -0.84 (-3.73, 2.05) 1.53 (-1.28, 4.34) 
Energy from protein, % 17 (14-22) -0.40 (-1.25, 0.46) -0.12 (-0.97, 0.73) -0.50  (-1.34, 0.34) -0.17 (-1.01, 0.66) 
Energy from carbohydrate, % 44 (35-53) 1.60 (-0.43, 3.63) 1.66 (-0.35, 3.68) 1.77 (-0.23, 3.78) 1.83 (-0.16, 3.81) 
Energy from added sugar, % 7 (2-13) -0.08 (-1.18, 1.03) 0.03 (-1.06, 1.13) 0.02 (-1.08, 1.12) 0.09 (-1.01, 1.19) 
Energy from total fat, % 35 (29-42) -1.35 (-3.04, 0.34) -1.01 (-2.68,  0.67) -1.35 (-3.05, 0.36) -1.03 (-2.72, 0.66) 
Energy from SFA, % 13 (11-17) -1.43*** (-2.24, -0.63) -0.86* (-1.65, -0.06) -1.51*** (-2.3, -0.70) -0.89* (-1.69, -0.09) 
Energy from MUFA, % 13 (10-17) -0.28 (-1.19, 0.63) -0.20 (-1.11, 0.71) -0.22 (-1.13, 0.70) -0.19 (-1.10, 0.72) 
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SUB DG, substitution dietary guidelines;  habitual, habitual diet; OFF DG, Danish official dietary guidelines; g, gram; MJ, mega joule; 572 
SFA, Saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids 573 
Levels of significance are marked as: * p<0.05, ** p=<0.01, *** p=0.001 574 
† simple liner regression models adjusted for baseline intake of the outcome variable 575 
‡ multiple liner regression model adjusted for baseline intake of the outcome variable, sex, age group (<50 and ≥50), BMI group (18.5-25 = 576 
Normal weight, >25-30 = Overweight, >30 = Obese) and interactions between intervention group and sex, intervention group and age 577 
group, and intervention group and BMI group 578 
§Vegetables are classified from type of food groups (e.g. all types of cabbage, rooted vegetables and onions are classified as coarse 579 
vegetables and all vegetables with a high water content like tomatoes and salad are classified as fine vegetables). 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
Energy from PUFA, % 5 (4-7) 0.43 (-0.004, 0.87) 0.02 (-0.42, 0.45) 0.47* (0.04,  0.91) 0.03 (-0.40, 0.46) 
   Normal weight       1.55*** (0.73, 2.36) 0.05 (-0.71, 0.81) 
   Overweight       -0.06 (-0.64, 0.51) -0.03 (-0.61, 0.55) 
   Obese       0.60 (-0.42, 1.63) 0.11 (-0.95, 1.18) 
Energy from alcohol, % 5 (1-14) 0.52 (-0.66, 1.69) -0.43 (-1.62, 0.76) 0.50 (-0.67, 1.67) -0.48 (-1.67, 0.70) 
Dietary fibre, g/MJ/day 2 (2-3) 0.24** (0.07, 0.42) 0.06 (-0.11, 0.24) 0.26** (0.09,  0.44) 0.08 (-0.09, 0.25) 
   Women       0.23* (0.01,  0.45) 0.22 (-0.01, 0.44) 
   Men        0.31* (0.04, 0.58) -0.12 (-0.39, 0.15) 
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Table 4: Between group differences in changes in energy adjusted diet composition (g/10MJ/day), total energy (MJ/day), energy 588 
contribution (E%) of macronutrients, dietary fibre (g/MJ) from baseline to after 12 months. 589 
 Model 1 † Model 2 ‡ 
 
SUB DG vs. habitual  
Mean between group 
difference, 95%CI 
OFF DG vs. habitual  
Mean between group 
difference, 95%CI 
SUB DG vs. habitual  
Mean between group 
difference, 95%CI 
OFF DG vs. habitual  
Mean between group 
difference, 95%CI 
Diet composition (g/10MJ/day):         
Bread and cereals 9 (-12,  29) 6  (-15, 26) 10  (-10, 31) 7  (-14, 27) 
   Whole grains 15**  (5, 26) 12*  (2, 22) 16**  (6, 27) 13*  (3, 23) 
Meat and meat products -22  (-47, 2) -24*  (-48,  -0.2) -22  (-47, 2) -24  (-48, 0.3) 
Poultry and poultry products -1 (-20, 18) 10 (-9, 28) 2 (-17, 20) 15 (-3, 33) 
Fish and fish products 25*  (5, 45) 25*  (6, 45) 23*  (3, 43) 24*  (5, 44) 
Fruit and fruit products -3  (-41,  35) 1  (-37, 38) -4  (-42, 34) -1  (-39, 36) 
Vegetables and vegetables products -20  (-69, 29) -13  (-62, 37) -20  (-69, 30) -11  (-61,  38) 
   Normal weight     -92  (-183,   0.1) -71  (-156,  15) 
   Overweight     -36  (-101, 29) 6  (-60,  72) 
   Obese     166**  (45, 287) 61  (-62, 185) 
Vegetables,     coarse§ -15  (-45, 16) -8  (-39, 23) -14  (-45,  17) -8  (-38,  23) 
Vegetables,  fine§ -8  (-40, 23) -10  (-41, 21) -8  (-39,  24) -9  (-41,  22) 
Potatoes and potatoes products -8  (-34, 19) 13  (-12, 38) -7  (-33, 20) 14  (-11, 39) 
   Women     14  (-20, 48) 4  (-28, 36) 
   Men     -37  (-77, 3) 29  (-8, 66) 
Milk and Milk products 22  (-29,  74) -1  (-52, 50) 19  (-33, 71) -4  (-54, 47) 
Cheese and cheese products -22  (-47, 3) -4  (-29, 21) -23  (-48, 2) -4  (-29, 21) 
Edible fats 0.4 (-4, 5) -1 (-6, 3) 0.1 (-4, 5) -2 (-6, 3) 
Sugar and candy^^ 9  (1, 18) 3  (-5, 12) 9*  (0.2, 17) 3 (-5, 12) 
Total energy, energy contribution of 
macronutrients and dietary fibre 
        
Energy, MJ 0.07  (-0.52, 0.66) 0.29  (-0.30, 0.88) 0.13  (-0.45, 0.71) 0.31  (-0.27,.89) 
Energy from protein, % -0.41  (-1.42, 0.60) 0.42  (-0.58, 1.43) -0.44  (-1.46 , 0.57) 0.42  (-0.59, 1.43) 
Energy from carbohydrate, % 0.96  (-1.00,  2.93) 0.86  (-1.09,  2.81) 1.03  (-0.95,  3.02) 0.90  (-1.07,  2.87) 
<50 years     -1.29  (-4.40,  1.83) -2.18  (-5.28, 0.92) 
≥50 years     2.67*  (0.15,  5.19) 2.95* (0.45,  5.45) 
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Energy from added sugar, % 0.93  (-0.17, 2.02) 0.10   (-0.99, 1.20) 0.86  (-0.24, 1.96) 0.07  (-1.02, 1.17) 
Energy from total fat, % 0.15  (-1.48,  1.78) -0.55   (-2.17,  1.07) 0.05  (-1.60, 1.69) -0.63  (-2.26, 1.00) 
Energy from SAF, % -0.68  (-1.53, 0.17) -0.82  (-1.66, 0.03) -0.73  (-1.59,  0.12) -0.84*  (-1.69, -0.001) 
Energy from MUFA, % 0.43  (-0.50,  1.36) 0.08  (-0.85,  1.00) 0.44  (-0.51, 1.38) 0.06  (-0.87,  1.00) 
Energy from PUFA, % 0.20  (-0.22, 0.62) 0.25  (-0.17, 0.67) 0.19  (-0.24, 0.61) 0.24  (-0.18, 0.66) 
Energy from alcohol, % -1.23 (-2.44, -0.03) -1.18 (-2.39,  0.04) -1.15 (-2.37, 0.07) -1.11 (-2.33, 0.11) 
Fibre, g/MJ/day 0.06  (-0.12, 0.24) 0.09 (-0.09, 0.27) 0.08 (-0.10, 0.26) 0.10 (-0.08, 0.28) 
SUB DG, substitution dietary guidelines;  habitual, habitual diet; OFF DG, Danish official dietary guidelines; g, gram; MJ, mega joule; 590 
SFA, Saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids 591 
Levels of significance are marked as: * p<0.05, ** p=<0.01, *** p=0.001 592 
† simple liner regression models adjusted for baseline intake of the outcome variable 593 
‡ multiple liner regression model adjusted for baseline intake of the outcome variable, sex, age group (<50 and ≥50), BMI group (18.5-25 = 594 
Normal weight, >25-30 = Overweight, >30 = Obese) and interactions between intervention group and sex, intervention group and age 595 
group, and intervention group and BMI group 596 
§ Vegetables are classified from type of food groups (e.g. all types of cabbage, rooted vegetables and onions are classified as coarse 597 
vegetables and all vegetables with a high water content like tomatoes and salad are classified as fine vegetables). 598 
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Abstract 20 
Background/Objectives: Addressing modifiable risk-factors such as diet can help prevent ischemic 21 
heart disease (IHD). The objective was to examine effects of applying targeted Substitution dietary 22 
guidelines (DG) on IHD risk factors in an adult Danish population with a minimum of one self-23 
reported risk factor for IHD.  24 
Subjects/Methods: In all 219 participants were at baseline randomly assigned to either I) targeted 25 
Substitution DG, II) Official DG, or III) Habitual diet in a six-month, single-blinded parallel 26 
randomised controlled trial, with a six months follow-up in a real-life setting. At baseline, at six 27 
months and at 12 months, dietary records, fasting blood samples analysed for concentrations of 28 
triglycerides, total cholesterol, high density lipoprotein-cholesterol, high-sensitivity C-reactive 29 
protein, glucose, haemoglobin A1c, insulin and alkylresorcinols, blood pressure and heart rate, 30 
anthropometrics, and background questionnaires were collected. Linear regression analyses were 31 
applied.  32 
Results: Compared to the Habitual diet, no overall differences in change in cardiometabolic risk 33 
factors were found in either of the two DG groups. A statistically significant decrease in waist 34 
circumference (-4.41 cm, 95%CI: -7.93, -0.88cm, p= 0.0145) from baseline to 12 month were found 35 
in obese study participants receiving the Official DG, when compared to the Habitual diet.  36 
Conclusion: In conclusion, when compared with the Habitual diet, neither the Substitution DG 37 
targeting prevention of IHD nor the Danish Official DG showed any overall beneficial effects on 38 
IHD risk factors in an adult Danish population with a minimum of one self-reported risk factor for 39 
IHD in a free-living dietary advice randomised controlled trial.   40 
 41 
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Introduction 42 
Ischemic heart disease (IHD) is the leading cause of morbidity and mortality worldwide with an 43 
estimated 7.4 million deaths due to IHD in 2015 
1,2
.  44 
Addressing behavioural risk factors such as an unhealthy diet may help improve clinical 45 
conditions contributing to the development of IHD such as hypertension, diabetes, 46 
hyperlipidaemia, overweight and obesity
1,3–5
. 47 
Nordic and European DG, including the Danish Official  DG, are based on systematic literature 48 
reviews of studies concerning the association between food intake and different diet related 49 
diseases 
6–8
.  In addition, the baseline part of the present study has shown that higher adherence 50 
to the Danish Official DG is associated with a more beneficial cardiometabolic risk profile in an 51 
adult Danish population 
9
. However, DG targeting one specific nutrition-related lifestyle disease 52 
such as IHD may be even more effective in prevention of IHD than guidelines targeting all 53 
relevant nutrition-related diseases.  54 
The evidence-base for the Danish official DG has found a convincing or probable causal 55 
relationship between the intake of fish, fruit and vegetables, whole grains and dietary fibre and 56 
substitution of saturated fat with polyunsaturated fat, and a reduced risk of IHD and overall  57 
cardiovascular diseases (CVDs) 
6
. This is supported by recent results from meta-analyses that 58 
provide strong evidence that replacing saturated fat (SFA) with polyunsaturated fat (PUFA) and 59 
whole grains benefit cardiovascular health 
10–12
.  60 
It is well established that when individuals change their dietary intake of specific foods, they 61 
primarily change their dietary composition rather than their total energy intake 
13
.  Therefore  it 62 
is important not only to evaluate the single foods or nutrients which are consumed but also to 63 
look at the replaced foods or nutrients 
14
.  64 
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By emphasising specific food and macronutrient replacements we have previously shown in this 65 
randomised controlled trial (RCT) that targeted substitution DG was effective in changing the 66 
dietary composition of the overall diet towards being more cardio-protective 
Arentoft et al. submitted
. 67 
However, the effect of targeted Substitution DG on IHD risk factors is still unknown. Therefore, 68 
the objective of this study was to examine the short- and long-term effects of applying targeted 69 
Substitution DG on IHD risk factors in an adult Danish population with a minimum of one self-70 
reported risk factor of IHD.  71 
Methods 72 
Study design  73 
The methodology of the study has been described previously 
Arentoft et al. submitted
. In short, a six-month 74 
single-blinded, parallel RCT was conducted in a real-life setting, with a six-month follow-up. At 75 
baseline, participants were assigned to one of three study groups I) food-based Substitution DG II) 76 
food-based Danish Official DG, or III) a habitual diet. 77 
Short- and long term effects of the DGs were defined as the changes in IHD risk factors from 78 
baseline to six months (end of the intervention) and from baseline to 12 months (follow-up), 79 
respectively.  80 
The study was conducted according to the guidelines laid down in the Declaration of Helsinki and 81 
approved by The Capital Region of Denmark Ethics Committee (Journal no. H-1-2013-110) and the 82 
Danish Data Protection Agency (Journal no. 2013-54-0571). Written informed consent was 83 
obtained from all study participants and they received a small remuneration of around 34 GBP for 84 
their participation in the study. The study was registered at ClinicalTrials.gov (registry name “Diet 85 
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and Prevention of Ischemic Heart Disease: a Translational Approach (DIPI)”, ID no. 86 
NCT02062424).  87 
Study participants  88 
Potential participants were identified using a unique personal identification number assigned to all 89 
Danish citizens in the Civil Registration System 
15
.   90 
The inclusion criteria were age between 30 and 65 years, and a minimum of one self-reported risk 91 
factor for IHD, i.e. overweight or obesity (BMI ≥ 25), waist circumference ≥80 cm for women and 92 
≥94 cm for men, and/or physical inactivity defined as being moderately physically active in leisure 93 
time for 15 minutes or less per week. 94 
The exclusion criteria were current smoking, pregnancy or plans to become pregnant within 12 95 
months, breastfeeding, history of cardiovascular disease (CVD), type-2 diabetes, chronic 96 
disease/disorders that could affect the results of the study (the chronic diseases that the subjects 97 
reported were evaluated by the physician in charge), drug abuse within the last 12 months, regular 98 
alcohol consumption >21 units/week for men or >14 units/week for women, allergies or intolerance 99 
of the food groups included in the DG, consumption of dietary supplements with high doses of 100 
nutrients that could have a potential effect on IHD risk factors (e.g. fish oils) and/or no access to a 101 
computer and internet. 102 
Randomisation and intervention 103 
After the baseline examination, the study participants were randomly assigned to one of the three 104 
study groups. 105 
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The guidelines given to the participants in the targeted Substitution DG group focused on five of the 106 
ten Danish Official DG (Table 1), where the scientific evidence for a relationship between the 107 
dietary factor and an IHD outcome was found convincing or probable  
6
.  108 
The guidelines given to the participants in the Official DG group included ten guidelines on food, 109 
beverages, and physical activity (Table 1). The Danish Official DG were updated based on a 110 
systematic literature review and knowledge regarding Danish food habits and relevant nutrition-111 
related diseases  
6
. 112 
Information about the DG was given via a leaflet with the respective guidelines and via a homepage 113 
(www.dipi.food.dtu.dk). Bi-weekly e-mails with two new recipes for each of the two study groups 114 
were sent out to the participants during the intervention period. In the habitual diet group the 115 
participants were also sent an email every second week, including a ‘thank you for still 116 
participating’ greeting.  117 
Assessment of ischemic heart disease risk factors  118 
Blood samples 119 
Fasting blood samples from venipuncture were analysed for concentrations of triglycerides (TAG), 120 
total cholesterol, high density lipoprotein-cholesterol (HDL-cholesterol), high-sensitivity C-reactive 121 
protein (hsCRP), glucose, haemoglobin A1c (HbA1c) and insulin. The blood samples were collected 122 
and handled according to hospital routines. TAG, total cholesterol, HDL-cholesterol and glucose 123 
were measured in plasma by Reflection Spectroscopy by 540 nm, and hsCRP was measured in 124 
plasma by Reflection Spectroscopy by 660 nm (Apparatus Vitros 5.1 FS, Ortho-Clinical 125 
Diagnostics, Bridgend Pencoed, United Kingdom). HbA1c was measured in plasma with High 126 
Performance Liquid Chromatography (HPLC) (D-100, Bio-Rad, Copenhagen, Denmark). Fasting 127 
plasma insulin was measured using the sandwich ELISA analysis principle (ADVIA Centaur XP, 128 
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Siemens, Ballerup, Denmark). The within-run variations (CV%) for the biochemical measurements 129 
were 0.7- 11%. Very low density lipoprotein-cholesterol (VLDL-cholesterol) was calculated from 130 
TAG using the equation; plasma VLDL-cholesterol = plasma TAG x 0,45 and low density 131 
lipoprotein-cholesterol (LDL-cholesterol) was calculated using The Friedewald Equation 
16
.  132 
The homeostatic model assessment (HOMA) was used to estimate insulin resistance (HOMA-IR). 133 
HOMA-IR was calculated using the formula: HOMA-IR = [glucose (nmol/L) * insulin 134 
(mU/mL)/22.5], using fasting values 
17
.   135 
Blood pressure and heart rate 136 
Seated blood pressure (BP) and heart rate (HR) were measured using an electric 137 
sphygmomanometer according to standardized procedures.  138 
Anthropometric measurements (height, weight, and waist circumference) 139 
Height was measured to the nearest 0.5 cm on a wall mounted Stadiometer (SECA, Hamburg, 140 
Germany). Fasting body weight in kg and trunk fat was registered on a fat analysis weight (Tanita 141 
BC 418 MA, Tokyo, Japan). Waist- and hip circumference were measured twice, with an 142 
anthropometric tape (SECA 201, Hamburg, Germany) and the average was reported.  143 
Body mass index (BMI) was defined as weight in kg divided by squared height in meters (kg/m
2
).  144 
Background questionnaires 145 
Lifestyle questionnaires were used to obtain information about the participant’s education level and 146 
the level of physical activity at leisure time.  147 
Statistical method 148 
Two multiple linear regression models were used to calculate changes in IHD risk factors in the 149 
group receiving the targeted Substitution DG and the group receiving the Official DG, when 150 
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compared to the Habitual diet group from baseline to six months and from baseline to 12 months. 151 
Model 1 was adjusted for baseline levels of the outcome variable, and model 2 was further adjusted 152 
for sex, age group (<50 and ≥50) and BMI group (18.5-25 = Normal weight, >25-30 = Overweight, 153 
>30 = Obese). In Model 2 we additionally tested for statistically significant interactions between the 154 
effects of intervention group and sex, intervention group and age group, and intervention group and 155 
BMI group. These interactions were tested to investigate whether the intervention had different 156 
effects for men and women, for participants above or below the 50 years of age or for normal 157 
weight, overweight or obese study participants. If an interaction was statistically significant, 158 
separate results according to the level of the effect modifier were provided.   159 
To check the model assumptions, the standardized residuals of the final models were examined for 160 
normality, variance homogeneity and linearity.  161 
The statistical analyses were carried out using RStudio (Version 0.99.441 – © 2009-2015 RStudio, 162 
Inc.). Statistical significance was established at p < 0.05.  163 
Results  164 
Baseline characteristics  165 
A flow chart of the study has been presented previously 
Arentoft et al. submitted
. A total of 222 participants 166 
were enrolled into the study.  Three participants dropped out of the study before randomisation and 167 
were excluded. Baseline characteristics of the remaining 219 study participants by intervention 168 
group are presented in Table 2.  169 
Retention 170 
Altogether, 203 study participants completed the examination after six months, corresponding to a 171 
retention rate of 93%, and 196 study participants completed the examination after 12 months.  172 
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Medication users  173 
Study participants taking cholesterol lowering (at baseline n=5, at 6 month n=7 and at 12 month 174 
n=3) and/or BP-lowering (at baseline n=3, at six month, n=2 and at 12 month n=6) medications 175 
were excluded from the statistical analysis including lipid biomarkers and BP, respectively.  176 
Differences in IHD risk factors from baseline to six and 12 months  177 
Table 3 and Table 4 show the between group differences in IHD risk factors from baseline to six 178 
months and from baseline to 12 months, respectively. 179 
When compared to the habitual diet, no overall differences in changes in cardiometabolic risk 180 
factors were found in neither of the two DG groups. A statistically significant larger decrease in 181 
waist circumference (-4.41 cm, 95%CI: -7.93, -0.88cm) was found from baseline to 12 month in 182 
obese study participants receiving the Official DG, when compared to the Habitual diet.  183 
Discussion 184 
In the present study no overall differences in changes in IHD risk factors were found in either the 185 
group receiving the Substitution DG or the group receiving the Official DG, when compared to the 186 
habitual diet.  187 
The results are in line with the findings of a recently published  six-month RCT with a 12 months 188 
follow up by Jenkins et al. 
18
. The study investigated the effect of dietary advises with and without 189 
food provision on weight loss and CVD risk factors and included 919 healthy overweight adult men 190 
and women  
18
. The study participants were randomised to four groups, all receiving the Health 191 
Canada´s Food Guide. No additional advice was given to the control group. The first intervention 192 
arm out of three received dietary advise due to the DASH diet and the Portfolio diet, the second 193 
intervention arm were weekly provided with foods reflecting this advice, and the third intervention 194 
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arm were provided with food and advice. Comparable with the previously found results on dietary 195 
intake 
(Arentoft et al. Submitted)
, Jenkin et al. also observed an increase in whole grain intake in all three 196 
groups when compared to the control group. However, Jenkins et al. only observed increases in 197 
intake of other recommended foods in the groups provided with foods when compared to the 198 
control group. In addition and in line with the results of the present study, Jenkin et al. found no 199 
difference in CVD risk factors from baseline to six months or from baseline to 18 months in either 200 
of the three intervention groups when compared to the control group. 201 
Several other RCTs conducted in a real life setting with a free living population comparable to the 202 
present study and the study by Jenkins et al. have investigated the effect of national DG and 203 
different diets such as the New Nordic Diet and the Mediterranean diet on CVD risk factors 
19–21
. In 204 
one RCT, Reidlinger et al. found a beneficial effect of adherence to the United Kingdom (UK) DG, 205 
broadly similar to the Official DG, when compared to a traditional British diet on selected CVD risk 206 
factors 
20
. Similarly, Estruch et al. found beneficial effects on CVD risk factors of two different 207 
Mediterranean diets (supplemented with extra olive or nuts) when compared to a low-fat diet 
19
.  208 
Differences between the results of the studies by Reidlinger et al. and Estruch et al. and the present 209 
study could be due to variations in the study design. In the present study adherence to the DG were 210 
sought achieved through dietary advice about the DG on leaflets, a homepage including information 211 
on the DG and recipes and biweekly e-mails with new recipes for inspiration and motivation. This 212 
communication form was chosen to reflect how information of DG is normally transmitted in real-213 
life. In contrast, adherence to both the UK DG investigated by Reidlinger et al. and the 214 
Mediterranean diet investigated by Estruch et al. were achieved by dietary advice provided by face-215 
to-face meetings with a dietitian, which may be assumed to be more a more motivating information 216 
medium for the study participants 
19,20
. In the study by Jenkins et al. on the other hand, the dietary 217 
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advice was provided through 20-30 minutes of telephone interviews administered weekly in the first 218 
months and monthly in the last five months of the intervention 
18
.   219 
Contrary to the present study, the participants in the studies by Reidlinger et al. and Estruch et al. 220 
were also provided with key foods of the UK DG or the Mediterranean diet. Adherence to DG or 221 
specific diets may be better when study participants get the “new” key foods free of charge, instead 222 
of having to change shopping behaviour to obtain them themselves. This was also shown in the 223 
study by Jenkins et al. where the adherence to dietary advice were higher in the groups provided 224 
with foods reflecting the dietary advice given 
18
. 225 
The baseline health status of the study participants may be of significance when measuring risk 226 
factors for CVD. In the present study, we recruited participants with a minimum of one self-227 
reported risk factor for IHD, but even though the majority of the study participants were overweight 228 
and obese and had elevated waist circumference, the study participants were generally healthy, non-229 
smoking, and not taking blood pressure- or hyperlipidaemia medication. This is similar to the 230 
populations of the studies by Jenkins et al. and Reidlinger et al. which also included healthy adult 231 
men and women. 
18,20,21
. However, in contrast, the RCT by Estruch et al. included middle-aged men 232 
and women with high cardiovascular risk 
19
.  233 
The fact that we did not observe any overall differences in change in IHD risk factors in the two DG 234 
groups when compared to the Habitual diet could also be due to the study participants 235 
baseline/habitual dietary intake of key food and nutrients included in both sets of DG. When 236 
compared to the habitual diet, we found the largest dietary changes in intake of whole grains, fish 237 
and SFA in both DG groups 
(Arentoft et al. submitted)
. An increased intake of both wholegrains and fish 238 
including high amounts of polyunsaturated fatty acids has been associated with reduced risk of IHD 239 
6
. In addition, there is strong evidence that consuming PUFA in place of SFA reduces IHD 
10,12,22
. 240 
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However, the study participant’s median baseline/habitual intake of whole grains and fish was 241 
already relatively high 
(20, 21 and Arentoft et al. Submittetd)
 and almost reached the recommended 75g/10MJ/ 242 
day and 50g/10MJ/day, respectively 
6
. By comparison, the mean baseline intake of whole grains in 243 
in the studies by Reidlinger et al. and Jenkins et al. was only 1.4 -1.5 servings/ day (1 serving 30 g) 244 
~ 43 - 45 g/day 
18,20
.  245 
Our study has some limitations. Ensuring adherence to DGs is difficult in a long-term RCT, both 246 
because of prohibitive costs and of what can be imposed on the study participants in a long-term 247 
trial. However, the present study does provide evidence for the effects of advising two different sets 248 
of DGs on IHD risk factors; one set targeting primary prevention of IHD and focused on specific 249 
substitutions and one set of DGs focusing on nutrition-related diseases relevant in Denmark with a 250 
wording more traditional in the European and Nordic countries, namely the Danish Official DG.  251 
Furthermore, the participants resided in areas of Greater Copenhagen with a relatively higher 252 
socioeconomic status and level of education compared to the general Danish population 
23
. 253 
A strength of this study is the real-life setting where participants were free-living and empowered to 254 
modify their dietary pattern.  255 
In conclusion, neither the Substitution DG targeting prevention of IHD nor the Danish Official DG 256 
showed any overall effects on IHD risk factors, when compared with the habitual diet, in an adult 257 
Danish population with a minimum of one self-reported risk factor for IHD in a free-living dietary 258 
advice RCT.   259 
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Table 1: The Substitution dietary guidelines and the Danish Official dietary guidelines  
Substitution dietary guidelines Official dietary guidelines 
 
Eat a variety of foods, but not too much, and be physically active 
Eat fruit instead of candy and cake 
 Eat coarse vegetables instead of fine vegetables† Eat fruits and many vegetables 
Eat fish instead of red meet Eat more fish 
Eat wholegrain products instead of products with no wholegrain grains Choose whole grains 
 
Choose lean meats and cold meats 
 
Choose low-fat dairy products 
Eat unsaturated fat instead of saturated fat Eat less saturated fat 
 
Eat foods with less salt 
 
Eat less sugar  
  Drink water 
† Vegetables are classified from type of food groups (e.g. all types of cabbage, rooted vegetables and onions are classified as coarse 
vegetables and all vegetables with a high water content like tomatoes and salad are classified as fine vegetables) 
 
Table 2 Baseline characteristics of the study participants by randomised intervention group (n=219) 
Participants characteristics HAB (n=73) SUB (n=74) OFF (n=72) 
  Median (p25-p75) Median (p25-p75) Median (p25-p75) 
Age (years) 51 (42, 55) 51 (42, 57) 53 (45, 58) 
Women, % (n) 59  (43) 58  (43) 60  (43) 
Weight (kg) 85.2 (71.8, 90.8) 82.2 (74.2, 88.8) 80.7 (70.5, 91.8) 
BMI† 26.0 (24.0 , 29.3) 27.0 (25.6 , 29.2) 26.8 (24.6, 29.4) 
Weight status†: 
         Normal weight, % (n) 33 (24) 22 (16) 28 (20) 
   Overweight, % (n) 51 (37) 56 (42) 51 (37) 
   Obese, % (n) 16 (12) 22 (16) 21 (15) 
Waist circumference (cm)  92.3 (85.7, 99.4) 92.3 (86.8, 98.2) 94.1 (83.1, 99.2) 
Hip circumference (cm) 106.9 (103.7, 112.4) 107.2 (104.5, 114.5) 107.1 (102.8, 112.7) 
Waist/hip-ratio 0.85 (0.80, 0.92) 0.85 (0.81, 0.90) 0.84 (0.79, 0.91) 
Body fat (%) 33.4 (25.0, 37.7) 34.6 (24.5, 37.9) 31.5 (25.7, 38.9) 
Trunk fat (%) 31.9 (26.5, 36.4) 33.7 (25.6, 36.2) 31.4 (27.4, 37.6) 
Systolic blood pressure (mm Hg) ‡ 128 (118, 138) 132 (120, 142) 128 (117, 137) 
Diastolic blood pressure (mm Hg) ‡ 79.8 (74.8, 87.0) 80.7 (75.6, 89.8) 80.0 (74.6, 86.6) 
   hsCRP (mg/L) 1.6 (0.5, 3.6) 1.4 (0.6, 3.2) 1.4 (0.5, 2.7) 
Lipid biomarkers ¨ 
         Total cholesterol 5.2 (4.7, 5.9) 5.4 (4.8, 6.3) 5.2 (4.6, 5.9) 
   LDL-HDL ratio 2.7 (1.7, 3.1) 2.5 (1.8, 3.0) 2.1 (1.6, 2.6) 
   LDL cholesterol (mmol/L) 3.1 (2.8, 3.8) 3.3 (2.6, 4.2) 3.1 (2.5, 3.7) 
   HDL cholesterol (mmol/L) 1.4 (1.1, 1.7) 1.5 (1.1, 1.7) 1.5 (1.2, 1.8) 
   VLDL cholesterol (mmol/L) 0.4 (0.3, 0.7) 0.5 (0.4, 0.7) 0.5 (0.3, 0.6) 
   TAG (mmol/L) 1.0 (0.7, 1.6) 1.1 (0.8, 1.6) 1.0 (0.8, 1.3) 
Glycaemic biomarkers ^ 
         Glucose (mmol/L) 5.5 (5.2, 5.8) 5.5 (5.2, 5.7) 5.4 (5.2, 5.8) 
   HbA1c (%) 5.0 (4.8, 5.1) 5.0 (4.9, 5.2) 5.0 (4.8, 5.2) 
   HOMA-IR 2.1 (1.6, 3.0) 1.9 (1.4, 3.0) 2.0 (1.3, 2.9) 
   Insulin (pmol/L) 60.5 (46.3, 81.8) 57.5 (41.3, 81.5) 57.0 (37.0, 80.5) 
Educational level 
         Primary school or high school, % (n) 22 (16) 26 (19) 29 (21) 
   Associate degree, % (n) 11 (8) 8 (6) 6 (4) 
   Undergraduate school, % (n) 37 (27) 42 (31) 40 (29) 
   Graduate school, % (n) 30 (22) 24 (18) 25 (18) 
Abbreviations: HAB, habitual diet; SUB, Substitution dietary guidelines; OFF, Official dietary guidelines; BMI, Body Mass Index; 
hsCRP, high-sensitivity C-reactive protein; LDL, low density lipoprotein-cholesterol; HDL, high density lipoprotein-cholesterol; VLDL, 
very low density lipoprotein-cholesterol;  TAG, triglycerides; estimated average glucose, eAG ; HbA1c , haemoglobin A1c;  HOMA-IR, 
homeostatic model of insulin resistance          
†BMI is calculated as weight in kilograms divided by the square of height in meters (kg/m2). 18.5-25 = Normal weight, 25-30 = 
Overweight, >30 = Obese. 
‡ all; n = 216, Substitution DG; n=72, Official DG; n=72, Habitual diet; n=72, after exclusion of those using blood pressure lowing 
medication 
¨ n=214 at baseline after exclusion of those using cholesterol lowering medication 
  ^ n=218 at baseline as it was not possible to draw enough blood for the glycaemic biomarkers analysis  
 
Table 3 Between group differences in cardiometabolic risk factors from baseline to the end of the intervention (6 month). 
  Model 1† Model 2‡ 
 
SUB vs. HAB  OFF vs. HAB SUB vs. HAB  OFF vs. HAB 
 
Mean between group 
difference, 95%CI 
Mean between group 
difference, 95%CI 
Mean between group 
difference, 95%CI 
Mean between group 
difference, 95%CI 
Weight (kg) -0.41 (-1.40, 0.59) -0.70 (-1.69, 0.29) -0.40 (-1.40, 0.60) -0.67 (-1.67, 0.32) 
BMI¨ 3.88 (-4.25, 12.02) 2.46 (-5.66, 10.59) -0.13 (-0.47, 0.20) -0.24 (-0.58, 0.09) 
Waist circumference (cm)  -0.17 (-1.53, 1.19) 0.28 (-1.07, 1.64) -0.29 (-1.62, 1.05) 0.11 (-1.22, 1.45) 
   Normal weight 
    
-0.27 (-2.75, 2.20) -1.07 (-3.44, 1.30) 
   Overweight 
    
-1.14 (-2.93, 0.64) 1.13 (-0.67, 2.93) 
   Obese 
    
2.45 (-0.67, 5.57) -0.98 (-4.19, 2.24) 
Hip circumference (cm) -0.45 (-1.52, 0.62) -0.04 (-1.10, 1.03) -0.61 (-1.64, 0.41) -0.09 (-1.11, 0.93) 
Waist/hip-ratio 0.004 (-0.008, 0.02) 0.002 (-0.01, 0.01) 0.003 (-0.009, 0.02) -0.00009 (-0.01, 0.01) 
Body fat (%) 0.20 (-0.44, 0.84) -0.04 (-0.68, 0.60) 0.08 (-0.54, 0.70) -0.10 (-0.72, 0.5) 
Trunk fat (%) 0.23 (-0.54, 0.99) -0.08 (-0.85, 0.68) 0.12 (-0.62, 0.87) -0.12 (-0.86, 0.62) 
Systolic blood pressure (mm Hg) ^ 1.39 (-1.80, 4.59) -1.00 (-4.16, 2.16) 1.25 (-1.95, 4.45) -1.28 (-4.46, 1.89) 
Diastolic blood pressure (mm Hg) ^ 1.57 (-0.13, 3.28) -0.45 (-2.14, 1.24) 1.37 (-0.32, 3.05) -0.73 (-2.40, 0.93) 
hsCRP (mg/L) § 0.23 (-0.18, 0.65) -0.03 (-0.44, 0.39) 0.18 (-0.23, 0.58) -0.04 (-0.44, 0.36) 
Lipid biomarkers ǁ 
           Total cholesterol -0.11 (-0.30, 0.07) -0.06 (-0.24, 0.11) -0.12 (-0.29, 0.06) -0.08 (-0.26 0.10) 
   LDL-HDL ratio 0.009 (-0.14, 0.16) 0.03 (-0.12, 0.18) 0.007 (-0.14, 0.16) 0.04 (-0.11, 0.19) 
   LDL cholesterol (mmol/L) -0.07 (-0.23, 0.08) -0.02 (-0.18, 0.13) -0.08 (-0.23, 0.08) -0.03 (-0.19, 0.12) 
   HDL cholesterol (mmol/L) -0.001 (-0.06, 0.06) -0.01 (-0.06, 0.05) -0.001 (-0.06, 0.06) -0.01 (-0.07, 0.05) 
   VLDL cholesterol (mmol/L) -0.04 (-0.12, 0.05) -0.02 (-0.10, 0.06) -0.04 (-0.12, 0.04) -0.02 (-0.10, 0.07) 
   TAG (mmol/L) -0.07 (-0.26, 0.11) -0.04 (-0.22, 0.15) -0.09 (-0.28, 0.10) -0.03 (-0.22, 0.15) 
Glycaemic biomarkers¶ 
           Glucose (mmol/L) 0.08 (-0.04, 0.19) 0.04 (-0.08, 0.16) 0.06 (-0.05, 0.18) 0.03 (-0.08, 0.15) 
   HbA1c (%) 0.01 (-0.07, 0.08) 0.01 (-0.06, 0.09) -0.001 (-0.08, 0.07) 0.01 (-0.07, 0.08) 
   HOMA-IR -0.05 (-0.43, 0.33) -0.02 (-0.40, 0.35) -0.06 (-0.44, 0.32) -0.04 (-0.42, 0.34) 
   Insulin (pmol/L) -2.23 (-11.99, 7.54) -1.67 (-11.34, 8.01) -2.56 (-12.37, 7.25) -2.29 (-12.00, 7.42) 
Abbreviations: HAB, Habitual diet; SUB, Substitution dietary guidelines;  OFF, Official dietary guidelines; BMI, Body Mass Index; BP, blood 
pressure; hsCRP, high-sensitivity C-reactive protein; LDL, low density lipoprotein-cholesterol; HDL, high density lipoprotein-cholesterol; 
VLDL, very low density lipoprotein-cholesterol;  TAG, triglycerides; HbA1c , haemoglobin A1c;  HOMA-IR, homeostatic model of insulin 
resistance          
† simple linear regression models adjusted for baseline intake of the outcome variable 
    ‡ multiple linear regression models adjusted for baseline intake of the outcome variable, sex, age group (<50 and ≥50), BMI group (18.5-25 = 
Normal weight, >25-30 = Overweight, >30 = Obese) and interactions between intervention group and sex, intervention group and age group, 
and intervention group and BMI group 
¨ BMI is calculated as weight in kilograms divided by the square of height in meters (kg/m
2
).  
   ^ n=216 at baseline, and n= 201 at 6 month after exclusion of those using BP-lowering medication 
  § n= 204 at baseline, and n=196 at 6 month due to lack in biochemical analysis of hsCRP 
   ǁ n=214 at baseline, and n=196 at 6 month after exclusion of those using cholesterol lowering medication 
  ¶ n=218 at baseline, and 201 at 6 month as it was not possible to draw enough blood for the glycaemic biomarkers analysis  
 
Table 4 Between group differences in cardiometabolic risk factors from baseline to follow-up (12 month). 
  Model 1† Model 2‡ 
 
SUB vs. HAB  OFF vs. HAB SUB vs. HAB  OFF vs. HAB 
 
Mean between group 
difference, 95%CI 
Mean between group 
difference, 95%CI 
Mean between group 
difference, 95%CI 
Mean between group 
difference, 95%CI 
Weight (kg) -0.23 (-1.43, 0.97) -0.52 (-1.71, 0.67) -0.19 (-1.40, 1.03) -0.47 (-1.68, 0.73) 
BMI¨ -0.07 (-0.47, 0.33) -0.19 (-0.59, 0.22) -0.06 (-0.47, 0.35) -0.17 (-0.58, 0.23) 
Waist circumference (cm)  -0.92 (-2.33, 0.50) -0.05 (-1.46, 1.36) -0.92 (-2.33, 0.48) -0.08 (-1.49, 1.32) 
   Normal weight 
    
-0.94 (-3.55,1.67) -0.43 (-2.88, 2.02) 
   Overweight 
    
-1.31 (-3.15, 0.53) 1.27 (-0.58,3.13) 
   Obese 
    
0.28 (-3.06, 3.63) -4.41 (-7.93,-0.88) 
Hip circumference (cm) 0.04 (-1.14, 1.21) -0.23 (-1.40, 0.94) -0.07 (-1.24, 1.11) -0.27 (-1.43, 0.90) 
   Normal weight 
    
0.06 (-2.15, 2.27) -1.20 (-3.27, 0.86) 
   Overweight 
    
-0.8 (-2.34, 0.76) 0.46 (-1.10, 2.03) 
   Obese 
    
2.27 (-0.56, 5.11) -1.05 (-3.99, 1.90) 
Waist/hip-ratio -0.008 (-0.02, 0.004) 0.001 (-0.01, 0.01) -0.007 (-0.02, 0.005) 0.0008 (-0.01, 0.01) 
Body fat (%) 0.61 (-0.18, 1.40) -0.05 (-0.83 0.74) 0.59 (-0.20, 1.38) -0.04 (-0.82, 0.74) 
Trunk fat (%) 0.75 (-0.16, 1.66) -0.05 (-0.95, 0.85) 0.75 (-0.16, 1.67) -0.03 (-0.93, 0.88) 
Systolic blood pressure (mm Hg) ^ -0.02 (-3.39, 3.35) -2.53 (-5.89, 0.83) -0.42 (-3.69 2.86) -2.99 (-6.26, 0.28) 
Diastolic blood pressure (mm Hg) ^ 0.47 (-1.43, 2.37) -1.00 (-2.90, 0.90) 0.24 (-1.63, 2.12) -1.22 (-3.09, 0.65) 
hsCRP (mg/L) § 0.11 (-0.41, 0.63) -0.03 (-0.55, 0.50) 0.07 (-0.4, 0.60) -0.03 (-0.56, 0.50) 
Lipid biomarkersǁ 
           Total cholesterol 0.07 (-0.18, 0.31) -0.14 (-0.38, 0.11) 0.07 (-0.17, 0.32) -0.14 (-0.38, 0.10) 
   LDL-HDL ratio 0.05 (-0.14, 0.24) -0.07 (-0.26, 0.12) 0.06 (-0.13, 0.26) -0.06 (-0.25, 0.14) 
   LDL cholesterol (mmol/L) 0.10 (-0.11, 0.32) -0.10 (-0.32, 0.11) 0.12 (-0.10, 0.33) -0.10 (-0.31, 0.11) 
   HDL cholesterol (mmol/L) 0.03 (-0.04, 0.11) -0.002 (-0.07, 0.07) 0.03 (-0.04, 0.10) -0.01 (-0.08, 0.07) 
   VLDL cholesterol (mmol/L) -0.05 (-0.15, 0.05) -0.01 (-0.11, 0.09) -0.06 (-0.16, 0.04) -0.01 (-0.11, 0.08) 
   TAG (mmol/L) -0.13 (-0.35, 0.09) -0.03 (-0.25, 0.19) -0.15 (-0.37, 0.07) -0.04 (-0.25, 0.18) 
Glycaemic biomarkers¶ 
           Glucose (mmol/L) -0.005 (-0.13, 0.12) 0.05 (-0.07, 0.17) -0.01 (-0.13, 0.10) 0.04 (-0.07, 0.16) 
   HbA1c (%) 0.005 (-0.07, 0.08) 0.06 (-0.01, 0.13) 0.003 (-0.07, 0.08) 0.06 (-0.01,0.13) 
   HOMA-IR -0.07 (-0.48, 0.34) 0.12 (-0.28, 0.52) -0.08 (-0.48, 0.32) 0.11 (-0.29, 0.51) 
   Insulin (pmol/L) -1.86 (-11.56, 7.84) 4.02 (-5.65, 13.69) -2.09 (-11.66, 7.48) 3.58 (-5.95, 13.10) 
Abbreviations: HAB, Habitual diet; SUB, Substitution dietary guidelines;  OFF, Official dietary guidelines; BMI, Body Mass Index; BP, blood 
pressure; hsCRP, high-sensitivity C-reactive protein; LDL, low density lipoprotein-cholesterol; HDL, high density lipoprotein-cholesterol; 
VLDL, very low density lipoprotein-cholesterol;  TAG, triglycerides; HbA1c , haemoglobin A1c;  HOMA-IR, homeostatic model of insulin 
resistance          
† simple linear regression models adjusted for baseline intake of the outcome variable 
   ‡ multiple linear regression models adjusted for baseline intake of the outcome variable, sex, age group (<50 and ≥50), BMI group (18.5-25 = 
Normal weight, >25-30 = Overweight, >30 = Obese) and interactions between intervention group and sex, intervention group and age group, 
and intervention group and BMI group 
¨ BMI is calculated as weight in kilograms divided by the square of height in meters (kg/m
2
).  
  ^ n=216 at baseline, and n= 190 at 12 month after exclusion of those using BP-lowering medication 
  § n= 204 at baseline, and n= 185 at 12 month due to lack in biochemical analysis of hsCRP 
  ǁ n=214 at baseline, and n=193 at 12 month after exclusion of those using cholesterol lowering medication 
 ¶ n=218 at baseline, and n=195 at 12 month as it was not possible to draw enough blood for the glycaemic biomarkers analysis  
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Table 1:  Overall Diet Quality Index (DQI) score, energy (MJ/d), diet composition (g/10 MJ/d), and energy 
contribution (E%) of macronutrients and dietary fibre (g/MJ) of the study population at baseline divided in 
tertiles of DQI score; medians (p10-p90), n=219. 
Abbreviations: T, tertile; g, gram; MJ, mega joule; E%, energy percentage; SFA, Saturated fatty acids; MUFA, 
monounsaturated fatty acids; PUFA, polyunsaturated fatty acids 
† n=201 after exclusion of those who did not eat fish 
‡ n=180 after exclusion of those who did not eat poultry 
¨ Vegetables are classified from type of food groups (e.g. all types of cabbage, rooted vegetables and onions are 
classified as coarse vegetables and all vegetables with a high water content like tomatoes and salad are classified as fine 
vegetables). 
§ n=194, after exclusion of those who did not drink alcohol. 
 
 T1 T2 T3 
DQI  3.2  (2.2-3.8) 4.5 (4.0-4.9) 5.8 (5.1-7.8) 
Energy MJ/d 10 (7-13) 8 (6-12) 8 (5-12) 
Diet composition (g/10 MJ/d)       
Bread and cereals 205 (130-281) 226 (170-307) 230 (136-338) 
     Whole grains 47 (24-72) 66 (40-98) 80 (40-142) 
Meat and meat products 148 (70-261) 142 (67-266) 125 (50-232) 
Fish and fish products † 24 (7-60) 47 (17-76) 92 (33-140) 
Poultry and poultry products ‡ 36 (7-123) 40 (2-105) 46 (14-102) 
Fruit and vegetables 285 (138-543) 418 (209-611) 505 (237-849) 
Fruit and food products 87 (30-202) 163 (59-323) 204 (53-435) 
Vegetables and vegetables products 180 (85-335) 216 (113-382) 270 (134-468) 
     Vegetables, coarse¨ 74 (24-178) 98 (27-183) 125 (51-259) 
     Vegetables, fine¨ 99 (45-174) 112 (52-221) 127 (58-305) 
Potatoes and potatoes products 65 (13-141) 48 (2-132) 50 (3-139) 
Milk and milk products  233 (68-440) 257 (67-537) 225 (74-540) 
Cheese and cheese products 40 (9-100) 46 (16-121) 49 (10-178) 
Edible fats 33 (20-50) 32 (16-49) 26 (17-40) 
Sugar and candy 52 (21-111) 36 (12-65) 25 (5-57) 
Energy distribution       
Protein, E% 16 (14-19) 17 (14-22) 19 (15-23) 
Fat, E% 36 (30-42) 36 (28-43) 34 (27-39) 
SFA, E% 14 (12-17) 13 (11-16) 12 (9-14) 
MUFA, E% 13 (11-17) 14 (11-17) 14 (10-16) 
PUFA, E% 5 (4-6) 5 (4-7) 5 (4-7) 
Carbohydrate, E% 45 (36-53) 45 (34-52) 43 (33-54) 
Added sugar, E% 10 (5-18) 6 (3-11) 4 (2-9) 
Dietary fibre, g/MJ 2 (2-3) 3 (2-3) 3 (2-4) 
Alcohol, E% § 5 (1-12) 5 (1-13) 6 (2-15) 
Table 2 Within group differences in dietary data from baseline to 6 or 12 months; means and 95% CI,  n=219 at baseline, n= 199 at 6 month and n= 186 at 12 
months. 
 Changes from baseline to 6 months Changes from baseline to 12 months 
Habitual diet  Substitution DG Official DG Habitual diet Substitution DG Official DG 
 Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† 
Diet composition 
(g/10MJ/d): 
            
Bread and cereals 13 (-3, 28) 0.101 19 (2, 37) 0.029 7 ( -8, 21) 0.365 2 ( -14, 18) 0.813 12 (-4, 28) 0.143 4 (-14, 21) 0.688 
   Whole grains -0.5 (-7, 6) 0.868 20 (9,30) 0.001 7 (1, 13) 0.024 -4 (-13, 4) 0.298 15 (6, 24 ) 0.001 10 (3,17) 0.009 
Meat  -4 (-25,17) 0.697 -23 (-43, -3) 0.024 -17 (-38, 5) 0.122 7 ( -16, 29) 0.546 -20 ( -42, 2) 0.070 -16 (-37,5) 0.124 
Fish  -0.3 (-13, 12) 0.956 13 (0.1, 26) 0.048 21 (5,38) 0.013 -8 (-21, 6) 0.248 17 (-1, 36) 0.068 24 (9, 38) 0.002 
Poultry 2 (-11, 14) 0.783 3 (-17, 24) 0.739 4 (-9, 17) 0.504 -3 (-17, 11) 0.677 -12 (-33, 8) 0.237 8 (-9, 25) 0.350 
Fruit  -12 (-30, 6) 0.197 18 (-16, 53) 0.294 20 (-13,54) 0.233 -1 (-29,27) 0.939 1 (-30, 32) 0.954 10 (-20, 40) 0.525 
Vegetables  -16 (-48, 16 0.324 30 (-5, 64) 0.090 6 (-23, 36) 0.671 14 (-16, 44) 0.346 -3 (-56, 50) 0.904 9 (-22, 40) 0.557 
Vegetables, coarse‡ -5 (-24, 14) 0.621 3 (-21, 28) 0.782 -6 (-25, 14) 0.547 8 (-12, 27) 0.421 -8 (-43,28) 0.674 3 (-18, 25) 0.755 
Vegetables, fine‡ -2 (-25, 21 ) 0.870 27 (3, 50) 0.028 13 (-8, 34) 0.228 16 (-11,43) 0.244 7 (-18, 32 ) 0.580 6 (-11, 24) 0.465 
Potatoes  3 (-14, 20) 0.694 -2 (-17,13 ) 0.813 7 (-16, 30) 0.537 4 ( -12, 20) 0.635 -3 ( -20, 15) 0.766 14 (-8, 37) 0.204 
Milk  -7 (-62,47) 0.791 12 (-17, 41) 0.410 24 (-24, 71.0) 0.321 -28 (-75, 19) 0.240 17 (-8, 42) 0.172 -36 ( -79, 7) 0.101 
Cheese 15.4 (-0.1, 31) 0.052 0.1 (-11, 11) 0.993 -1.9 (-18, 15) 0.821 21 ( 1, 41) 0.038 0.7 (-12, 13) 0.913 18 (-3, 38) 0.090 
Sucker and candy -6.0 (-13, 1) 0.081 -4 (-11, 4) 0.334 -2.8 (-9, 3) 0.368 -6 (-13, 1) 0.085 2.0 ( -5, 9) 0.574 -2 ( -9, 5) 0.530 
Dietary fibre, g/MJ/d 0.02 (-0.1, 0.2) 0.832 0.3 (0.2, 0.5) 2.4 e
-05
 0.1 (-0.01, 0.2) 0.079 0.02 (-0.1, 0.1) 0.785 0.1 (-0.02, 0.3) 0.080 0.1 (-0.001, 0.3) 0.051 
Energy MJ and 
E% of macronutrients  
            
Energy, MJ -0.7 (-1.2, -0.2 ) 0.001 -0.8 (-1.3,-0.3) 0.002 -0.51 (-1.0, 0.01) 0.053 -0.9 (-1.4, -0.4) 0.001 -0.7 (-1.3, -0.2) 0.005 -0.5 (-1.0, 0.1) 0.090 
Protein, E% 0.4 (-0.4, 1.1) 0.334 0.1 (-0.6, 0.8) 0.788 0.4 ( -0.4, 1.1) 0.334 0.3 (-0.4, 1.1) 0.343 -0.01(-0.9, 0.9) 0.980 0.8 (0.04, 1.6) 0.040 
Carbohydrate, E% -0.02 (-1.5, 1.5) 0.982 2.0 (0.5, 3.6) 0.012 1.6 (-0.02, 3.2) 0.053 -0.5 (-1.9, 1.0) 0.500 0.9 (-0.7, 2.6) 0.264 0.1 (-1.5, 1.8) 0.872 
Added sugar, E% -0.7 (-1.7, 0.2) 0.113 -0.9 (-1.8,-0.1) 0.042 -0.9 (-1.8, -0.03) 0.042 -1.0 (-1.9. -0.03) 0.043 -0.2 (-1.1, 0.7) 0.647 -1.3 (-2.4, -0.2) 0.025 
Total fat, E% 0.03 (-1.2, 1.3) 0.962 -1.8(-3.2, -0.4) 0.011 -1.0 (-2.3, 0.4) 0.169 0.08 (-1.2, 1.4) 0.902 -0.3 (-1.8, 1.2) 0.696 -0.6 (-1.9, 0.8) 0.384 
SFA, E% 0.4 (-0.2, 1.1) 0.190 -1.4 (-2.1,-0.8) 3.5 e
-05
 -0.6 (-1.3, 0.1) 0.088 0.3 (-0.4, 1.0) 0.356 -0.7 (-1.4, -0.03) 0.041 -0.8 (-1.4, -0.1) 0.030 
MUFA, E% -0.2 (-0.9, 0.8) 0.549 -0.6 (-1.4, 0.2) 0.134 -0.2(-0.9, 0.5) 0.595 -0.2 ( -1.0, 0.7 ) 0.695 0.1 (-0.7, 0.9) 0.804 0.09 (-0.6, 0.8) 0.793 
PUFA, E% -0.02 (-0.3, 0.3) 0.878 0.3 (-0.1, 0.7) 0.184 0.05 (-0.3, 0.4) 0.745 -0.01 (-0.4, 0.3) 0.964 0.1 (-0.3, 0.5) 0.602 0.3 (-0.02, 0.7) 0.068 
Alcohol, E% -0.6 (-1.9, 0.7) 0.341 -0.1 (-1.0, 0.9) 0.897 -1.0 (-2.1, 0.1) 0.087 0.4 (-0.6, 1.4) 0.400 -0.8 (-1.7, 0.1) 0.092 -0.3 (-1.5, 0.9) 0.605 
Abbreviations: Substitution DG, targeted substitution dietary guidelines; Official DG, Danish official dietary guidelines, MJ, mega joule; E %, energy percentage; 
SFA, Saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids 
† pared t-test 
‡ Vegetables are classified from type of food groups (e.g. all types of cabbage, rooted vegetables and onions are classified as coarse vegetables and all vegetables with 
a high water content like tomatoes and salad are classified as fine vegetables). 
 
Table 3 Within group differences in IHD risk factors from baseline to 6 or 12 months; means and 95% CI,  n=219 at baseline, n= 203 at 6 month and n= 196 
at 12 months. 
Abbreviations: IHD, ischaemic heart disease; Substitution DG, targeted substitution dietary guidelines; Official DG, Danish official dietary guidelines, WC, Waist 
circumference; HC,  Hip circumference; BP,  blood pressure; hsCRP, high-sensitivity C-reaktive protein;  LDL-c, low-density lipoprotein cholesterol; HDL-c, high-
density lipoprotein cholesterol; VLDL-c, very low-density lipoprotein cholesterol;  TAG, triglyceride; HbA1c, haemoglobin A1c; HOMA-IR, homeostatic model 
assessment insulin resistance 
† pared t-test 
‡ n=216 at baseline, n= 201 at 6 month and n= 190 at 12 month after exclusion of those using BP-lowering medication 
¨ n= 204 at baseline, n=196 at 6 month and n= 185 at 12 month due to lack in biochemical analysis of hsCRP 
^ n=214 at baseline, n=196 at 6 month and n=193 at 12 month after exclusion of those using cholesterol lowering medication 
§ n=218 at baseline, 201 at 6 month and n=195 at 12 month as it was not possible to draw enough blood for the glycaemic biomarkers analysis 
 
 Mean changes (95% CI) from baseline at six months Mean changes (95% CI) from baseline at 12 months 
habitual diet  substitution DG official DG habitual diet substitution DG official DG 
 Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† Mean (95% CI) Pr>|t|† 
Weight (kg) -0.2 (-0.8, 0.5) 0.601 -0.6 (-1.2, 0.1) 0.071 -0.9 (-1.7, -0.04) 0.040 0.1 (-0.8, 0.9) 0.839 -0.2 (-1.2, 0.8) 0.644 0.3 (-0.4, 1.0) 0.385 
BMI† -0.1 (-0.3, 0.2) 0.581 -0.2 (-0.4, 0.03) 0.089 -0.3 (-0.6, -0.01) 0.044 0.1 (-0.1, 0.3) 0.4082 0.03 ( -0.2, 0.3) 0.816 -0.1 (-0.4, 0.3) 0.611 
WC (cm)  0.5 (-0.5, 1.4) 0.311 0.3 (-0.7, 1.2) 0.541 0.8 (-0.2, 1.8) 0.127 -1.7 (-2.5, -0.9) 8.5e
-05
 -2.6 (-3.6, -1.6) 9.3e
-07
 -1.7 (-2.9, -0.4) 0.009 
HC (cm) -1.5 (-2.2, -0.8) 0.0001 -1.9 (-2.8, -1.1) 1.3e
-05
 -1.5 (-2.3, -0.8) 0.0001 -1.3 (-2., -0.6) 0.001 -1.3 (-2.2, -0.4) 0.005 -1.5 (-2.4, -0.6) 0.001 
WC/HC-ratio 0.02 (0.01, 0.03) 0.001 0.02 (0.01, 0.03) 0.0003 0.02 ( 0.01, 0.03) 6.1e
-05
 -0.01 (-0.01,0.003) 0.188 -0.01 (-0.02, -0.01) 0.001 -0.01(-0.01,0.01) 0.417 
Body fat (%) -0.41(-0.9, 0.04) 0.075 -0.2 (-0.6, 0.2) 0.289 -0.5 (-1.0,0.1) 0.085 -0.03 (-0.6, 0.5) 0.908 0.6 (0.1, 1.1) 0.025 -0.1 (-0.7, 0.6) 0.817 
Trunk fat (%) -0.4 (-0.9, 0.1) 0.099 -0.2 (-0.7, 0.3) 0.438 -0.5 (-1.2, 0.1) 0.123 -0.1(-0.6, 0.5) 0.780 0.7 (0.1, 1.3) 0.030 -0.1 (-0.9, 0.6) 0.735 
Systolic BP (mm Hg)‡ -2.4 (-4.7, -0.1) 0.043 -1.2 (-3.8, 1.4) 0.366 -3.1 (-5.2, -0.9) 0.006 -2.1 ( -4.8, 0.7) 0.145 -2.2 (-5.1, 0.7) 0.128 -3.8 (-5.9, -1.6) 0.001 
Diastolic BP (mm Hg)‡ -1.4 (-2.6, -0.1) 0.032 0.1 (-1.2, 1.5) 0.832 -1.7 (-3.0, -0.4) 0.010 -1.9(-3.3, -0.5) 0.010 -1.4 (-3.1, 0.2) 0.079 -3.6 (-5.7, -1.4) 4.4e-05 
hsCRP (mg/L)¨ -0.1 (-0.4, 0.2) 0.396 -0.1 (-0.5, 0.3) 0.651 -0.2 ( -0.6, 0.2) 0.301 -0.04 (-0.5, 0.4) 0.843 -0.02 (-0.4, 0.4) 0.936 -0.1 (-0.5, 0.3) 0.692 
Lipid biomarkers^             
Total cholesterol 0.02 (-0.1, 0.2) 0.736 -0.1 (-0.3, 0.04) 0.121 -0.1 (-0.2, 0.03) 0.140 0.1 (-0.1, 0.3) 0.305 0.1 (-0.1, 0.3) 0.142 -0.1 (-0.3, 0.1) 0.331 
LDL-HDL ratio ( )  ( )  ( )  ( )  ( )  ( )  
LDL-c (mmol/L) 0.1 (-0.1, 0.2) 0.307 -0.1 (-0.2, 0.1) 0.376 -0.03 (-0.1, 0.1) 0.631 0.1 (-0.1, 0.3) 0.198 0.2 (0.02, 0.3) 0.030 -0.1 (-0.3, 0.1) 0.415 
HDL-c (mmol/L) -0.1 ( -0.1, -0.03) 0.001 -0.1 ( -0.1, -0.01) 0.020 -0.1 (-0.1, -0.02) 0.004 -0.1 (-0.1, -0.01) 0.015 -0.03 (-0.1, 0.02) 0.258 -0.1 (-0.1, 0.01) 0.095 
VLDL-c (mmol/L) 0.04 (-0.003, 0.1) 0.070 -0.005 (-0.1, 0.1) 0.907 0.01 ( -0.1, 0.1) 0.807 0.05 (-0.01, 0.1) 0.118 0.0001 (-0.1, 0.09) 0.955 0.02 (-0.1, 0.1) 0.515 
TAG (mmol/L) 0.1 (-0.01, 0.2) 0.096 -0.02 ( -0.2, 0.2) 0.858 0.02 (-0.1, 0.2) 0.772 0.1 (-0.02, 0.2) 0.095 -0.02 (-0.2, 0.2) 0.845 0.06 (-0.1, 0.2) 0.470 
Glycaemic 
biomarkers§ 
            
Glucose (mmol/L) -0.2 (-0.3, -0.1) 0.0001 -0.1 (-0.2, -0.1) 0.002 -0.2 (-0.3, -0.1) 0.001 -0.01(-0.1, 0.1) 0.779 -0.01 (-0.1, 0.1) 0.804 0.04 (-0.04, 0.1 ) 0.304 
HbA1c (%) 0.1 (0.1, 0.2) 1.5e
-06
 0.2 (0.1, 0.2) 4.1e
-06
 0.1 (0.1, 0.2) 3.9e
-05
 0.2 (0.1, 0.2) 2.9e
-09
 0.2 (0.1, 0.2) 6.3e
-09
 0.2 (0.2, 0.3) 1.2e
-10
 
HOMA-IR -0.03 (-0.3, 0.2) 0.800 -0.1 (-0.4, 0.2) 0.385 -0.04 (-0.3, 0.2) 0.740 -0.02 ( -0.3, 0.2) 0.899 -0.2 (-0.5, 0.2) 0.395 0.1( -0.2, 0.4) 0.411 
Insulin (pmol/L) 1.8 (-4.7, 8.3) 0.586 -1.6 (-9.7, 6.5) 0.691 0.6 (-6.2, 7.5) 0.853 -1.1 (-7.3, 5.1) 0.734 -5.6 (-14.9, 3.7) 0.234 3.7 (-3.3, 10.8) 0.293 
